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Abstract: The Prevalence and Patterns of IgE-mediated Food Allergy 
and Sensitisation in South African Children with Atopic Dermatitis 
 
Background: The prevalence of food allergy in South Africa is unknown, but previously thought to be 
low, particularly in black South Africans. We hypothesised that food allergies would be low in Xhosa 
patients, even those at increased risk of food allergy such as children with atopic dermatitis (AD). This 
study aimed to determine the prevalence of, patterns and risk factors for, IgE-mediated food allergy 
in South African children with moderate to severe AD. It is the first food allergy prevalence study in 
South Africa to utilise controlled food challenges and component analysis, and is unique for its 
comparison of food allergy patterns between ethnic groups in the same geographical area.   
Methodology: This was a prospective, observational study in a paediatric university hospital in Cape 
Town. Children with moderate to severe AD, aged 6 months to 10 years, were randomly recruited 
from the dermatology clinic. They were assessed for sensitisation and allergy by questionnaire, skin 
prick tests (SPT), Immuno Solid Phase Allergen Chip (ISAC) test and incremental food challenges. 
Sensitised patients were also tested for specific IgE by ImmunoCAP test. 
Results: One hundred participants (59 black Africans and 41 of mixed race) were enrolled, median age 
42 months. There were high overall rates of food sensitisation (66%) and food allergy (40%).  Egg (25%) 
and peanut (24%) were the most common allergies. Black participants had comparable sensitisation 
(69% vs 61%) but lower allergy rates (34% vs 46%) than mixed race participants. This was especially 
evident for peanut allergy (15% vs 37%, p=0.01). Early onset AD (< 6 months), severe eczema, and 
young age < 2 years were significant risk factors for food allergy. The ISAC test was less sensitive than 
SPT and ImmunoCAP tests. Only 42% of cases of perceived food allergy were confirmed as true food 
allergy. 
Component tests for peanut followed similar trends in both ethnic groups with Ara h 2 being the most 
strongly associated with peanut allergy. However, the likelihood of peanut allergy with a positive       
Ara h 2 was significantly lower in Xhosa than mixed race patients (53% v 93%, p=0.01).  Ara h 8 and 9 
were associated with tolerance to peanut.  The SPT to peanut achieved best Receiver Operating 
Characteristic (ROC) area under the curve indicating the best predictive value for peanut allergy in 
both ethnic groups. Internationally derived 95% positive predictive values (PPV) for SPT, peanut 
specific IgE and ImmunoCAP  Ara h 2 performed well in the mixed race group, but poorly in the Xhosa 














reactive carbohydrate determinants or parasitaemia, or by a difference in peanut consumption 
patterns.  
Egg allergy was common in both ethnic groups, and the best predictive value for egg allergy was 
achieved by SPT to fresh raw egg white. Internationally derived 95% PPV for egg allergy did not 
perform well in our population. Cow’s milk allergy was uncommon in this study. 
The prevalence of co-morbid allergic conditions, including aeroallergen sensitisation, asthma and 
allergic rhinitis, was high.  
Conclusion: The prevalence of food allergy is high in South African children with moderate to severe 
AD, and comparable with food allergy rates in AD patients of similar severity in westernised countries. 
There are ethnic differences, with significantly lower peanut allergy rates in black Africans compared 
to mixed race patients.  
 
Internationally derived 95% PPV for peanut, egg and cow’s milk allergy did not produce good 
predictive values in our study population, particularly in Xhosa patients.  SPT remains an excellent test 
in both ethnic groups for diagnosing peanut allergy, and SPT to raw egg white and fresh milk are the 
superior tests in egg and milk allergy diagnosis. Ara h 2 is the most useful component in differentiating 
between peanut sensitisation and true allergy.  
 
The reasons for ethnic differences in food allergy patterns are unclear, and may reflect environmental 
or genetic differences. A change in protective environmental factors may presage an increase in food 
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AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SPT:          Skin Prick Test 
ISAC:        Immuno Solid Phase Allergen Chip 
sIgE:         Specific IgE 
PPV:         Positive Predictive Value 
ROC:         Receiver Operating Characteristic  
 
There is evidence of a significant increase in the prevalence of food allergy, mostly studied in 
westernised countries, over the past 2-3 decades.1-3 The rise in food allergies has followed a few 
decades after a documented increase in respiratory allergies, the latter having also been observed in 
South Africa.4   Food allergy prevalence studies are methodologically difficult and time consuming.  
Standardised definitions of food allergy and standardised diagnostic work-ups are needed in order to 
be able to compare data between studies and regions.5 
The prevalence of food allergy in South Africa is unknown. A handful of studies have looked at food 
sensitisation profiles and food allergy diagnosed according to self-report, but neither is a good 
representation of clinically relevant food allergy.  The gold standard diagnostic test in equivocal cases 
of food allergy, or when there is a discrepancy between history and screening test results, is the 
controlled incremental food challenge.6 Double blind placebo controlled food challenges are 
considered the gold standard, but require more time, staffing and preparation of foods. Incremental 
open food challenges are usually sufficient to confirm or refute food allergy in young children, who 
have few subjective symptoms.7 Prior to this study, there have been no food allergy prevalence studies 
in South Africa utilising oral food challenges for the diagnosis of food allergy.  
Atopic dermatitis is a significant risk factor for concomitant IgE-mediated food allergy. Children with 
moderate to severe eczema have a 5-8 fold higher prevalence of IgE-mediated food allergy than the 
general population. 8-10  The most common food allergies in children with atopic dermatitis are to hen’s 
egg, cow’s milk, peanut, tree nuts, soya, fish and wheat.  However, the prevalence of sensitisation to 














prevalence of true food allergy, thus there are many cases of “false positives” if sensitisation is taken 
as a measure of food allergy. Therefore, in the assessment of food allergy, a thorough history should 
always be combined with results of laboratory tests, and in equivocal cases an oral food challenge is 
necessary. 
 As food challenges are time and resource consuming, and carry the risk of the patient reacting, an 
attempt has been made at reducing the number of food challenges by the creation of “95%” or “100%” 
positive predictive values (PPVs) for skin prick tests or specific IgE, which differ for each individual 
food. 11,12   If the patient’s result for that test falls above the 95% PPV, the chance of the patient 
reacting to that food during a challenge is deemed to be ≥ 95%.  These internationally derived PPVs 
are used in clinical practice to diagnose patients with values ≥ 95% PPV as allergic without needing to 
perform a food challenge.  However, 95% PPVs are population specific, and may be affected by 
selection criteria of that population, environmental, socio-economic and ethnic factors.  
This study investigated sensitisation and allergy patterns to commonly allergenic foods in 100 children 
with atopic dermatitis, attending a dermatology clinic at a university hospital in Cape Town, South 
Africa (Red Cross Children’s Hospital).  These children were all of South African descent, either Xhosa 
(black African from the Western Cape) or mixed race (of mixed black African and Caucasian descent). 
These 2 ethnic groups make up by far the majority of children attending the Red Cross Children’s 
Hospital hence could be recruited in meaningful numbers. One of the main drivers for undertaking our 
study was the widespread perception that food allergy is uncommon in South African children, 
particularly in children of black South African origin. We chose a population of children with moderate 
to severe atopic dermatitis to evaluate the prevalence of food allergy in a population at high risk for 
food allergy. 
 
The thesis is structured as follows: 
Chapters 2 and 3 review the epidemiology of food allergy and the relationship between atopic 
dermatitis and food allergy. Studies on food allergy prevalence in South Africa are detailed in chapter 
4. In chapter 5, the aims, objectives and methodology of our study are described in detail. Results of 
the study for sensitisation and food allergy patterns, as well as risk factors for food allergy, are 
described in chapter 6, including an analysis of ethnic differences. More detail on patterns for 
individual foods are provided in chapters 7 (peanut), 8 (egg) and 9 (other foods).  Children with atopic 
dermatitis, as well as food allergy, are at increased risk for other atopic conditions: allergic co-
morbidity is described in chapter 10, looking at the interaction between eczema, food allergy, 














patterns, including the timing of introduction of commonly allergenic foods and more detail on peanut 
consumption patterns, to try and ascertain whether this may influence food allergy patterns.  Finally, 
chapter 12 concludes the study findings and looks at some of the possible reasons why food allergy 
may be on the rise in a country such as South Africa.  
 
This study has several unique features which have helped to create a vast database of information: 
Firstly it is unique in its utilisation of controlled food challenges as part of a diagnostic algorithm for 
food allergy, giving accurate results for food allergy prevalence. 
Secondly it is unique in the use of component derived diagnostics for food allergy testing. The study 
utilises the ImmunoCAP ISAC technology, a microchip technology allowing testing to 103 allergenic 
components simultaneously.   At the commencement of the study, this technology was new to South 
Africa.  
Patients who were sensitised by skin prick test or ISAC test also underwent standard ImmunoCAP 
testing for specific IgE’s to whole extracts as well as components. Therefore in this study we are also 
able to compare the performance of 3 diagnostic tests in the prediction of food allergy: skin prick tests, 
ISAC test and ImmunoCAP tests.  This allowed analysis of sensitivities and specificities of a variety of 
tests, as well as analysis of positive predictive values, and Receiver Operating Characteristic (ROC) 
curve production for various diagnostic entities.  
Lastly, the study is unique in that it analyses ethnic differences in food sensitisation and allergy 
patterns within the same defined geographical area. This study compares food sensitisation and 
allergy patterns in Xhosa patients with those of mixed race origin to assess whether there are clinically 
relevant differences.  
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Chapter 2:  
The Epidemiology of Food Allergy 
 
Abbreviations 
AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SPT:          Skin Prick Test 
sIgE:         Specific IgE 
PPV:         Positive Predictive Value 
 
2.1 Introduction 
Food allergy represents a significant public health concern. The prevalence of food allergy varies 
significantly based on geographical region, allergens tested, criteria used for diagnosing food allergy, 
age of the population, setting of the population sample and concomitant atopic conditions.1   
Variations in the definition of food allergy and inconsistencies in study design make studies on food 
allergy prevalence difficult to compare. Self-report significantly over-estimates food allergy 
prevalence by up to 10-fold,2 hence objective measurements are necessary to establish a true food 
allergy diagnosis. Similarly, sensitisation to foods is much higher than clinically relevant allergies, 
hence sensitisation should always be combined with more objective information to prove allergies. 
Recent large population based studies such as the EuroPrevall® study in Europe 2 and HealthNuts® 
study in Australia 3 have utilised food challenge testing and can be considered flagship studies of food 
allergy prevalence.  
2.2 Allergenic foods 
Despite the large number of food that can cause IgE-mediated reactions, most prevalence studies have 
focused on the most common allergenic foods, namely cow’s milk, hen’s egg, peanut, tree nut, wheat, 
soya, fish and shellfish.  Such allergens account for up to 90% of food allergy reactions. Other food 
allergens may be particularly prevalent in certain geographical areas, for example peaches in 

















Table 2.1: Most common allergens by age 
Most common allergens in children Most common allergens in adults 
Cow’s milk Fish 
Hen’s egg Shellfish  
Peanut Peanut 





2.3 Difficulties in Diagnosing Food Allergy 
There are several diagnostic challenges in food allergy prevalence studies. The marked heterogeneity 
in diagnostic methodology and definitions of allergy make studies difficult to compare. A major pitfall 
is that sensitisation does not equate to allergy. Some of the inherent difficulties in diagnostic tests are 
mentioned briefly below: 
 Skin Prick Testing (SPT): SPT is operator dependent and requires the patient to be off 
antihistamines. Ethnic differences in skin thickness and reactivity to histamine  may influence 
outcomes.5 The source of the allergen extracts may also influence results since these may not 
represent local allergens.4,5 A study in the United Kingdom found Black patients to have lower SPT 
reactivity but higher specific IgE (ImmunoCAP) reactivity.6 
 Food-Specific IgE (sIgE):  Helminth infections may strongly amplify the IgE response and can  lead 
to false elevation of specific IgE levels.7  
 Cross reactivity between components of food allergens and environmental allergens are 
increasingly recognised. An example is grass pollen cross-reacting with cereals, soya and peanut 
by specific IgE to similar carbohydrate determinants.8 Interpreting a specific IgE level for food 
without considering cross-reactivity can lead to false positives for true food allergy. This is an 
important consideration since aeroallergen sensitivity has increased significantly in South Africa 
in the last few decades.9,10   Component resolved diagnostics has refined the art of cross-reactivity 
recognition, but high cost and poor availability make it prohibitive in many parts of South Africa.  
 95% positive predictive value cut off levels for skin prick tests and specific IgE are commonly used 
to diagnose food allergy.11,12 However, these cut-offs may be population specific and thus not 














 Questionnaire-based diagnosis is influenced by local culture and language. Self-reporting of 
perceived food allergy reactions significantly overestimates allergies.2  
 Oral Food Challenges: The definitive method of assessing the prevalence of IgE-mediated food 
allergy in young children is by oral food challenges.13,14 The gold standard is considered the double 
blind placebo controlled food challenge. However, open challenges suffice in most cases, 
particularly in young children and when the reaction recapitulates the history of a prior reaction.   
However, food challenges demand resources, both financially and in terms of expertise. Travel 
limitations and parental expense are additional issues, particularly in the African setting. Non-
participation or refusal to undergo food challenge may lead to over- or underestimation of allergy.   
Food challenges have been sorely underused in African countries to date and previous food 
prevalence studies have omitted them entirely.  
 
2.4 Prevalence of Food Allergy 
 
Several meta-analyses and large cohort studies, mostly in the US, UK, Europe and Australia, have 
estimated food allergy prevalence, using different definitions and methodologies. 
A meta-analysis of food allergy of 51 studies investigating food allergy to cow’s milk, hen’s egg, peanut, 
fish and shellfish in children up to 18 years showed self-reported food allergy to vary between 3 and 
35%.2 Challenge proven food allergy in these studies was between 1% and 10.8%  (on average 0.9% to 
milk, 0.3% to egg, 0.3% to fish). A recently published European meta-analysis showed a challenge 
proven food allergy rate of 1% in children. 15   A German study assessing doctor-diagnosed food allergy 
prospectively reported a rate of 4.6% at 1 year, 6.6% at age 2 and 3.9% at ages 3-6. 16   A birth cohort 
study in the UK utilising oral food challenges showed cumulative incidence of 6% at 3 years.17   A Danish 
birth cohort study showed that 3.7% of children had a positive food challenge by 6 years age,18  and a 
similar Danish study on young adults showed a prevalence of 1.7%.19   An Israeli study based on 
sensitisation and strong history reported a food allergy prevalence of 1.2% with a uniquely high 
proportion of sesame allergy. 20  
A study in the United States (US) analysing data from an infant feeding practices study showed 
probable food allergy (food-related symptoms or doctor-diagnosed allergy) in 6% of one year olds. 21 
A subsequent US national health survey estimated 3.9% of children to be affected by food allergy 














(1%).22,23  The recently published HealthNuts® study from Australia showed more than 10% prevalence 
of challenge proven food allergy to common allergens of childhood in 1 year olds (3% to peanut, 8.9% 
to raw egg, 0.8% to sesame).3  
Studies from developing countries show varying prevalence of food allergy. Recent studies from China 
show challenge-proven food allergy rates of 3.8-7.3%,24,25 and a Thai study shows a challenge proven 
food allergy rate of 0.45%.26  Food allergy prevalence from large population-based studies and meta-
analyses are summarised in Table 2.2.  
The prevalence of food allergy in an unselected population in South Africa is unknown and is currently 
being studied in the Western Cape in the South African Food Sensitisation and Food Allergy prevalence 
study (SAFFA study).   
In summary, food allergy peaks in the first 2 years of life, then diminishes towards late childhood as 
tolerance to several foods develops over time. The true incidence of food allergy varies from 1% to 
over 10% depending on the geographical area and age of the patient studied. The prevalence of food 
allergy in South Africa is unknown and currently being studied. 
 
2.5  Allergies to specific foods 
2.5.1 Cow’s Milk 
Cow’s milk allergy peaks in the first year of life and can be either IgE-mediated, non-IgE-mediated or 
a combination of both. Based on several studies, the documented prevalence of cow’s milk allergy is 
between 0.3% and 3.5% of young children (under the age of 5), 27-32 less than 1% in older children, and 
less than 0.5% in adults. 28,33 
Studies have indicated a generally good prognosis for cow’s milk allergy, with 45-56% outgrowing the 
allergy by the age of one, 60-76% by age 2, 85-90% by age 3, and 97% at 15 years.34,35 The prognosis 
in a tertiary referral centre study was, however, more guarded with 5% of children outgrowing the 
allergy by 4 years of age and 21% by 8 years.36 The prognosis of cow’s milk allergy may vary according 
to the mechanism of the allergy. A Finnish study on cow’s milk allergic children showed that those 
with non IgE-mediated allergy have a tolerance of 64% by age 2, 92% at 3 years, and 96% by 4 years; 
versus 31, 53 and 63% of those with immediate reactions respectively.37 Acquisition of tolerance is 
faster in those with: 
-   initial specific IgE < 2 kU/L 
-  delayed vs IgE-mediated reactions 














Table 2.2: Summary of food allergy prevalence from meta-analyses and large population-based studies 
Location 
 (year of publication) 
Study Size Method of food 
allergy diagnosis 
Age of patients Prevalence of food allergy 
Europe (2007) 2 Meta-analysis of 
51 studies; 6 
studies included 
food challenges 
Oral food challenge Children and 
adults 
1-10.8% (average 3%) 






Symptom + IgE 2.7% 
Convincing history or challenge 
+ve 2.6% 
Challenge +ve 1% 
 
Symptom + IgE 2.2% 
Challenge +ve 0.9% 
Germany ( 2010 ) 16 1082 Doctor-diagnosed 
food allergy  
1-6 years 4.6% (1 year) 
6.6% (2 years) 
3.9% (3-6 years) 
UK  (2008) 17 969 Oral food challenge 3 years 6% 
Denmark   (2009) 18 562 Oral food challenge 6 years 3.7% 
Denmark (2009) 19 1272 Oral food challenge Young adults 1.7% 
Israel (2002)20 9070 Food specific serum 
IgE with clinical 
symptoms 
0-2 years 1.2% 
USA (2008) 21 2441 Questionnaire: food 
related symptoms or 
doctor diagnosed 
allergy 
1 year 6% 




2.5% overall, 3.9% in children 
China (2011)24 497 Food challenges 0-12 months 3.8% 
China (2012)25 1604 Food challenges 0-2 years 5.5% - 7.3% 
Thailand (2005)26 656 Questionnaire 
Food challenges 
6 months – 6 years 6.25% by questionnaire 



















2.5.2 Egg allergy 
Egg allergy is more prevalent in children than in adults, and is usually IgE-mediated. The estimated 
prevalence is 0.5-5% in early childhood, 27-29, 32,33,40  dropping significantly to less than 0.5% in older 
children and adults. 28,32,41 
Previous studies have demonstrated a good prognosis for egg allergy, with around 50% of egg allergic 
children outgrowing the condition by the age of 3 years, and 66% by the age of 5.42-43  However, figures 
in tertiary referral centres are more guarded, probably reflecting a more complex patient group. A 
study from the USA in a tertiary referral centre has shown that 11% of children outgrew their egg 
allergies by the age of 4, 26% by the age of 6 years, 53% by 10 years, and 82% by age 16. 44 
 
Factors associated with persistence of egg allergy include: 
- high initial egg specific IgE,  
- multiple food allergies, 
- multiple atopic conditions,  
- ovomucoid sensitivity 
- slow decrease in specific IgE over time. 45 
 
2.5.3 Wheat allergy 
Wheat allergy is self-reported in about 4.5% of the population46 but confirmed in less than 
1%.29,31,32,33,40,41  Wheat allergy can manifest in both IgE-mediated and non-IgE mediated symptoms. 
The natural history of wheat allergy is less well studied, but the majority of patients tend to become 
tolerant by adolescence.47 A study from the United States showed tolerance development in 29% by 
4 years, 56% by 8 years, and 65% by 12 years.48  Poorer outcomes in wheat allergy have been 
associated with: 
- SPT wheal > 5 mm to gliadin 
- Higher wheat serum IgE levels.  
 
2.5.4 Fish and shellfish allergy 
Fish allergy is one of the few allergies that may be more common in adulthood than childhood. A wide 
variety of fish and shellfish species have been implicated depending on availability and consumption 
patterns. A South African study of fish allergic patients showed yellowtail, hake, snoek and abalone to 














only 15-21% of those patients with a perceived fish allergy had proof of allergy by sensitisation or food 
challenge.49,50 
Large US based studies have shown a prevalence of fish allergy in ≤ 0.2% of children and ≤ 0.5% of 
adults,,28,32,40,51,52  and shellfish in ≤ 0.5% of children and ≤ 2.5% of adults. 28,29,31-33,41,51,52   Seafood 
allergy is lifelong in the majority of cases.  
2.5.5 Peanut allergy 
Peanut allergy prevalence varies significantly between geographic regions: In The EuroPrevall study, 
the overall prevalence of peanut allergy was 2.6%,53,54  with wide variation between countries from 
0.06% (Israel)20 to 5.9% (Sweden).55 Prevalence of peanut allergy is about 0.8% of the population in 
the United States. 56 In a South African study of 212 Xhosa high school patients, 1.9% were sensitised 
to peanut but none reported allergic symptoms.57  
Peanut allergy usually starts in early childhood and is outgrown in only a small proportion (20%) of 
patients.58,59  A negative SPT or low level of peanut specific IgE make outgrowing the allergy more 
likely.  
The prevalence of tree nut allergy in the US is approximately 0.5%.53  The prevalence amongst 
European children in the EuroPrevall study varied from 0.2% (France)60 to 1.4% (UK).61 The prevalence 
may be higher in adolescents and adults as allergy to tree nuts can occur for the first time in adult life.  
Allergy to tree nuts are outgrown in only about 10% of children, especially those with low specific IgE 
< 5kU/L. 59, 62 
2.5.6 Allergy to Plant Food 
Allergic symptoms to various fruits and vegetables may be true allergies or cross reactivities (pollen 
fruit syndrome). In a recent review (EuroPrevall study), the prevalence of perceived allergy to any 
fruits varied between 0.4-11.5%, and challenge proven food allergy to fruits was 0.1-4.3%.63 
Table 2.3 summarises the prevalence of allergy to individual food allergens, as well as the long term 


















Table 2.3: Summary of Food Allergy Prevalence to Individual Food Allergens   
Allergen Prevalence in Young Children Prognosis 
Cow’s Milk 0.3-3.5% (< 0.5% in adults) >80% outgrown by 16 years 
Hen’s Egg 0.5-8% (<0.5% in adults) >80% outgrown by 16 years 
Wheat < 1% Majority outgrow- 65% by 12 
years 
Fish < 0.2% (children) and < 0.5% 
(adults) 
Usually allergic for life 
Shellfish < 0.5% (children) and < 2.5% 
(adults) 
Usually allergic for life 
Peanut 0.06-5.9% 20% outgrown 
Tree Nut 0.2-1.4% 10% outgrown 
Plant food 0.1-4.3%  
 
2.6. Food-related anaphylaxis and fatalities 
Food allergy appears to be the most common trigger of anaphylaxis in the community. One third to 
half of anaphylactic episodes can be attributed to foods;64,65  this proportion seems to be higher in 
children, in  which food is responsible for up to 85% of anaphylactic reactions.66 In adults, shellfish and 
nut are the most common triggers of food-induced anaphylaxis,67 and in children, peanut, tree nut, 
milk and egg. 66 
The prevalence of food-induced anaphylaxis is difficult to estimate in view of varying definitions of 
diagnosis of anaphylaxis and diff rent methodologies of acquiring data. However, there is evidence 
that anaphylaxis is increasing64 and, by inference, the prevalence of food-induced anaphylaxis is 
increasing. In the US, comparison of results in a similar geographic region from 1983-1987 and 1993 
to 1997 showed a 71-100% increase in anaphylaxis. 64,65  An Australian study which reviewed national 
databases for information on anaphylaxis from 1997-2005 showed an increase in food-induced 
anaphylaxis admissions of 350% over this period.68 Data from Red Cross Hospital suggests a marked 
increase in cases seen at the allergy referral clinic with a diagnosis of anaphylaxis from 41 in 2008, to 
171 in 2012 (unpublished data). 
There are no studies which directly address the prevalence of food induced fatalities.  By 
extrapolation, an estimate of 150 deaths per year in the USA due to food induced anaphylaxis has 














Studies from the USA, UK and Australia investigating anaphylactic deaths have revealed the following 
risk factors for fatal reactions: 69-71 
- Adolescents and young adults 
- Delayed use of adrenaline 
- Comorbid moderate to severe persistent asthma, and poorly controlled asthma 
 
2.7. Food allergy and co-morbid conditions 
Food allergic patients are significantly more likely than non-allergic patients to have related atopic 
conditions. In patients with food allergy, studies have shown that: 72 
- 35-71% have evidence of atopic dermatitis 
- 33-40% have evidence of allergic rhinitis 
- 34-49% have evidence of asthma 
 
Eczema, especially severe and early onset, is a major risk factor for food allergy. The prevalence of IgE-
mediated food allergy in patients with moderate to severe atopic dermatitis is 30-40% based on 
studies in Europe and US, 73-76 and will be further explored in chapter 2.  Our study aims to explore the 
prevalence of food allergy in South African children with moderate to severe atopic dermatitis.  
  
2.8   Increase in food allergy 
Many studies have suggested a true rise in prevalence of true food allergies over the last 10-20 years77 
but further confirmation of this is required.  This probable increase in food allergy requires urgent 
further investigation as it may be due to modifiable environmental factors. 77,78  
American data shows that, from 2004 to 2006, there was an increase from approximately 2000 to 
10 000 hospital discharges per year of children under 18 years with a diagnosis related to food 
allergy.72 Another American study showed that the number of visits to paediatric emergency 
department for food-induced anaphylaxis increased steeply from 14.9/10 000 visits in 2001 to 38 per 
10 000 visits in 2006. 79  Random telephone surveys regarding peanut and tree nut allergy in the US 
using the same methodology showed an increase in reported peanut allergy from 0.4% to 1.4% 
between 1997 and 2008. 56  UK data reports peanut reactivity in a cohort of 4 year old children born 
between 1994-1996 at 1.5%, compared to reported peanut allergy of 0.5% in a cohort born in 1989.80  














There is no South African data on changes in food allergy prevalence but a general consensus amongst 
allergologists that food allergy consultations are on the increase.  Our study is the first study looking 
at prevalence of challenge-proven food allergy in South African children. The concern is that South 
Africa may be experiencing a current increase in food allergy, and that contributing environmental 
factors need to be identified.  
 
2.9. Risk factors for food allergy 
Below is a summary of risk factors for food allergy from population-based epidemiological studies to 
date.82 The full implication of these risk factors and peri-natal exposure to allergens remains 
controversial and under active research.  
1. Genetics: there is an increased risk in families of food allergy sufferers, certain HLA types and 
specific genes (eg filaggrin gene defects leading to a higher risk of ezema with food allergy).82 
2. Associated atopic disease: Atopic dermatitis is a major risk factor for food allergy, and asthma 
is a risk factor for increased severity of reactions.72,73 
3. Route of exposure: Exposure via the non-oral route during critical exposure periods (inhaled 
or via cutaneous route) may increase the risk of acquiring food allergy. 
4. Timing of ingestion of allergen: recent studies have suggested that first ingestion of food 
allergens during a “window” between 4 and 7 months of age may be protective. 83,84   
5. Diet: reduced consumption of omega 3 fatty acids may be a risk factor, as are dietary 
differences in food preparation, e.g. roasted peanut is more allergenic than boiled peanut.  
6. Vitamin D may be protective. 85 
7. Anti-acid medication may allow increased immune exposure to ingested allergens. 86 
8.  Hygiene hypothesis: implies an advantage of diverse microbial exposure in children (reduced 
risk of food allergy in rural farming areas, families with pets and more siblings; increases risk 
with early antibiotic use and caesarean section). 
9. Geographical location may affect patterns of allergen exposure and thus allergy rates. This 
may be due to a difference in food consumption patterns, e.g. early introduction of peanut in 
Israel may be associated with lower peanut allergy rates. 87 Moreover, urban-rural status may 


















2.10  Ethnicity and food allergy prevalence 
Apart from geographical variation, ethnic differences in food allergy prevalence within a particular 
region may occur.89 Studies in the UK and USA have suggested higher rates of IgE-mediated 
sensitisation in Black subjects,6 but rates of clinical reactivity are less well documented.  In a large, 
cross-sectional survey of households in the USA, Black and Asian children had significantly higher odds 
of reported food allergy than white children. 90 
Recent studies have suggested that non-whites may be at greater risk of food allergy, especially if they 
are living in a westernised environment.  In the recent HealthNuts study, Asian children who were the 
“first generation” in Australia, whose parents were born in East Asia, had a higher prevalence of egg 
as well as peanut allergy than children with two Australian-born parents, even though their parents 
were less atopic.91,92  
 
2.11 Conclusion 
We find ourselves currently in the middle of a “food allergy epidemic”, which may have already peaked 
in some countries, and certainly has made food allergy a major public health concern. Up to 10% of 
young children have at least one food allergy, most commonly to hen’s egg, cow’s milk or peanut. 
Severe and complex food allergies have also increased. Accordingly, a scale-up in allergy services has 
become a health priority in several countries.  Food allergy prevalence is currently being studied in 
South Africa.  
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Chapter 3:  
 




AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SPT:          Skin Prick Test 
sIgE:         Specific IgE 
EPAAC:    Early Prevention of Asthma and Allergy in Children 
 
 
3.1 Introduction  
 
Atopic dermatitis (AD) is form of eczema which usually begins in early infancy, and is characterised by 
a typical distribution, extreme pruritis and a chronic relapsing course.1   The prevalence of both AD 
and food allergies has increased in recent decades, especially in high socio-economic countries, at a 
rate too fast to be explained by genetic drift alone; it seems there may be a common environmental 
factor accounting for such an increase. In several westernised countries the prevalence of eczema is 
10-30%, representing a significant chronic disease burden.  
 
There are many triggers for AD, including specific immunological responses to inhalable respiratory 
allergens, defined food allergens, and inflammatory reactions to microbial agents; as well as non-
specific responses to irritants, heat, humidity and stress. Moreover, skin barrier dysfunction and 
complex interplay of cells and mediators in the skin immune system all contribute to the clinical 
appearance of eczema (figure 3.1). 2,3  
The relationship between food allergies and eczema is complex and multifaceted, with often 
conflicting perspectives amongst clinicians, patients and families. There is increasing evidence, both 
clinical and laboratory, for a role of food hypersensitivity in the pathogenesis of AD in a subset of 
patients. Numerous studies have shown that the prevalence of clinically significant food allergy in 
children with moderate to severe AD is high at 30-40% (see table 3.1), yet not all food allergies lead 
to an exacerbation of eczema. The relationship between food allergy and eczema is important to 














hand unnecessary diets which are not based on proper diagnosis may lead to nutritional compromise 
and psychological distress. 
Figure 3.1: Triggers of Atopic Dermatitis 
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Table 3.1: Studies on Challenge-proven Food Allergies in Atopic Dermatitis 
Study  
(year) 
Location (setting) Number of 
Patients 
Positive SPT or IgE Food Allergy 
Sampson et al 
(1985)10 
USA                      (allergy 
clinic) 
113 (with severe 
atopic dermatitis) 
 56% 
Burks et al   
(1998) 11 
USA (allergy clinic) 165 (mean age 48 
months) 
60% positive SPT 38.7% 




63 (mean age 2.8 
years) 
65% positive IgE 37%  




74 (median age 2.5 
years) 
59% positive IgE 33.8% 




44 (mean age 7.5 
months) 
61% positive SPT 
and/or IgE 
27%  
Kim et al (2013)15 Korea 
(dermatology clinic) 
 95 (mean age 6.85 
years) 
41% positive IgE 8.3% 















As many food allergies are transient conditions that improve with increasing age, the close association 
between food allergy and eczema is of greater significance in the paediatric AD population than in 
adult patients. 4,5 
This article will explore the association between food allergies and eczema in children from 3 
perspectives: 
- The co-existence of  food allergies in patients with eczema  
- The possible  role of food allergies in the pathogenesis of eczema 
- The possible role of eczema in the pathogenesis of food allergies  
Moreover the association between eczema and other atopic conditions will be discussed in brief.   
 
3. 2. Co-existence of food allergies and atopic dermatitis 
 
3.2.1 Prevalence of food sensitisation and allergy in children with AD 
When looking at the interplay between food allergies and eczema, the distinction between food 
sensitivity (a positive skin prick test or specific IgE to foods) and food allergy (a clinically significant 
reaction upon ingestion of the offending food protein) is a particularly important one. Several studies 
in the past 10-20 years have shown that children with AD have a propensity to both sensitisation and 
allergy to common food allergens:   
 
The EPAAC™ study (Early Prevention of Asthma in Atopic Children) studied almost 2200 infants with 
eczema and looked at sensitisation patterns to common food and aeroallergens.6 Globally, food 
sensitisation rates were as follows (South African figures in brackets):  
Any food: 48.6% 
Egg white: 41.9% (SA 47.1%) 
Cow’s milk: 27.4% (SA 28.4%) 
Peanut: 24.4% (SA 26.8%) 
 
The high rate of sensitisation to foods in mirrored in several other studies which generally suggest 
sensitisation to common food allergens in children with AD (mostly attending tertiary referral centres) 
the region of 60% (table 3.1). This is much greater than the overall prevalence of food sensitisation in 
the general population of around 16%.7,8  In the EPAAC study, the number of children who were 
sensitised to the most common food allergens did not increase during the second year of life 














Numerous studies have shown that the prevalence of food allergy (positive responses to food 
challenge or recent history of significant reaction in a sensitised patient) in children with moderate to 
severe AD is 30-40%, as summarised in table 3.1. This is significantly higher than in the general 
population, in which food allergy peaks at 4-8% at one year of age (see chapter 2) and then falls 
progressively until late childhood, after which prevalence remains stable at 1-2%.7 
 
In summary, children with AD are at high risk of food allergies but only about half of those sensitised 
to common foods are clinically allergic.  
 
3.2.2 Types of food allergens 
In children, classical food proteins most commonly cause food allergies in AD patients; and egg, milk, 
peanut, wheat and soy account for 90% of allergenic foods in children with AD.5, 16 Overall, egg allergy 
is the most frequent cause of food induced eczematous symptoms, occurring in about two thirds of 
children with eczema who have food allergy. Children typically outgrow their clinical reactivity to egg, 
milk, wheat and soy despite persistently positive skin prick tests, whereas peanut, treenut, fish and 
shellfish allergy is typically lifelong. 17, 18 
In addition to classical food proteins, AD sufferers may more rarely react to foods which cross react 
with pollen (more commonly with adolescents and adults) or food additives/biogenic amines (usually 
non- IgE mediated food allergy). 1 
 
3.2.3 Patterns of clinical reactivity in food allergy in patients with AD 
Patients with AD reacting to foods generally do so in one of three patterns: 19,20 
1. Non-eczematous reactions (usually immediate): cutaneous (pruritis, rashes, 
urticaria)/gastrointestinal (vomiting, diarrhoea) /respiratory symptoms/anaphylaxis. Such 
non-eczematous reactions make up 50% of cases and usually occur within 2 hours of food 
ingestion. 
2. Isolated eczematous reactions :  these occur in 10% of reactions and are usually delayed > 6 
hours after food ingestion 
3.  Combination of non- and eczematous reactions: occurs in 40% of cases 
The majority (at least 75%) of reactions occur within 2 hours of food ingestion; up to 25% of reactions 
occur after 2 hours (most commonly pruritis/ gastrointestinal symptoms/ eczema). 20-22 
75%- 94% of positive food reactions in AD patients involve cutaneous reactions, and include diffuse 














generally eruptions in sites affected by/predisposed to AD. 23  The pattern of cutaneous reactions may 
vary with disease activity: Sampson noted that children with food allergy who have AD may develop 
urticaria on food challenge when they are in remission but when their disease is active the same 
challenge can elicit morbilliform or eczematous reactions. 24 
In 90% of cases of clinically manifested food allergy the patient will have an IgE-associated response. 
During a positive immediate reaction such children have evidence of IgE response with higher plasma 
concentration of histamine, eosinophil granule products and eosinophil activation markers. 25, 26   
10% of cases of food allergy in AD are non-IgE mediated and not associated with food- specific IgE. 
Food specific T cells may play a predominant role in the pathogenesis of such reactions. 20    Non-IgE 
mediated food allergy is more commonly seen in wheat allergy as compared with cow’s milk and egg, 
and is generally more difficult to diagnose. 27    
The characteristics of early and late cutaneous reactions to foods in AD are summarized in table 3.2 
below: 
 Table 3.2: Early vs Late Cutaneous Reactions to Food in Atopic Dermatitis 21,22,27,28 




Frequently morbilliform rashes, pruritis 
or urticaria, often at sites of predilection 
for AD 
Frequently eczematous 
Positive SPT/specific IgE 
 
Frequently Not necessarily 
Typically associated 
foods 
Often hen’s egg, cow’s milk, peanut Frequently wheat, less often soy and cow’s 
milk 
Frequency In up to 90% of food induced reactions Make up 10% of food induced reactions in 
isolation; although 40% of reactions have a 
combination of early and late reactions 
 
 
3.3   The possible role of food allergies in the pathogenesis of eczema  
Although the co-existence of food allergies and AD is high, the association is complex and not 
necessarily causal in all patients. There is, however, substantial clinical and laboratory evidence of a 














3.3.1 Clinical evidence of causality 
1. Several studies have shown that 60-80% of children with atopic dermatitis are sensitised to at 
least one common food allergen, and 30-40% have proven food allergies  
2. Oral food challenges can reproduce skin symptoms.  
3. Clinical studies have shown that at least 50% of the children with AD who react to certain foods 
will react with a worsening of eczema, either in addition to immediate food reactions (40%) or 
alone (10%).  Eczema can be exacerbated in 2 ways:29 
i. either directly  with IgE-mediated mast cell dependent development of new eczematous 
reactions 30, or  
ii. indirectly with early morbilliform rash/pruritis leading to itch -scratch cycle and secondary 
exacerbation of AD. 
4. The presence of IgE to food and aeroallergens is associated with earlier onset and more severe 
AD. 9,31,32 
5. The greater the level of IgE and the earlier it is elevated, the more severe and persistent AD is 
likely to be.32  
6. The strength of association between eczema and IgE mediated food allergy increases with 
increasing severity of AD. 33 
7. Appropriate dietary elimination results in significant improvement in atopic dermatitis in 
selected patients34-36 
3.3.2 Histological evidence of causality 
Patterns of cytokine expression found on lymphocytes infiltrating acute AD lesions are predominantly 
of the T helper cell type 2 (Th2) type (Interleukin (IL)4, IL5 and IL13) suggesting a role of the IgE 
antibody as well as Th2 cytokine mileau in the pathogenesis of the lesions.36,37  Th2 cytokines promote 
eosinophil influx into legional skin lesions, upregulate  vascular adhesion cells and upregulate high 
affinity IgE receptors on antigen presenting cells including Langerhans cells, thus also promoting 
chronic allergic inflammation. In addition to direct IgE-allergen activation of cutaneous mast cells, IgE 
seems to be involved in other mechanism such as high spontaneous basophil histamine release in 
patients with AD and food hypersensitivity.  
3.4   Eczema and skin barrier defects as a risk factor for development of food allergies 
The EPAAC study showed that patients with early onset AD < 3 months are at significantly greater risk 














eczema developed before 12 months of age, the frequency of high risk IgE-mediated sensitivity 
increased with increasing disease severity. 
A recent explanation for the possible role of eczema in food allergy development relies on 
dysregulation of the epithelial barrier in AD, allowing for easier and earlier uptake of food and airborne 
allergens in the environment by the non-dietary route. Therefore, exposure of food proteins on AD 
skin may act as a risk factor for evasion of oral tolerance and development of food allergies. 39,40  For 
example,  application of peanut containing skin creams on inflamed skin has been associated with an 
increased risk of sensitising children to peanuts. 41  
There has been recent identification of loss of function mutations in the gene encoding the protein 
filaggrin as possible causal mechanism in development of eczema.42 Adequate functioning of skin 
barrier is dependent on the filaggrin-based keratin cytoskeleton.  Patients with AD have increased 
frequency of the most common filaggrin null mutations (R501X and 2282del4) compared with healthy 
subjects. Filaggrin gene defects result in scaly itchy dry skin as well as increased permeability of the 
skin to proteins, representing a mechanism by which atopic dermatitis may be associated with 
increased risk of allergic sensitization.43 
3.5  Risk factors for food allergy in eczema 
 
Younger age, more severe eczema and early age of onset of eczema are major risk factors for food 
allergy and should be taken into account when selecting patients for food allergy screening.39 The 
EPAAC study showed early onset eczema to be a risk factor for food sensitisation. 38   Age at the time 
of assessment also influences food allergy rates, which peak in young children at or below 2 years’ 
age, and fall towards late childhood and adulthood, reflecting natural tolerance acquisition in a 
proportion of patients. 32 
 
3.6    Diagnosis of food allergy in atopic dermatitis patients 
Evaluation for food allergy should be considered in: 
1. Moderate to severe eczema, that does not respond to appropriate and adequate topical 
treatment. 
2. Early onset eczema < 6 months 
3. Eczema in the infant if accompanied by gut dysmotility 
4. History of immediate-type food reaction 















The aims of food allergy evaluation in AD should be differentiated, namely 
i. Proving that food allergies result in non-eczematous type (usually immediate) reactions  
which may be of immediate danger to the patient  
ii. Proving that food allergy results in delayed eczematous reaction that directly exacerbates 
AD.  
An accurate history of what the patient eats, the condition of the skin, possible reactions (both atopic 
dermatitis and acute reactions) and extra-cutaneous symptoms can be useful to guide food related 
investigations. 
The vast majority of food reactions in atopic dermatitis are IgE-mediated, hence tests for IgE 
sensitisation (SPT and specific IgE ImmunoCAP tests) are useful in the investigation of food allergy. 
However, there is no 100% reliable test for identifying which foods trigger atopic dermatitis. 
Sensitisation rates are far higher than clinically relevant allergy rates, hence frequently food 
allergy/tolerance needs to be proven by a provocation test (oral food challenge). 
Tests with no or poor evidence to support their use include IgG testing, ELISA/ACT, applied kinesiology, 
ALCAT testing, analysis of hair samples, Vega testing, cytotoxic testing and others.    
 
3.6.1 Immediate (IgE mediated) hypersensitivity food reactions 
The diagnosis of immediate type (IgE mediated) food allergy is made by taking a thorough history, 
looking for specific IgE sensitisation (SPT and ImmunoCAP), and performing oral food challenges if 
indicated.1  Negative skin and ImmunoCAP tests are good for excluding an immediate type reaction, 
but cannot exclude a delayed type reaction. The presence of “positive” tests indicating sensitisation is 
not synonymous with food allergy. The predictive values for a history of a food reaction, positive SPT 
and positive food specific IgE in isolation are all poor for diagnosing food allergy in AD. The level of 
sensitisation must be interpreted in conjunction with the history, and in many cases where uncertainty 
remains, a food challenge test will be the best means to definitively prove food allergy or food 
tolerance.  
Skin-prick tests have high negative predictive values and are a good predictor that subjects will not 
have an immediate type reaction on exposure but cannot exclude a delayed type reaction. However, 
positive predictive values are low,44,45 hence a “positive” result does not equal clinical reactivity. 
Published “cut-off levels” for clinical relevance have been studied for selected allergens in the USA 
(child >2 years: milk ≥8mm, egg ≥7mm, peanuts ≥ 8mm; child <2 years: milk ≥6mm, egg ≥5mm, 














heightened SPT reactivity may lag behind reductions in specific IgE levels and may remain positive for 
years after a food has been successfully reintroduced into the diet.    
ImmunoCAP testing for food specific IgE has high negative predictive values, but positive predictive 
values are low.44,46  Published “cut-off levels” for clinical relevance have been studied for selected 
allergens. The values that achieved a 95% PPV are known for milk (≥15kU/L; ≥5kU/L if age <2), egg 
(≥7kU/L; ≥2kU/L if age <2), peanuts (≥14kU/L) and fish (≥20kU/L).44,46  It is not currently known 
whether these results can be extrapolated to South Africa and other lower/middle income countries. 
Atopy Patch Testing has not been shown to add significant information to a skin test as a diagnostic 
test for food triggers of acute or delayed reactions to foods.47,48  
If the diagnosis of food allergy or tolerance is not absolutely clear or the clinical relevance of a positive 
food allergy test is not certain, a food challenge should be performed. The gold standard is the double-
blind placebo-controlled food challenge.49,50  This requires two separate challenges with a suitable 
vehicle, one with and one without the food under consideration, to avoid the patient and the operator 
from knowing which of the challenges contains the active food. For an open challenge the food is given 
in its usual form and therefore both the observer and the patient know the food is being ingested.  
Although this may be associated with false positive reactions it is acceptable in infants and young 
children with objective symptoms and as a preliminary screening of foods that are at a low level of 
suspicion as a negative challenge is definitive. 
 
3.6.2 Delayed eczematous food allergy reactions 
The diagnosis of delayed eczematous reactions is more difficult than the diagnosis of immediate 
reactions.1 In such cases specific IgE and skin prick tests may not correlate with the presence or 
absence of a delayed food reaction. In these cases an elimination-reintroduction diet is the only 
reliable way of determining whether or not a food is a trigger.  Such diets must be done under 
supervision of a dietician. If patients respond to any dietary intervention, it is highly recommended 
that the food should be reintroduced to confirm the diagnosis. This may be a formal food challenge in 
hospital in the presence of any sensitisation or history of immediate reactions to the food(s), or a 
home challenge/reintroduction in the absence of sensitisation or a history of only delayed symptoms. 
If a formal food challenge is performed for atopic dermatitis, the schedule may need to be prolonged 
to observe the patient for up to six hours after the maximum dose for immediate and intermediate 
reactions.  It is important to review the patient at 24 hours for scoring to formally document delayed-
type worsening of atopic dermatitis.  In cases of prolonged avoidance of a food, it is recommended to 














there has not been a history of any immediate reactions- as immediate reactivity may have developed 
over time.51 After prolonged avoidance of a food, or if there is any evidence of IgE-mediated 
sensitisation having occurred, food challenge should be performed under controlled circumstances.  
 
The process of elimination-rechallenge testing for diagnosis of food allergy involves:52 
 Removing all sources of the suspected food or foods for four to six weeks to bring about an 
improvement in the atopic dermatitis. If the atopic dermatitis does not improve within four 
weeks, it is unlikely that food allergy is a relevant trigger and oral food challenges are not 
necessary. In this case a normal diet should resume immediately.  
 Even if the atopic dermatitis has resolved, foods should be reintroduced sequentially to assess 
for a return (or worsening) of the atopic dermatitis, prior to ascribing the improvement to the 
exclusion diet. This is because the improvement may be coincidental or reflect a placebo effect. 
Concomitant therapies and other environmental factors should not be changed during the 
period of assessment for food allergies.  In addition, if multiple foods have been excluded it is 
imperative to see which of these foods is truly responsible and exclude only those foods, while 
allowing the return of non-contributory foods into the diet. 
 Food reintroduction may be performed as a standard food challenge with a single food in 
incremental doses. If there is no immediate reaction, then give the food for three to four days 
successively and monitor atopic dermatitis scores daily. In selected cases where there has not 
been prolonged exclusion of the food and there was no immediate type reaction, a home 
challenge may be performed.  
 Should the skin not react to the introduction of this food, challenge with a new food every three 
to four days. 
 However, should the food exacerbate the atopic dermatitis, it may be considered a causal food 
allergen and be removed from the diet to bring about the improvement in the symptoms for 
the second time. Where doubt still exists, a second re-challenge may be necessary.  
 
3.7   Therapeutic elimination diets 
There is no specific diet for the treatment of unselected patients with atopic dermatitis so patients 
should not routinely be placed on exclusion diets.53 Elimination diets are potentially harmful. Food 
allergy should only be considered in specific cases, and elimination diets reserved for those children 
who have been proven to be allergic and tailored to the individual after appropriate investigations, 














must be done under the supervision of a dietician and should always be combined with atopic 
skincare.  
Removing foods from one’s diet requires support and education, especially in cases where the food is 
common and present in many hidden sources. A dietician must be consulted to ensure the allergen is 
completely eliminated from the diet, as well as to provide alternatives to ensure nutritional adequacy 
of the residual diet.  
3.8   Natural history of food allergy in eczema 
The natural history of food allergy resolution is variable and may differ in those with and without 
atopic dermatitis. It varies between allergens, with milk, egg, soy and wheat resolving earlier, and 
more commonly than allergies to peanuts or tree nuts.43 Allergy to fish and shellfish, which more 
commonly develops later, may be life-long. In atopic dermatitis, approximately 25% of patients will 
outgrow their food allergy after one year.17,34 Patients with severe concomitant IgE mediated food 
allergy/anaphylaxis should be followed up very frequently, but all patients should be reassessed after 
12 months. Repeat testing should be followed by food reintroduction in the form of a formal food 
challenge to reduce the risk of immediate reactions that may be present or may have developed, in 
order to restore a normal diet wherever possible. 
3.9   Eczema as part of the atopic march 
The concept of the atopic march describes the progression of atopic disorders from atopic dermatitis 
and food allergy in infants to allergic rhinitis and asthma in children.54 
Clinical studies have shown that other atopic disorders (asthma and allergic rhinitis) develop in 50-
80% of children with AD. 55,56    The main risk factors for progression to asthma are early onset AD, IgE 
sensitisation to common environmental allergens and severity of AD.  Approximately  70% of patients 
with severe AD develop asthma compared with 20-30% with mild AD and 8% of the general 
population. 57,58 
In children with AD and egg allergy, respiratory allergies develop in approx 90%.59  Early  IgE responses 
to egg represent the most important infantile marker for atopy. 59,60  
Aeroallergen sensitisation is common in AD patients. In the recent EPAAC study 20-40% of AD patients 
were sensitised to house dust mite. 38 The presence of allergic sensitisation to aeroallergens in AD at 
one year was positively related to the occurrence of asthma. In contrast to food allergy sensitisation, 














Environmental and genetic studies suggest that a defect in the epithelial barrier may contribute 
towards the progression of the atopic march, skin defects providing a site for inhaled antigen 
sensitization. 61,62          
3.10 Conclusion 
A large proportion of children with moderate to severe AD (30-40%) will have a co-existing food 
allergy, mostly IgE-mediated. In approximately half of those AD patients who react to food, there will 
be a flare-up of eczema, mostly in combination with immediate symptoms, but sometimes in isolation. 
This means that in 15-20% of children with moderate to severe AD, food allergies play a role in the 
eczema pathogenesis. 
In patients with moderate to severe eczema, or where there is a high suspicion of a food allergy, food 
allergies should be actively excluded.  History, SPT and specific IgE are sensitive but not specific in AD 
sufferers, hence there is a crucial role for food challenges to confirm or refute clinically significant 
allergies. In cases in whom there are no symptoms of immediate allergies or no evidence of IgE 
sensitisation, elimination-rechallenge diets should be instituted if there is a high suspicion of food 
allergies exacerbating the eczema.  
Early diagnosis of co-existing food allergies can lead to better management of food allergies and 
reduce the risk of exposure to food antigens.  Blanket elimination diets are ineffective and may be 
nutritionally harmful, and all too often parents embark on an unsupervised elimination diet because 
of conflicting advice. Integrated treatment for eczema involves targeted elimination diets eliminating 
foods which the child is proven to be allergic to, combined with atopic skin care. 
Both eczema and food allergies are an early part of the allergic march and have a close association 
with respiratory allergies. The child with eczema should be managed in an integrated manner taking 
into account the risks of associated allergies.  
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Chapter 4:  
Food Allergy Prevalence in South Africa 
 
Abbreviations 
AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SPT:          Skin Prick Test 
sIgE:         Specific IgE 
EPAAC:    Early Prevention of Asthma and Allergy in Children 
 
4.1 Introduction 
Current data on food allergy prevalence in South Africa is scanty, and studies have relied on patient 
report and sensitisation profiles, rather than oral food challenges.  Indeed, the concept of the food 
allergy clinic, offering controlled food challenges, is a relatively new one in South Africa which was 
only introduced in the past 10 years. Anecdotally, and from the few existing previous studies, food 
allergy rates were thought to be extremely low in South Africa, especially in black South Africans.1,2   
In particular, peanut allergy, which has seen a significant increase in developed countries over the past 
few decades,3,4 was virtually undiagnosed in Black South Africans until recently. However, a true 
estimation of food allergy prevalence in South Africa has not been performed in unselected 
populations or using food challenges for diagnosis.  
This section summarises previous studies in South Africa which have included an investigation into 
food allergy.   
4.2   Previous studies in South Africa of food sensitisation and allergy  
In the early 1990’s in Bloemfontein, Mercer et al studied 771 patients (aged 3 months-15 years) 
attending the paediatric allergy clinic.5 Patients were predominantly Caucasian (personal 
communication, Dr Mercer).  As part of allergic rhinitis evaluation, skin prick test (SPT) and specific IgE 
(sIgE) to foods were performed.  sIgE in the entire group  was positive  for wheat (24.4%), milk (9.9%) 
and fish (5.9%). Similarly, SPT in 275 children over the age of 6 years showed sensitisation mainly to 














reactivities, e.g. wheat and grass cross-reacting.6  None of the patients had symptoms of food allergy, 
although foods were reported as a possible trigger of allergic rhinitis in 3.5%.  
In the mid 1990’s in Gauteng, SPT to foods were performed in 58 of 468 Caucasian patients (aged  4-
18 years) at a paediatric asthma clinic.7  SPT positivity was defined as 2mm greater than the negative 
control.  Sensitisation patterns in these selected patients were as follows: wheat 30.4%, peanut 18.2%, 
fish 15.1%, soy 12.7%, egg 6.9% and milk 5.4%. Only one patient had a history consistent with food 
allergy, but further details were not provided. 
In 2005, 100 children (aged 2 months to 20 years) attending a tertiary asthma clinic in Pretoria 
underwent SPT to common foods.8 By ethnicity, 67% were black Africans and the remainder 
Caucasian.  Sporik’s 95% positive predictive value cut off points for SPT,9 which correlate with a high 
probability of food reactions, were exceeded for peanut (9%), egg white (7%), wheat (4%), fish (4%) 
and milk (3%). There was no mention of clinical reports of allergy. 
In 2008, a study on an unselected group of 212 Xhosa high school patients in Cape Town (aged 15-24 
years) showed positive SPT (≥3mm above the negative control) for food allergens in 5.4% of subjects, 
most commonly to egg white (3.3%), peanuts (1.9%) and milk (1.9%). 10   None of these students 
reported intolerance to these foods.  
These studies are summarised in table 4.1 below.  Marked heterogeneity in sensitisation rates reflect 
different age groups, intercurrent atopic conditions and aeroallergen cross-sensitisation rates. It is 
difficult to extrapolate actual food allergy rates from these studies since the focus is mainly on 
sensitisation with some patient reports of allergic symptoms. However, interestingly, of the total 645 






















Table 4.1 Summary of previous food sensitisation/food allergy prevalence studies in South Africa 
Date (place) Population (age range) Sensitisation Confirmed Allergy 
Early 1990’s 
(Bloemfontein)5 
761 children with 
allergic rhinitis (3 
months-15 years) 
sIgE positive for wheat 
24.4%, milk 9.9% and 
fish 5.9%.  
SPT positive for 
wheat 30.6%, milk 
30.6%, fish 26.2%.  
No reported food allergy 
symptoms except 
possible trigger for 
allergic rhinitis in 3.5% 
Mid 1990’s (Gauteng)7 58 Caucasian children 
with asthma (4-18 years) 
SPT positive for wheat 
30.4%, peanut 18.2%, 
fish 15.1%, soy 12.7%, 
egg 6.9% and milk 5.4%.  
 
One patient reported 
food allergy 
2005 (Pretoria)8 100 patients (67 Black 
and 33 Caucasian) with 
asthma (2 months-20 
years)  
SPT over 95% Positive 
Predictive Value for 
allergy: 
peanut 9%, egg white 
7%, wheat 4%, fish 4%, 
and milk 3%. 
None 
2008 (Cape Town)10 212 unselected Xhosa 
high school patients (15-
24 years) 
SPT positive for egg 
white 3.3%, peanuts 




4.3 Previous Studies in South Africa Looking at Food Allergy and Atopic Dermatitis 
Atopic dermatitis (AD) is a particular risk factor for food allergy, with a complex (and not necessarily 
causative) relationship between these two entities, as described in chapter 3.   Studies in high-income 
westernised countries have shown high rates of sensitisation (60-80%) as well as challenge proven 
food allergy (27-40%) in children with moderate to severe AD.11-14      Two previous studies in South 
Africa have examined food allergy in patients with AD (table 4.2).  
The first study in 1998 involved parental questionnaire-based perceptions of food reactions in 112 
children with atopic dermatitis.15   By recall, the commonest triggers of cutaneous symptoms were 
tomatoes, oranges, sweets, pineapple, chocolate, and sulphur dioxide containing soft-drinks. These 
foods were reported to cause symptoms in up to 49% of the children. The foods that commonly cause 
IgE mediated reactions, namely egg, fish, milk, and peanut, were reported to cause reactions in up to 














The second study formed part of the EPAAC™ (The Early Prevention of Asthma in Atopic Children) 
study, in which children aged 12-24 months with eczema underwent sIgE tests to egg, milk and 
peanut.16 A heterogenous group of 161 South African infants from various centres was included. Rates 
of sensitisation were similar to those reported in westernised countries in the study, namely: egg 
47.1%; cow’s milk 28.4% and peanut 26.8%. Eleven infants (7.2%) in the South African cohort had 
peanut sIgE levels above 14 kU/L, more than the 95% predictive value for a positive food challenge.16 
However, there was no mention of clinical reports of symptoms of immediate food allergy.  
True allergy rates in this population cannot be accurately extrapolated from these studies since the 
first study is questionnaire based, whilst the other made use of sensitisation patterns. 
Table 4.2 Summary of food sensitisation/allergy prevalence studies in children with atopic dermatitis in South 
Africa  
Study population Food allergy diagnosis Results 
112 children with atopic 
dermatitis (1994)15 
Questionnaire  Perceived allergy to tomatoes, oranges, sweets, 
pineapple, chocolate, soft drinks in up to 49%, and 
egg, fish, milk, and peanut, in up to 25%  
 
161 children (12-24 
months) with AD from 
various centres and ethnic 
backgrounds (2005)16 
 
Sensitisation (specific IgE> 
0.35 U/L) 
Sensitisation to egg 47.1%; cow’s milk 28.4% and 
peanut 26.8%. Peanut sIgE greater than 95% 
positive predictive value for allergy in 7.2% 
 
 
4.4 Concluding remarks 
To date, very few studies in South Africa have looked into food allergy prevalence. They are based 
on sensitisation patterns and questionnaires; none to date have used food challenges in equivocal 
cases. These studies have shown significant sensitisation rates to commonly allergenic foods. Food 
allergy rates cannot be ascertained from these studies, however there have been extremely few 
reports of food allergy symptoms. This data, together with anecdotal experience in South African 
allergy clinics until the year 2010 when our study was commenced, suggested a low allergy rate, 
especially amongst black South Africans. This led to the hypothesis that black South Africans may 
have relative protection against food allergy, even in the face of a “food allergy epidemic” in other 
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Chapter 5:  
Study aims, objectives and methodology 
 
Abbreviations 
AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SPT:          Skin Prick Test 
sIgE:         Specific IgE 
ISAC:        Immuno Solid Phase Allergen Chip 
ISU:          ISAC Units 
PPV:         Positive Predictive Value 
SCORAD:  Scoring Atopic Dermatitis 
 
5.1 Study Title: 
A prospective, descriptive study to determine the prevalence of IgE-mediated food sensitisation and 
allergy in South African children with atopic dermatitis attending a tertiary medical centre  
 
5.2 Motivation for the study 
With the background to the study described in chapters 2-4, it is evident from numerous studies in 
Europe and the USA that IgE-mediated food allergy has an important association with atopic 
dermatitis in a subset of patients. However, to date this has been inadequately studied in South Africa.  
Anecdotally, food allergy, particularly peanut allergy, is rare in South African children, particularly 
those of non-Caucasian decent. Our hypothesis driving the study was that food allergy is uncommon 
even in high risk South African children, such as those with atopic dermatitis (AD).  
The aim of this study was to determine the prevalence of IgE-mediated food allergy in South African 
children with atopic dermatitis, presenting to a tertiary paediatric unit in an urban region in the 
Western Cape. We explored possible factors influencing sensitivity and allergy to foods, including 

















5.3   Objectives of the study 
5.3.1 Primary objective 
The primary objective was to determine the prevalence of IgE-mediated food allergy to any one or 
more of 7 common allergenic foods (hen’s egg, cow’s milk, peanut, tree nuts, soy, wheat and fish) in 
a South African urban population of children with atopic dermatitis.  
5.3.2 Secondary objectives  
1. To determine the rate of sensitisation to common food allergens in South African children with 
atopic dermatitis.  
2. To explore the association between atopic dermatitis severity and the prevalence of food 
sensitisation and allergy. 
3. To explore the association between age at the time of study entry, as well as age of onset of 
eczema, and the prevalence of food sensitisation and allergy. 
4. To explore the association between ethnic origin and the prevalence of food sensitisation and 
allergy. 
5. To explore patterns of peanut consumption in the study population. 
6. To measure sensitisation to peanut component antigens Ara h1, 2, 3, 8 and 9, and to explore 
whether patterns of component antigen sensitisation are associated with tolerance versus clinical 
peanut allergy. 
7. To explore whether the internationally derived 95% positive predictive values (PPV) levels for 
positive food challenge using skin prick tests (SPT) and specific IgE to cow’s milk, egg and peanut 
are relevant to the study population. 
8. To compare skin prick tests, specific IgE by ISAC test, and specific IgE by ImmunoCAP test as 
measures of detecting IgE-mediated food sensitivity and allergy in the study population. 
 
5.4   Sample size 
Sample size was calculated based on the estimate that in the South African population of children with 
AD the prevalence of food allergy would be approximately half of that demonstrated in westernised 
countries, i.e. 15% in comparison to 30% from previous studies in westernised countries. At 80% 
power and 5% significance level, this gave a sample size of 53. In order to include meaningful numbers 
















5.5   Inclusion and Exclusion Criteria 
5.5.1 Inclusion criteria 
i. Children presenting to the paediatric dermatology clinic at Red Cross Hospital with atopic dermatitis  
ii. Children of South African descent. 
iii. Children in the age range 6 months to 10 years. 
iv. Children for whom informed consent could be obtained from the parent or legal guardian. 
5.5.2  Exclusion criteria 
i. Children for whom no informed consent could be obtained from the parent or legal guardian. 
ii. Children with significant chronic illness (apart from that related to their atopic predisposition, such 
as asthma).  
iii. Unwillingness or inability to comply with study requirements or procedures including food 
challenge. 
 
5.6 Study definitions 
5.6.1 Definition of atopic dermatitis (Williams 20051) 
The diagnosis requires evidence of itchy skin (or parental report of scratching or rubbing) plus three 
or more of the following: 
 History of involvement of the skin creases (e.g. fronts of elbows, backs of knees, fronts of ankles, 
and areas around the neck or eyes) 
 History of asthma or hay fever (or history of atopic disease in a first-degree relative if the child is 
under four years of age) 
 History of generally dry skin in the past year 
 Onset in a child under two years of age (criterion not used if the child is under four years of age) 
 Visible flexural dermatitis (including dermatitis affecting the cheeks or forehead and outer aspects 
of limbs in children under four years) 
    
The diagnosis of atopic dermatitis was made by a paediatric dermatologist in all cases of study 
participants. 
 
5.6.2 Positive Skin Prick Test 
A SPT was considered positive if it resulted in a weal diameter of 3mm or greater than the negative 














5.6.3 Positive Specific IgE 
A specific IgE  ≥0.3 ISAC Units (ISU) for the ISAC 103 test, or ≥ 0.35 kU/L by standard ImmunoCAP test 
was considered positive.  
 5.6.4  IgE-mediated food sensitisation 
Sensitisation was defined as a positive skin prick test and/or positive food specific IgE. 
5.6.5 IgE-mediated food allergy  
For the purposes of this study, food allergy was be defined as either: 
 A convincing clinical history of significant type I allergic reactions after isolated ingestion 
of a food in the preceding 6 months, with significantly positive SPT/sIgE*; or  
 Positive food challenge 
 
 *Significantly positive SPT/sIgE was at or above the internationally derived 95% positive predictive 
value for peanut, hen’s egg and cow’s milk allergy, either by SPT2 (8mm for peanut, 7 mm for hen’s 
egg, 8 mm for cow’s milk) or specific IgE3 (14 kU/L for peanut, 7 kU/L for hen’s egg, 15 kU/L for cow’s 
milk). Table 5.1 depicts 95% and 100% decision points that were being used in our allergy clinic at the 
time of the study. 
 
Table 5.1 Summary of 95% and 100% Positive Predictive Values 2,3  
Allergen >95% PPV decision point  for 
specific IgE (in kU/L-using 
Phadia ImmunoCAP 
method)  
100% PPV for skin prick test 
diameter (mm)  
Egg White  2 (<2 yr) 
7  (>2 yr) 
5mm (<2 yr) 
7mm (> 2 yr) 
Cow’s Milk 5   (<1 yr) 
15 (>1 yr) 
6mm (< 2 yr) 
8mm (> 2 yr) 
Peanut 14 4 mm (< 2 yr) 
8 mm (> 2 yr) 















5.6.6. Outcome of food challenge 
The outcome of food challenges was determined by evaluating the participant using the criteria in 
table 5.2 below.4,5 
A positive food challenge was defined by the presence of either: 
o One or more major criteria. 
o Two or more minor criteria. 
An indeterminate food challenge was defined by the presence of one minor criterion. 
 A negative food challenge was defined by the absence of major or minor criteria. 
 
Table 5.2 Criteria for determining the outcome of food challenge 
 Major Criteria 
1. Confluent erythematous pruritic rash 
2. Respiratory signs (at least one of the following): 
 Wheezing 




3. ≥ 3 Non-confluent urticarial lesions 
4. ≥ 1 Site of angioedema 
5. Hypotension for age not associated with vasovagal episode 
6. Evidence of severe abdominal pain (such as abnormal stillness or doubling over) that 





3. Persistent rubbing of nose or eyes that lasts for ≥ 3 minutes 
4. Persistent rhinorrhea that lasts for ≥ 3 minutes 
5. Persistent scratching that lasts for ≥ 3 minutes 
 
All symptoms should be of new onset and not due to ongoing disease.  Reactions during food challenge 
were defined as immediate if they occurred within 2 hours of consumption of the last administered 
















5.7  Design and setting 
This prospective, observational study was conducted over 3 years, March 2010-March 2013 at Red 
Cross Children’s Hospital, a paediatric university hospital in Cape Town. Patients were randomly 
recruited from the waiting area in the dermatology clinic, but not the allergy clinic, to minimise referral 
bias for food allergic patients.  
5.8  Recruitment and assessment 
5.8.1   Recruitment and enrolment 
Recruitment took place at the paediatric dermatology clinic at Red Cross Children’s Hospital. The study 
nurse had access to the pile of hospital folders of patients attending the clinic. By sequentially 
inspecting the folders, which were in random order, she identified the first 4 folders of patients with 
a diagnosis of AD, and invited those children to participate in the study. This continued on a weekly 
basis until 100 patients had been recruited. Parents were given written information on a sheet in the 
language of their choice: English, Xhosa or Afrikaans. Details of the study were discussed with the 
family, using an interpreter if necessary. If they agreed to participate, written informed consent was 
obtained from the parent/legal guardian for study participation in their language of choice. As far as 
was practically possible, the assessments were performed during the original hospital visit to avoid 
unnecessary travel and inconvenience to patients. An exception was the food challenges, which 
required patient selection after the allergy test results had been processed, and were planned for 
another day. In some cases skin tests had to be deferred to another day if the patient had recently 
taken antihistamines. 
5.8.2   General and allergy assessment  
An allergy questionnaire was completed, with a member of the study team going through each 
question with the parent/caregiver in their preferred language. This included the following details: 
 age and date of birth 
 ethnic origin and socio-economic status 
 history of timing of introduction of cow’s milk, hen’s egg, wheat, soy, fish, peanut and tree nuts. 
 detailed history of allergic reactions to the above foods or any other foods, including symptoms, 
severity and timing of reaction following consumption. Parents were specifically asked about the 
presence of rashes, flushing, itchy throat/clearing of throat, swelling, vomiting and diarrhoea, 
cough, wheeze, stridor and signs of circulatory compromise.   
 history in the child of asthma or allergic rhinitis. 














 detailed consumption history of peanut products 
 weight and relevant general examination findings were also recorded 
5.8.3  Atopic dermatitis severity assessment  
The severity of atopic dermatitis was assessed at the initial visit using the SCORAD Index (SCORing 
Atopic Dermatitis),6 which is a standardised clinical evaluation of atopic dermatitis, scored from 0 to a 
maximum total of 103 points. It consists of evaluating the extent of atopic dermatitis (body surface 
area of involved skin), and the intensity of atopic dermatitis based on scores for erythema, papulation, 
excoriation, oozing, lichenification and skin dryness. Subjective symptoms of pruritis and insomnia are 
assessed by visual analogue scale.   Scoring was performed by a trained dermatology nurse and was 
recorded on the dedicated forms.  
Severity of atopic dermatitis was defined as follows:  
o SCORAD < 15:    mild 
o SCORAD 15-40:  moderate 
o SCORAD > 40:    severe 
 
5.8.4  Skin Prick Testing (SPT) 
All patients underwent skin prick testing. SPT were performed using solutions from ALK Abello (ALK, 
Madrid, Spain)  and ALK lancets, to egg white extract, cow’s milk, soy, wheat (flour), fish (cod), peanut, 
positive (10mg/mL histamine) and negative (saline) controls. In addition, modified skin prick tests for 
egg and milk were performed using a drop of raw egg white and fresh 2% cow’s milk. 
The skin on the forearm was pricked through a drop of the extract. Results of the SPTs were read at 
15 minutes, recorded as average weal diameter size in millimetres (mm) and deemed positive for 
sensitisation if the weal size was 3 mm or more above the negative control at 15 minutes. 
5.8.5 Blood testing for food specific IgE 
A blood sample was taken from all participating patients for IgE testing by the ImmunoCAP® ISAC test 
(Immuno Solid Phase Allergen Chip Test, Phadia™), using the103 allergen microarray chip. In patients 
with a positive skin prick test or ISAC test, ImmunoCAP® tests were also performed to those particular 
foods. An ISAC value at or above 0.3 ISAC Units or an ImmunoCAP test value at or above 0.35 kU/L 
was considered positive for sensitisation. 
 5.8.6  Food Challenges 
All patients with evidence of sensitisation to the foods being tested underwent a food challenge unless 














more than one allergen, they underwent multiple food challenges on different days at least one week 
apart. All challenges were performed within 4 weeks of the original screening tests.  
 
Food challenges were performed as open incremental supervised oral challenges at the Red Cross 
Hospital pediatric allergy department. 7  On the day of the food challenge, children were examined to 
ensure they were fit for the challenge, and the investigator ensured that they had been compliant 
with a histamine washout period. Before the start of the challenge, and before every dose escalation, 
the patient underwent a full set of observations including temperature, oxygen saturations, blood 
pressure, pulse rate and peak expiratory flow rate in the case of asthmatic children.  
Foods were given in their native form, starting with a lip dose, increasing every 15 minutes over a 
further 6 doses, and ending with a full portion of the food (17 g peanut butter, 100 mL cow’s milk or 
soya milk, 30 g scrambled egg, 20g wheat, 40g fish). A dosing schedule for food challenges is depicted 
in table 5.3. 
The criteria for determining the outcome of a food challenge included only objective signs of new 
onset (table 5.2). 
Food challenges were stopped if they met the positive criteria. Patients were treated according to the 
severity of their reaction with antihistamine syrup (for mild to moderate reactions) or intramuscular 
adrenaline (for severe reactions). Patients were observed for a minimum of 2 hours after a negative 
challenge and 2-4 hours after a positive challenge. If a reaction was equivocal, the challenge was 
continued until the top dose was reached or until symptoms satisfied criteria for a positive food 
challenge. 
After a negative challenge, parents were encouraged to include the food regularly in the diet and to 
report any unexpected reactions on subsequent consumption. The investigator contacted the 
patient’s family per telephone 48-72 hours after the food challenge to enquire about the patient’s 
wellbeing and delayed symptoms.  
5.8.7 Follow up of children with results suggestive of food allergy 
If children had clinical history/food challenge suggestive of clinically significant food allergies, then 
appropriate food avoidance advice was given by a trained dietician. A written treatment plan was 
given to the family and relevant professionals. Further follow up was organised in the paediatric 
















Table 5.3: Doses of foods used for food challenges 
FOOD LIP 
CHALLENGE 
DOSE  1 
(20 
MINUTES) 
DOSE  2 
(40 
MINUTES) 
DOSE  3 
(60 
MINUTES) 
DOSE  4 
(80 
MINUTES) 
DOSE  5 
(100 
MINUTES) 
DOSE  6 
(120 
MINUTES) 











on lower lip 
 
 
0.5g 2g 5g 10g 30g  





5 mL 10 mL 30 mL 200 mL (or 
160 g soya 
yoghurt) 
  
Cod (plain) Rub small 
amount fish 
on lower lip 
 
 
0.5g 2g 10g 40g   
Wheat 





on lower lip 
 
 
1g 3g 6g 20g   





0.3g 0.6g 2.3g 4.5g 11g 17g 





0.25g 0.5g 2g 4g 10g 15g 





0.5g 2g 4g 15g   
 
5.9 Ethics 
The study was approved by the University of Cape Town’s Faculty of Science Human Ethics committee 
(reference 426/2009). Informed consent was obtained from a parent/legal guardian for study 















5.10 Data Entry and Statistics 
Data was entered into a clinical records form by the principal investigator, and subsequently checked 
and entered on to a computerised database using STATA version 11.1 (Stata Corp, College Station, 
Texas). Continuous variables were analysed using the Mann-Whitney test, and categorical variables 
were analysed using the chi-squared or Fisher’s exact tests. In addition, the two sample test of 
proportion was used to test for statistical difference between proportions. A p- value of <0.05 was 
considered statistically significant.   
5.11 Comparison between Ethnic Groups 
The two main ethnic groups attending the dermatology and allergy clinics at the Red Cross Children’s 
Hospital are Xhosa patients (the indigenous black Africans in the Western Cape) and mixed race 
patients (mixed black African and Caucasian). Food allergy patterns were thus compared between 
Xhosa and mixed race patients. Such an inter-ethnic comparison was aimed at determining: 
o Whether there were inter-ethnic differences in the prevalence of food sensitisation and allergy 
o whether any potential confounding factors might be responsible for inter-ethnic differences  
o whether there were inter-ethic differences in the performance characteristics of diagnostic tests 
o whether there may be any practical implications of differing food allergy patterns 
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AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SPT:          Skin Prick Test 
sIgE:         Specific IgE 
ISAC:        Immuno Solid Phase Allergen Chip 
ISU:          ISAC Units 
PPV:         Positive Predictive Value 
SCORAD:  Scoring Atopic Dermatitis 
 
6.1 Introduction 
The complex relationship between atopic dermatitis (AD) and food allergy has been described in 
Chapters 2 and 3.1,2  Eczema, particularly of early onset,  is a known risk factor for food allergy.3  The 
majority (around 90%) of food reactions in patients with AD are, at least in part, IgE-mediated. 4-7  
Studies from high income countries have demonstrated a high degree of sensitisation (around 60%) 
as well as proven allergies (around 30-40%) to common foods in children with moderate to severe 
AD.8-12    Geographical area and ethnicity may influence sensitisation and/or allergy rates, as discussed 
in chapter 2.13-16 
The aim of this study was to determine the prevalence of IgE-mediated food allergy and sensitisation 
to common food allergens in children, with AD, presenting to a specialised paediatric unit in an urban 
region in the Western Cape, South Africa. Objectives and methodology have been described in the 
previous chapter, chapter 5. This chapter describes the overall results in terms of food sensitisation 
and allergy prevalence, as well as risk factors for food allergy. It also explores ethnic differences in 

















6.2   Background characteristics and demographics 
100 patients participated in the study, 59 Xhosas and 41 of mixed race. Although eligible, there were 
no Caucasians or Asians amongst the study population, reflecting the demographics of the population 
attending this dermatology clinic. One patient was excluded from analyses pertaining to peanut and 
fish, as she defaulted her peanut and fish challenges. Thirteen potentially eligible patients refused 
study entry, mainly due to time constraints, hence 88% of patients approached participated in the 
study.  
There were 54 males and 46 females. The age of participants ranged from 7-118 months, with a 
median age of 42 months, interquartile range 19-68 months. The median age of onset of eczema was 
6 months, interquartile range 3-12 months. Fifty patients had moderate and 50 had severe eczema.  
Total serum IgE ranged from 5 to over 5000 kiU/L (no further dilutions were performed), with a median 
of 1015 kU/L, interquartile range 220-2754 kU/L.  
Gender distribution, age, age of onset of eczema, eczema severity and total IgE were comparable 
between the two ethnic groups with no statistically significant differences (Table 6.1).  Monthly 
income was significantly lower in the Xhosa group, at a median of R2000 per month, compared with 
R3500 for the mixed race group (p=0.01).  
6.3   Tests performed 
All patients underwent skin prick tests (SPTs) to hen’s egg, cow’s milk, wheat (flour), fish (cod), soya 
and peanut. Cashew nut was unavailable as a SPT in South Africa at the time of the study. All 100 
patients underwent Immuno-Solid Phase Allergen Chip (ISAC 103) tests. In those who were sensitised, 
or if there was a discrepa cy between history and sensitisation, specific IgEs by ImmunoCAP® test 
were also performed (n= 69).   
Seventy-one food challenges were performed in 47 patients (31 to egg, 25 to peanut, 5 each to cow’s 
milk and fish, 3 to soya, and 2 to wheat).  Thirty-two of the food challenges were positive (17 to peanut, 
14 to egg, 1 to milk). There was one case of anaphylaxis during a peanut challenge, for which the 
patient required intramuscular adrenaline for stridor. The rest of the reactions were mild, mostly 
cutaneous, and treated with oral antihistamines. 
All patients who reported immediate-type allergic symptoms but had a negative SPT were non-allergic 















Table 6.1: Baseline characteristics of the study population 
 Overall Xhosa Mixed Race Difference 
between 
ethnic groups  
Number of 
participants 
100 59 41  
Gender 
distribution 
54% males,  
46% females 
54% males,  
46% females 
54% males, 46% 
females 
P=0.95* 
Age (median in 
months) 
42  40 48  P=0.09 # 







Age of eczema 
onset (median in 
months) 
6 6 6  Equal 
Serum median 
total IgE (kU/L) 
1015 656 1562 P=0.31 # 
Symptoms of 
asthma 





R2500 R2000 R3500 P=0.01++ 
*= difference non-significant by chi-squared test 
#= difference non-significant by Mann Whitney test 
++ = difference significant by Mann Whitney test 
 
6.4   Food Sensitisation Patterns 
 Overall 66 (66%) patients were sensitised to at least one food. Sensitisation was detected in 61 cases 
by SPT (of which 45 were also ISAC positive), and in an additional 5 cases by ISAC. In the latter 5 cases 
which were missed by SPT, the patients were confirmed to be not allergic.  
By ethnicity, 41/59 Xhosas (69%) and 25/41 of mixed race (61%) were sensitised to at least one of the 
foods tested; there was no significant difference between ethnic groups for overall sensitisation 
(p=0.37). The most common food to which patients were sensitised was egg (54%), followed by peanut 
(44%), milk (27%), fish (13%), soya (9%) and wheat (6%).  No patients were sensitised to cashew nut 
by the screening ISAC test.  
There were no significant ethnic differences for sensitisation rates to individual foods, apart from fish, 
which was significantly more positive in the mixed race group at 22% versus 7% in Xhosa patients, 
p=0.03 (Table 6.2).  
Of those with a positive SPT, the median number of positive SPT overall was 2 (2 for Xhosas, 3 for 















6.5   Food Allergy Patterns 
Overall, 40% of patients in the cohort (34% of Xhosas and 49% of mixed race, p=0.1) had at least one 
IgE-mediated food allergy. There were no gender differences in food allergy rates, with  37% of male 
and 43% of female participants having food allergy (p=0.51). 
Of the 55 cases of food allergy in 40 children, 32 were diagnosed by food challenge, and 23 by 
significant sensitisation (above the internationally derived 95% positive predictive values for food 
allergy) and recent past history of a reaction to the food.  Table 6.4 at the end of the chapter describes 
all the cases of food allergy, symptoms and how the diagnosis was made.   
All allergic patients were SPT positive to the food, 34/40 (85%) were ISAC positive. All cases of peanut 
allergy in Xhosa patients were challenge- proven. Of the 40 patients with allergy, 28 (70%) of patients 
had one allergy, 9 (22.5%) had 2 allergies and 3 patients (7.5%) had 3 different food allergies.    
Overall, 14 patients reported a severe reaction with respiratory symptoms after previous exposure to 
peanut (7), tree nut (2) or egg (5). Two of these egg allergic patients were subsequently shown in the 
study to have outgrown their allergies. In addition, one severe reaction was elicited on food challenge 
(peanut). There were no parental reports of food allergy manifestations after a negative food 
challenge.  
Foods most commonly implicated in food allergy were egg (25%) and peanut (24%) followed by tree 
nut (3%), cow’s milk (2%) and fish (1%). Cow’s milk allergy was low (2%) but 8 further patients reported 
that they had signs of allergy to dairy products in the past but now tolerated it. There were no 
confirmed allergies to wheat or soya.  
The prevalence ratio for food allergy for mixed race relative to Xhosa patients was 1.44 (p=0.13). 
Allergy rates were not significantly different between ethnic groups for egg, cow’s milk and fish 
allergies. However, the peanut allergy rate was significantly higher in the mixed race group at 38% 
versus 15% in the Xhosa group, p=0.01. Tree nut allergy was also significantly higher in the mixed race 
group (7% versus 0%), p=0.04.  
Food sensitisation and allergy prevalence are summarised in Table 6.2 and figure 6.1.  Ethnic 


















Table 6.2: Food Sensitisation and Allergy Patterns 
 Overall 
sensitization 
and allergy to 
at least one 
food* 
Egg Peanut Cow’s Milk Soya Wheat Fish Cashew Nut 
 Sens Allergy Sens Allergy Sens Allergy Sens Allergy Sens Allergy Sens Allergy Sens Allergy Sens Allergy 
Overall 
(n=100) 
66% 40% 54% 25% 44% 24% 27% 2% 9% 0% 6% 0% 13% 1% 0 3% 
Xhosa  
(n=59) 
69% 34% 59% 24% 41% 15% 22% 0% 8.5% 0% 7% 0% 7% 1.6% 0 0% 
Mixed race 
(n=41) 







0.1 0.2 0.7 0.1 0.01$ 0.2 0.1 0.8 1 0.7 1 0.03
$ 
0.7 1 0.04$ 
*By screening tests- Skin prick test (except cashew nut) or ISAC  
# By chi-squared test  
Sens= sensitised 






























Figure 6.1 - Overall prevalence of sensitisation and 
















6.6   Proportion of sensitised patients who were allergic 
Overall, 66% of patients were sensitised to at least one food, and 40% of patients were allergic to at 
least one food.  Therefore, 40/66 (60 %) of sensitised patients were confirmed as allergic. Out of 152 
cases of sensitisation, 55 (36%) translated into allergies.  
There was a significant ethnic difference in fall-off between sensitisation and allergy: in the mixed race 
patients, 25 were sensitised and 20 allergic, hence 80% of sensitised patients were allergic; in the 
Xhosa patients, 41 were sensitised and 20 allergic, hence 49% of sensitised patients were allergic,          
p = 0.002. 
Overall 46% of egg-sensitised patients were egg-allergic (58% in mixed race and 40% in Xhosas,               
p= 0.08). Overall, 57% of peanut-sensitised patients were peanut-allergic (75% in mixed race and 39% 
in Xhosas, p < 0.001). 7% of milk sensitised patients were allergic (14% in mixed race and 0% in Xhosas, 
p=0.003). 
6.7 Risk factors for food allergy 
6.7.1 Age of onset of eczema and food allergy rates 
The median age of onset of eczema was 6 months in both ethnic groups (range 1-96 months).  Fifty-
six children had onset of eczema at or less than 6 months of age, of those 31 were allergic (55%); 44 















































This trend was similar in both ethnic groups: in Xhosa patients, 16/33 (48%) with early onset eczema 
(≤6 months) had allergies, compared with 4/26 (15%) with later onset (p=0.008).  In mixed race 
patients, 15/23 (65%) with early onset eczema (≤ 6 months) were food-allergic, compared with 5/18 
(28%) with later-onset eczema (p=0.017). The influence of age of onset of eczema (divided into 
tertiles) on food sensitisation and allergy rate is depicted in figure 6.3. 
 
 
6.7.2 Eczema severity and food allergy rates 
The SCORAD score was normally distributed with mean score 41 (range 16-71). In those with moderate 
eczema (SCORAD 15-40, n=50), 15 were allergic (30%). In those with severe eczema (SCORAD>40, 
n=50), 25 were allergic (50%) (p=0.04).  
6.7.3  Age at time of assessment and food sensitisation and allergy rates 
Sensitisation rates were higher in the younger age groups, implying that food sensitisation occurs early 
on. Similarly, allergy rates peaked in the 0-2 year old participants (59%) in comparison to the older age 
groups (25% in over 4 year olds), p=0.003.  The proportion of allergic to sensitised patients was higher 
in the younger age groups, implying that a positive SPT is more likely to reflect a true allergy in the 0-
2 year age group.  Sensitisation and allergy rates by age are depicted in figure 6.4.   
Egg allergy in particular was higher in the younger age groups (50% in under 2 year olds, 13% in over 
2 year olds, p< 0.001).  This is likely a reflection of the natural acquisition of tolerance to egg over time. 


























Figure 6.3 - Influence of Age of Onset of Eczema on 
















The trends in ISAC-determined sensitisation patterns at 1 year, 2 years, 4 years and 10 years for 
individual food allergens are depicted in table 6.3. This shows that sensitisation peaks by one year of 
age for cow’s milk, hen’s egg, soya and peanut. Fish sensitisation remained stable from 1 to 10 years, 
and wheat sensitisation increased over time in this popul tion, likely reflecting cross-reactivity with 
grass pollens developing in the older children.   
 
Table 6.3 ISAC-determined sensitisation patterns to individual foods over time  
                                                                          Age in Years 
Food allergen 1 year 2 years 4 years 10 years 
Egg  63%      (5/8) 38%      (12/32) 35%    (21/60) 32%    (32/100) 
Cow’s Milk 12.5%   (1/8)  9%       (3/32)  7%     (4/60) 6%      (6/100)  
Peanut 63%      (5/8) 34%      (11/32) 33%    (20/60) 30%    (30/100) 
Wheat 0% 0% 2%      (1/60)  3%      (3/100) 
Fish  12.5%   (1/8) 16%      (5/32) 12%    (7/60)  15%    (15/100) 
Soya 25%      (2/8) 12.5%   (4/32) 10%    (6/60) 11%   (11/100) 
 
6.7.4 Ethnicity as a risk factor for food allergy 
As discussed in section 6.5, mixed race children had a higher prevalence of peanut and tree nut allergy 
than Xhosa patients, and a greater chance of being food-allergic if sensitised. This was despite 
equivalent median age of onset of eczema, eczema severity and median age of the study population 





























Figure 6.4   Influence of Age at Study Entry on 















6.8   Food-induced flares in AD 
Fifteen of the 40 patients (38%) with IgE mediated food allergy reported an eczema flare-up as part of 
their late symptomatology.  
In addition, another 18 (18%) patients who were not sensitised to the food in question reported a late 
eczema flare (> 2 hours after ingestion) after eating the food. Whilst this may represent a non-IgE 
mediated allergy, these patients were not investigated any further as the focus of this study was on 
IgE mediated food allergy. 
6.9   Previous diagnosis of food allergy 
Only 7 of the 40 allergic children (18%) had previously been diagnosed with food allergy. Of the 18 
food allergic children with intercurrent asthma symptoms, which puts them at greater risk of severe 
reactions, only 4 (22%) had doctor-diagnosed food allergy. 
6.10 Peanut consumption patterns 
Despite a difference in monthly household income (table 6.1), there were no significant differences in 
peanut consumption patterns between Xhosa and mixed race groups. Amongst Xhosa children, 78% 
had consumed peanut before, compared to 85% of mixed race children (p=0.4). In those who had 
introduced peanut into their diets, the median age of introduction was 19 months in the Xhosa group, 
and 12 months in the mixed race group (p=0.08). The median number of peanut servings per week in 
those consuming peanut was 3 for both ethnic groups. This will be discussed in more detail in chapter 
12. 
6.11 Discussion 
This is the first study to investigate the rate of challenge-proven food allergy in children in Southern 
Africa. We targeted children with moderate-severe AD at high risk for food allergy, under the 
hypothesis that even in this high risk group, we would observe a low prevalence of food allergy, 
especially in the Xhosa group.  However, we observed a high proportion of children sensitised and 
allergic to common food allergens, with equivalent rates to those reported in similar selected cohorts 
in westernised countries. This finding is significant, as food allergy prevalence in South Africa has 
previously been thought to be low, especially in Black Africans.  
The overall sensitisation rate to common allergenic foods was 66%; highest for egg (54%), peanut 
(44%) and cow’s milk (27%). The allergy rate was 40%; highest to egg (25%), peanut (24%) and tree 














of > 40 (“severe eczema”) as well as age below 2 years. These risk factors have similarly been described 
in previous AD/food allergy studies. 3,17-18 
Ethnic differences in sensitisation and allergy rates were evident between the indigenous black African 
Xhosas and the mixed race group. Food sensitisation was higher in the Xhosa population (69%) than 
in the mixed race cohort (61%). The allergy rate was surprisingly high in the Xhosas at 34%, yet lower 
than that in the mixed race cohort (49%). There were a significant number of cases with challenge 
proven peanut allergy in the Xhosa population (15% of Xhosa participants), in whom peanut allergy 
has been seldom reported previously.    
Of particular interest was the proportion of truly allergic versus sensitised patients. This proportion 
was significantly lower in the Xhosa population compared with the Mixed race population (49% of 
sensitised Xhosas were allergic; versus 80% of mixed race patients). This was especially pronounced 
for peanut allergy, with only 39% of peanut-sensitised Xhosas having a proven allergy; versus 75% in 
the mixed race group (p=<0.001).   
The common assumption that the high “false” sensitisation rates in black Africans may be caused by 
large levels of non-specific IgE as a result of helminthic or parasitic infection, 19-22 may not hold true in 
this study population. Although we did not assess for parasite infestation or sensitisation, the total IgE 
was found to be higher in the mixed race group (median 1562 kiU/L) than the Xhosa group (median 
656 kiU/L).  In peanut sensitised patients, the mixed race group had a higher total IgE (median 1703) 
than their Xhosa counterparts (median 1011). Moreover, a higher cross reactivity between peanut and 
Timothy grass 23 cannot explain the “falsely high” peanut sensitisation rate in Xhosa patients, nor can 
differences in peanut consumption patterns. This will be explored further in chapter 7, which focuses 
on peanut allergy patterns.  
Therefore, the Xhosas seem genuinely highly sensitised to certain foods, but less allergic. There is a 
suggestion that, although allergies are now emerging strongly amongst Black South Africans, there 
may still be factor(s) providing relative “protection” in the Xhosa patients against an allergic 
manifestation. Such factors may include dietary patterns and microbial exposure, but require further 
exploration. Our concern is that, as the traditional lifestyle is replaced by a westernised lifestyle, the 
strong genetic propensity to food allergy may become unmasked via epigenetic changes, leading to 
further increases in allergy rates.24 
In this study, the skin prick test was 100% sensitive in detecting food allergies, in both Xhosa and mixed 
race participants. Therefore, the lower skin prick test reactivity recently described in Black cohorts15 














emphasises the high sensitivity but low specificity of allergy screening tests, and the vital role of food 
challenges in equivocal cases. Seventy-one food challenges were performed in 47 patients, with 32 
positive challenges.  This means that in almost half of the study population, history and screening 
investigations were not deemed adequate proof of allergy versus tolerance.  
The ISAC test was used for plasma food-specific IgE in view of its high specificity, multiple allergen 
component testing on a small blood volume, and inclusion of aeroallergen sensitisation.25  However, 
in this study the sensitivity of ISAC for detecting food allergy was 85% compared with 100% for SPT.  
In this population, only a low percentage (18%) of food-allergic patients had previously had their 
allergies formally diagnosed. This means that a significant proportion of children with moderate to 
severe atopic dermatitis may have unrecognised food allergies which could cause immediate reactions 
or eczema flares. Moreover, those patients who had not been previously diagnosed would not have 
had access to emergency treatment plans and dietetic input.  
 
6.12 Conclusion 
Food allergy rates in this cohort of South African children with moderate to severe AD are high and 
equivalent to westernised counterparts. There are ethnic differences, with Xhosas having equivalent 
sensitisation rates but lower allergy rates, than children of mixed race. In the case of peanut, egg and 
cow’s milk, Xhosa children are less likely than children of mixed race to be truly allergic if they are 
sensitised.  Further research should explore possible “protective” factors for food allergy in the Xhosa 
population, whilst a window of opportunity for possible intervention still exists. 
Young age, early onset eczema (< 6 months) and severe eczema AD are significant risk factors for food 
allergies.  In keeping with recent guidelines,26-27 our study confirms the importance of early referral of 



















Table 6.4 Summary of test results and clinical findings in patients with IgE mediated food allergy 
Patient Ethnicity Age    (in 
months) 





001 Mixed 46 Egg Food challenge positive 










Egg white 0.21 
Ovomucoid 1.33  
004 Mixed 32 Egg  Food challenge positive 
(generalised pruritis and macular 
rash. Late exacerbation of 
eczema) 
EWE 1 mm 
REW  
20 mm 




 Peanut  Food challenge positive 




 nAra h 1 1.7 
 nAra h 2  12 
 nAra h 3   6 
Peanut   15.2 
rAra h 1    0.72 
rAra h 2   16.9 
rAra h 3    3.54 
rAra h 8    0.08 
rAra h 9    0.09 
005 Xhosa 44 Peanut Food challenge positive 
(Wheals, facial flushing, 
generalised pruritis, irritability. 
Late worsening of eczema) 
Peanut 13mm nAra h 1   0 
nAra h 2  9.4 
nAra h 3   0 
Peanut   87.6 
rAra h 1   3.81 
rAra h 2   58.8 
rAra h 3   4.98 
rAra h 8   3.06 
rAra h 9   1.23 
007 Mixed 90 Peanut History: recent symptoms of itchy 
rash, tight throat and wheeze 
after peanut butter ingestion 
Peanut 15mm nAra h 1  0.8 
nAra h 2   15 
nAra h 3   0 
Peanut   19.3 
rAra h 1    0.1 
rAra h 2   41.7 
rAra h 3   0.27 
rAra h 8   0.26 
rAra h 9   0.17 
   Treenut -
cashew 
History: recent symptoms of itchy 
rash, tight throat and wheeze 
after cashew nut ingestion 
Not done Negative Cashew 30.2 
010 Mixed 7 Egg History: Background of wheeze 
and rash with egg. Recent 
symptoms still with immediate 
onset hives, pruritis and vomiting 
after scrambled egg 
EWE  6mm 
REW 15mm 
nGal d 1  0.4 
nGal d 2  0.5 
nGal d 3  1.5 
nGal d 5  3.3 
Egg white 8.38 
Ovomucoid 1.85 
   Peanut Food challenge positive 
(itchy throat, clearing of throat, 
vomiting, abdominal cramps) 
Peanut 20mm nAra h 1  1.8 
nAra h 2  1.0 
nAra h 3  3.7 
Peanut   94.8 
rAra h 1   6.32 
rAra h 2   17.0 
rAra h 3   5.86 
rAra h 8   0.59 
rAra h 9   37.6 
   Treenut History: recent symptoms of 
diffuse urticarial rash and itchy 
throat/cough after cashew nut 
ingestion 
Not done Negative Cashew  35.5 
011 Mixed 88 Peanut History: recent history itchy rash, 
flushing, itchy mouth and wheeze 
with peanut butter ingestion 
Peanut 12mm nAra h 1 1.1 
nAra h 2 7.4 
nAra h 3 0.5 
Peanut   14.5 
rAra h 1   14.9 
rAra h 2   4.76 
rAra h 3   0.36 
rAra h 8   0.21 
rAra h 9   0.22 
   Egg History: recent itchy rash, itchy 
mouth, clearing of throat and 




nGal d 1  38 
nGal d 2   12 
nGal d 3   0 
nGal d 5   0 















Patient Ethnicity Age    (in 
months) 





012 Xhosa 40 Peanut Food challenge positive 
(Red, itchy eyes, flushing of face 
and generalised pruritis, 
complained of itchy mouth and 
clearing of throat.) 
Peanut 15mm nAra h 1     0 
nAra h 2  2.8 
nAra h 3   0 
Peanut   6.66 
rAra h 1   2.14 
rAra h 2   6.43 
rAra h 3   0.04 
rAra h 8   0.01 
rAra h 9    0.0 
015 Xhosa 24 Peanut Food challenge positive 
(Generalised pruritis. Vomiting 
twice. Diarrhoea) 
Peanut 16mm  
negative 
Peanut  1.12 
rAra h 1   0.03 
rAra h 2   0.32 
rAra h 3   0.02 
rAra h 8   0.05 
rAra h 9   0.0 
019 Xhosa 86 Peanut Food challenge positive 
(>3 urticarial lesions, oral itch, 
retching. Late eczema flare) 
Peanut 4mm nAra h 1  3.1 
nAra h 2    0 
nAra h 3    0 
Peanut   23.4 
rAra h 1   6.82 
rAra h 2   0.84 
rAra h 3  1.21 
rAra h 8   0.48 
rAra h 9   1.06 
   Egg History: recent itchy rash, itchy 
mouth, clearing of throat and 




nGal d 1  38 
nGal d 2   12 
nGal d 3   0 
nGal d 5   0 
Egg white 44.6 
Ovomucoid 63.2 
020 Xhosa 44 Egg Food challenge positive 
(generalised pruritis, diffuse 
truncal macular rash, anxiety. 
Late worsening of eczema) 
EWE  5mm 
REW10mm 
nGal d 1  2.5 
nGal d 3  3.2 
nGal d 5  3.5  
Egg white >100 
Ovomucoid 
>100 
026 Mixed  52 Egg History: itchy rash, angioedema 




nGal d 1  14 
nGal d 2  5.7 
nGal d 3   25 
nGal d 5  3.3 
Egg white 53.6 
Ovomucoid 22.7 
   Peanut History: recent itchy rash, 
angioedema, tight throat, light 
headedness and wheeze after 
peanut butter ingestion requiring 
IM adrenaline in emergency 
department 
Peanut 12mm nAra h 1  5.1   
nAra h 2   53 
nAra h 3  3.6 
Peanut >100 
rAra h 1   4.1 
rAra h 2   68.6 
rAra h 3  0.76 
rAra h 8  0.45 
rAra h 9  0.66 
031 Mixed  10 Milk Food challenge positive 
(generalised pruritis, facial 
flushing, vomiting x 2) 
Fresh milk 
17mm 
nBosd8 0.7 Cow’s milk 21.2 
Casein 31.2 
   Egg Food challenge positive 




nGal d 1   0 
nGal d 2  0.7 
nGal d 3  1.2 
nGal d 5   0 
Egg white 42.5 
Ovomucoid 0.85 
   Peanut Food challenge positive (multiple 
wheals on face, generalised 
pruritis, flushing, anxiety) 
Peanut 11mm nAra h 1  0.9  
nAra h 2  2.2 
nAra h 3  1.1 
Peanut  62.5 
rAra h 1   6.68 
rAra h 2  16.2 
rAra h 3   7.6 
rAra h 8   0.1 
rAra h 9   0.1 
033 Xhosa 12 Egg Food challenge positive 
(generalised pruritis, macular 
rash trunk, vomiting) 
EWE   4mm 
REW  8mm 
nGal d 1  22 
nGal d 2  5.8 
nGal d 3   21 




034 Xhosa 16 Egg History: recent itchy rash, 






nGal d 1  2.0 
nGal d 2  0 
nGal d 3  0 
nGal d 5  0 
Egg white  4.1 














Patient Ethnicity Age    (in 
months) 





038  Mixed 101 Peanut History: itchy rash and clearing of 
throat/ cough and retching 
shortly after ingestion of peanut, 
recurrently 
Peanut 7mm Negative Peanut  1.68 
rAra h 1   0.24 
rAra h 2    0.38 
rAra h 3   0.13 
rAra h 8   0.16 
rAra h 9   0.98 
039 Mixed 17 Egg Food challenge positive 
(Macular rash on trunk, 
generalised pruritis, anxiety) 
EWE 6mm 
REW 8mm 
nGal d 1 0.7 
nGal d 2   0 
nGal d 3   0 
nGal d 5   0 
Egg white 0.43 
Ovomucoid  
0.27 
040 Xhosa 10 Egg Food challenge positive 
(pruritis, vomiting and copious 




nGal d 1  1.6 Egg white 19.2 
Ovomucoid 46.8 
041  Xhosa 17 Egg Food challenge positive  
(macular rash on trunk, pruritis, 
clingy, vomit x1) 
EWE  4mm 
REW  7mm 
All negative Egg white 0.52 
Ovomucoid 0.22 
046 Xhosa 86 Fish History: Recurrent itchy rash, 
hives and angioedema on 
ingestion of white fish. Whilst 
waiting for food challenge had a 
similar reaction hence challenge 
cancelled 
Cod Fish 4mm nCypc1  8.7 
nGadc1  7.9 
Cod 10.4 
047 Xhosa 22 Egg Food challenge positive 
(diffuse truncal and facial 




nGal d 1  31 
nGal d 2  19 
nGal d 3   0 




052 Xhosa 16 Egg History: Cough and vomit with 
itchy rash after ingestion of egg 
on several occasions; happened 
again accidentally whilst awaiting 




Negative Egg white 7.7 
Ovomucoid 3.6 
rGal d 2  5.94 
rGal d 3  0.08 
053 Mixed 32 Egg Food challenge positive 
(angioedema of lip, peri-oral and 
facial hives)  
EWE  0 
REW 10mm 
nGal d 1 0.6 
nGal d 2 1.1 
nGal d 3 0.6 
nGal d 5  0 
Egg white 14.6 
Ovomucoid 20.5 
057 Mixed 10 Egg Food challenge positive 
(macular rash on trunk, anxious, 
dry cough) 
EWE  0mm 
REW 10mm 
Negative Egg white 12.0 
Ovomucoid 0.15 
rGal d 2  19.5 
rGal d 3  0.29 
   Peanut Food challenge positive  
(flushing of face, wheals>3, 
pruritis) 
Peanut 12mm Negative Peanut  1.89 
rAra h 1  0 
rAra h 2  0.08 
rAra h 3  0.21 
rAra h 8  0.02 
rAra h 9  0.01 
 
059 Xhosa 37 Egg Food challenge positive 
(itchy eyes and mouth, macular 




nGal d 3 0.4 Egg white 6.2 
rGal d 1    6.14 
rGal d 2    2.09 
rGal d 3    1.48 
 
   Peanut Food challenge positive 
(generalised pruritis, severe 
abdominal pain and vomiting) 
Peanut     11 
mm 
nAra h 2 0.6 Peanut  1.83 
rAra h 1      0 
rAra h 2   1.66 
rAra h 3   0.01 
rAra h 8   0.01 














Patient Ethnicity Age    (in 
months) 





060 Mixed 10 Egg History: Recent reaction with 
flushing, hives and worsening of 
eczema 
EWE  6mm 
REW 13mm 
nGal d 1  0.9 
nGal d 2    0 
nGal d 3  1.0 
nGal d 5  1.1 
Egg white> 100 
Ovomucoid 52.6 
062 Xhosa 18  Egg History: Recent history of diffuse 
urticarial rash within 30 minutes 
of egg ingestion, and late 
worsening of eczema. Reacted 
again whilst awaiting challenge 
EWE  7mm 
REW 12mm 
nGal d 1  1.0 
nGal d 2  0.6 
nGal d 3   0 
nGal d 5   0 
Egg white 40 
Ovomucoid 6.35 
064 Xhosa 27 Peanut Food challenge positive 
(multiple wheals on face, itchy 
mouth, irritability, late flare of 
eczema) 
Peanut 17mm nAra h 1  1.6 
nAra h 2  0.6 




rAra h 1  11.5 
rAra h 2  8.98 
rAra h 3  0.23 
rAra h 8   0 
rAra h 9   0 
066 Xhosa 48 Peanut Food challenge positive 
(Itchy eyes and mouth, 
generalised pruritis. Vomiting.  
Late exacerbation of eczema) 
Peanut 16mm nAra h 1   0  
nAra h 2  3.8 
nAra h 3   0 
Peanut  10.0 
rAra h 1   0.19 
rAra h 2   6.8 
rAra h 3   0.24 
rAra h 8   0.04 
rAra h 9   0.04 
069 Xhosa 12 Egg Food challenge positive 
(Macular rash, pruritis, erythema 
of left eye, vomiting. Worsening 
of eczema the next day) 
EWE 7mm 
REW 11mm 
nGal d 1  0.5 
nGal d 2  0.7 
Egg white 5.15  
Ovomucoid 0.8  
074 Mixed  19 Egg History : recent urticaria, 
angioedema and flushing shortly 
after egg ingestion, and late 
eczema flare up 
EWE 11mm 
REW 21mm 
nGal d 1 2.2 
nGal d 2  0 
nGal d 3  0 
nGal d 5  0 
Egg white 48.7 
Ovomucoid 45.0 
   Peanut History recent itchy rash, 
coughing, angioedema and 
flushing shortly after ingestion of 
peanut butter, and late eczema 
flare 
Peanut 22mm nAra h 1  2.6 
nAra h 2  3.4 
nAra h 3  1.8 
Peanut  52.7 
rAra h 1  6.8 
rAra h 2  25.5 
rAra h 2  1.59 
rAra h 8  0.12 
rAra h 9  0.13 
075 Mixed  83 Peanut History:  immediate diffuse 
urticarial, clearing of throat, 
cough and late eczema flare up 
after peanut butter ingestion 
Peanut 20mm nAra h 1   0 
nAra h 2  5.7 
nAra h 3   0 
Peanut   3.36 
rAra h 1   0 
rAra h 2   3.97 
rAra h 3    0 
rAra h 8  0.05 
rAra h 9  0.94 
079 Mixed  17 Treenut  History: recent history urticaria, 
flushing, angioedema and 
wheeze within 30 minutes of 
cashew nut ingestion. 
Not done negative Cashew 1.61 
086 Xhosa 21 Egg Food challenge positive 
(Angioedema of lips, generalised 




nGal d 1 7.7 
nGal d 2 4.4 
nGal d 3 2.2 
nGal d 5 4.7 
Egg white > 100 
Ovomucoid > 
100 
   Peanut  Food challenge positive (pruritis, 
urticarial rash and stridor 







Peanut 9mm  
nAra h 1  2.5 
nAra h 2  4.6 
nAra h 3  2.2  
Peanut 88 
rAra h 1   23.2 
rAra h 2   80.2 
rAra h 3   8.26 
rAra h 8   0.05 














Patient Ethnicity Age    (in 
months) 





087 Mixed  48 Milk History: Positive recent 
symptoms with immediate 
urticarial rash, pruritis, vomiting 
and late flare of eczema. Whilst 
awaiting challenge had a further 
episode of angioedema and itchy 









Milk extract 0 
Fresh milk 
6mm 
nBosd4  1.0 
nBosd5  0.9 
nBosd8  0.4 






Casein  4.01 
087 Mixed 48 Egg Food  challenge positive 
(Generalised pruritis, nausea and 




nGal d 1  11 
nGal d 2  4.2 
nGal d 3  6.1 




   Peanut History: recent itchy rash, tight 
throat, wheeze and vomiting 
shortly after peanut ingestion. 
Peanut 10mm nAra h 1  12 
nAra h 2  11 
nAra h 3  1.1 
Peanut  99.2 
rAra h 1  62 
rAra h 2  64.5 
rAra h 3  3.52 
rAra h 8  0.3 
rAra h 9  64.9 
089 Mixed  90 Peanut Recent and recurrent history 
itchy rash, flushing and late 
exacerbation of eczema 
Peanut 15mm nAra h 1  0 
nAra h 2  8.9 
nAra h 3  0 
Peanut   11.5 
rAra h 1   1.01 
rAra h 2   25.6 
rAra h 3   1.07 
rAra h 8   0.43 
rAra h 9   30.9 
090 Mixed  43 Peanut Food challenge positive 
(multiple wheals, itchy eyes, 
pruritis.) 
Peanut 9mm nAra h 1  0 
nAra h 2  4.3 
nAra h 3  0 
Peanut 8.03 
rAra h 1  1.35 
rAra h 2  14.3 
rAra h 3  0.65 
rAra h 8  0.15 
rAra h 9  0.18 
091 Xhosa 18 Egg History: Recent history diffuse 
urticarial rash, itching in mouth 
and coughing after cooked egg 
ingestion; followed by late 
eczema flare up. 
EWE 15mm 
REW 15mm 
nGal d 1  0 
nGal d 2  0 
nGal d 3  0 
nGal d 5  0.6 
Egg white  9.47 
Ovomucoid 2.10 
   Peanut  Food challenge positive 
(generalised pruritis, facial 
flushing, rhinorrhoea) 
Peanut 13mm nAra h 1  0 
nAra h 2  2.2 
nAra h 3  0 
Peanut  23.5 
rAra h 1   0.35 
rAra h 2   17.1 
rAra h 3   0.05 
rAra h 8   0.05 
rAra h 9   0.02 
093 Mixed  59 Peanut Food challenge positive 
(pruritis, macular rash, anxiety, 









Peanut 10mm nAra h 1  9.1 
nAra h 2  1.8 
nAra h 3  1.2 
Peanut > 100 
rAra h 1  >100 
rAra h 2  22.2 
rAra h 3   8.88 
rAra h 8  0.45 














Patient Ethnicity Age    (in 
months) 





097 Xhosa 15 Egg History: Recurrent urticaria, 
pruritis and angioedema on 
history; with late flare up of 
eczema. Called up for challenge 





negative Egg white 1.01 
Ovomucoid 0.85 
098 Mixed  7 Peanut Food challenge positive 
(multiple> 3 urticarial lesions, 
pruritis, late worsening of 
eczema) 
Peanut 10mm nAra h 2  0.8 Peanut   12.7 
rAra h 1   0.45 
rAra h 2   2.63 
rAra h 3   0.2 
rAra h 8   0.02 
rAra h 9   0.17 
 
EWE= egg white extract 
REW= raw egg white 
n (eg nAra h 2) =native component of Ara h 2 
r (eg rAra h 2)=recombinant component of Ara h 2 
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Chapter 7:  
Peanut Sensitisation, Allergy and Component Patterns in South 
African Children with Atopic Dermatitis 
 
Abbreviations 
AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SCORAD: Scoring Atopic Dermatitis Score 
SPT:          Skin Prick Test 
ISAC:        Immuno Solid Phase Allergen Chip 
PPV:         Positive Predictive Value 
NPV:         Negative Predictive Value 
ISU:          ISAC Units 
IQR:          Interquartile range 
ROC:         Receiver Operating Characteristic  
 
7.1 Introduction 
The increase in allergy to peanut in westernised countries 1-3 has sparked international interest in 
peanut allergy. Peanut allergy prevalence varies significantly between geographic regions: in the 
EuroPrevall study, the overall prevalence of peanut allergy was 2.6%,4,5 with wide variation between 
countries from 0.06% (Israel)6 to 5.9% (Sweden).7  
Apart from geographical variation, ethnic differences in peanut allergy prevalence within a particular 
region may occur. Recent studies have suggested that non-whites may be at greater risk of food 
allergy, especially if they are living in a westernised environment. 8-10   In the recent HealthNuts study, 
Asian children who were the “first generation” in Australia, whose parents were born in East Asia, had 
a higher prevalence of peanut allergy than children with two Australian-born parents, even though 
their parents were less atopic.11  
Sensitisation does not equate to allergy in peanut-sensitised patients, and food challenges may be 
required to differentiate between asymptomatically sensitised and truly allergic patients.  95% 
positive predictive values (PPVs) have been established to more reliably predict food allergies and 
reduce the number of labour-intensive and potentially hazardous food challenges.  However, these 














Peanut components are prefixed “Ara” after the first 3 letters of the genus and first letter of the 
species of peanut, viz Arachis Hypogaea. Roman numerals after the preix are usually numbered in the 
order in which they were discovered. Component testing for peanut proteins helps differentiate 
between non-specific cross reactive components such as Ara h 8 and Ara h 9 and specific peanut 
components such as Ara1,2 and 3, which are heat resistant storage proteins.  Ara h 2 (2S albumin 
storage protein) has been shown to be the most important component in prediction of food allergy in 
several countries, including the UK,14,15 Sweden,16 France,17,18  Japan19 and the United States,20  with a 
positive result (>0.35kU/L) to Ara h 2 having a high predictive value for peanut allergy. In 
Mediterranean countries, the lipid transfer protein Ara h 9 is an important peanut allergen.21  Ara h 8, 
in the PR10 protein group of labile food allergens, is more prominent in those exposed to certain 
pollens such a birch, alder and Timothy grass.16,22  Thus the pattern and relevance of peanut 
components may vary between geographical areas and possibly between ethnic groups.23  
There is very little data on peanut allergy in South Africa. In a South African study of 212 Xhosa high 
school patients, 1.9% were sensitised to peanut (SPT≥3mm above the negative control) but none 
reported allergic symptoms.24 Eczema, especially early onset and more severe in nature, is a significant 
risk factor for developing food allergy including peanut allergy.25  In 2009, as part of the Early 
Prevention of Asthma and Allergies in Children (EPAAC) study, 114 South African infants with atopic 
dermatitis were shown to have a sensitisation rate of 26.8% to peanut.26  This study did not, however, 
explore clinical food allergy.  
The aim of this chapter is to describe sensitisation, allergy and component patterns in peanut allergy 
in our cohort of children with AD. It also aims to compare peanut sensitisation and allergy patterns 
between children of black South African origin (Xhosa) and children of mixed race origin. Patterns of 
peanut component sensitisation (Ara h 1,2,3,8 and 9) and the value of internationally derived 95% 
positive predictive values for peanut allergy will be explored in the two ethnic groups. It is the first 
study in South Africa to utilise oral food challenge tests in equivocal cases, and also the first to analyse 
peanut component patterns.  
 
7.2 Methodology 
The 100 children who took part in this study were screened for peanut allergy by allergy questionnaire, 
skin prick test (SPT) to peanut extract (Alk Abello, Madid Spain), and ImmunoCAP ISAC (103) test which 
tested for peanut components Ara h 1, 2, 3 and 8. The patients who were sensitised to peanut by SPT  
or ISAC test (n=44) futher underwent immunoCAP testing to whole peanut extract and components, 














regarding peanut allergy, an incremental open food challenge was performed as a day case at the Red 
Cross Children’s Hospital. The challenge food was given in the form of peanut butter, starting with  a 
lip challenge, them moving from 0.3g to 17 g of peanut butter over 2 hours with dose increments 
every 15-20 minutes.  
7.2.1 Study definitions 
IgE-mediated peanut sensitisation was defined as a positive SPT (3 mm or more above the negative 
control) and/ or positive food specific IgE by ISAC (≥ 0.3 ISAC units) 
 
 IgE-mediated peanut allergy was defined as either: 
 A positive food challenge 
 A convincing clinical history of significant type I allergic reactions after isolated ingestion of 
peanut-containing food in the preceding 6 months, with significantly positive SPT/sIgE above the 
internationally derived 95% positive predictive value for peanut of 8 mm for SPT and 14 kU/L for 
ImmunoCAP. 27,28   
 
7.3 Results 
100 children were recruited into the study, 59 Xhosas and 41 of mixed race. One patient of mixed race 
did not complete her peanut challenge hence was excluded from the analyses.   The median age at 
the time of participation was 42 months overall; 40 months  in Xhosas and 48 months in mixed race 
patients (p=0.09). Other baseline characteristics which could affect peanut sensitisation and allergy 
patterns such as age of onset of eczema, SCORAD score for eczema severity, total IgE levels, 
sensitisation to Timothy grass as a cross reacting antigen, concomitant egg allergy and asthma, and 
median age of peanut introduction were not significantly different between the 2 ethnic groups. Such 
baseline characteristics are depicted in Table 7.1. 
All 100 patients underwent SPT to peanut allergen; as well as ISAC testing to peanut components 
Ara1,2,3 and 8.  Forty-four (44) patients who were sensitised by SPT or ISAC also underwent 
ImmunoCAP testing to whole peanut extract, and recombinant Ara h 1,2,3,8 and 9. Twenty-five 
patients underwent a peanut challenge,  16 Xhosa and 9 of mixed race. Of these 25 challenges,  64% 

















Table 7.1. Inter-ethnic Comparison of baseline characteristics which could affect peanut 
sensitisation and allergy  patterns 






Median age at time of 
study entry  
 
40 months 48 months 0.09++ 
Median age of peanut 
sensitised patients 
31 months 52 months 0.27++ 
Median age of peanut 
allergic patients 
37 months 52 months 0.26++ 
Median age of onset 
of eczema 
 




37 (32-45) 44 (33-52) 0.07++ 
Median SCORAD in 
peanut sensitised 
patients (IQ range) 
36 (31-46) 44 (34-42) 0.13++ 
Total IgE (median in 
kU/L) 
 
656 1562 0.31++ 
Total IgE in peanut 
sensitised patients 
(median in kU/L) 
1059 1701 0.26++ 
Proportion of patients 
sensitised to Timothy 
grass 
29% 46% 0.08* 
Timothy grass 
sensitisation in peanut 
sensitised patients 
33% 55% 0.24*  
Co-existing asthma 
 
36% 44% 0.4* 
Co-existing egg allergy 
 
24% 27% 0.73* 
Median age of 
introduction of peanut 
19 months 12 months 0.08* 
 
++    by Mann-Whitney test 


















7.3.1 Peanut sensitisation and allergy patterns 
Overall, 44% (44) patients were sensitised to peanut, 41% (24/59) of Xhosa patients and 50% (20/40) 
of mixed race patients (inter-ethnic difference in sensitisation non-significant p=0.1). Of those 
sensitised,  41 were skin prick test positive (of which 30 were ISAC positive) and an additional 3 were 
ISAC positive in the absence of a positive SPT. None of the patients with a positive ISAC but negative 
SPT were subsequently found to be allergic.  
Overall, 25 % (25) of patients were peanut allergic: 15% (9/59) of Xhosa patients and 38% (15/40) of 
mixed race patients (inter-ethnic difference significant p=0.01).  All of the 9 Xhosa patients who were 
classified as allergic were diagnosed by positive food challenge.  In the mixed race group, 7  patients 
were diagnosed by positive food challenge, and  8  had a convincing recent history of a peanut allergy 
(4 of these had a history of anaphylaxis) and had skin prick test above the 8 mm level.  89% (21/24) 
patients with peanut allergy were positive by ISAC components 1, 2, 3 or 8. This means by using the 
ISAC test alone, 3 cases (11% of cases) of peanut allergy may have been missed.  
Overall, 57% of peanut-sensitised patients were peanut-allergic; this ratio was 75% in mixed race and 
38% in Xhosas, significantly different at p < 0.001. Sensitisation and allergy patterns are depicted in 
figure 7.1. 
Figure 7.1 Chart showing proportion of patients with peanut sensitisation and allergy, by ethnicity 
 
A:S=allergic:sensitised 
Despite the differences in peanut allergy rates, median values for whole peanut ImmunoCAP, 
ImmunoCAP rAra h 2, ISAC nAra h 2 and skin prick test diameter in peanut allergic and tolerant patients 











Sensitisation and allergy patterns by ethnicity 














Table 7.2: Peanut sensitisation and allergy patterns in Xhosa and mixed race patients 





















Proportion of sensitised to allergic 
patients 
 
38% 75% <0.001*$ 
ImmunoCAP whole peanut in 







ImmunoCAP whole peanut in 
peanut sensitised but tolerant 






ImmunoCAP rAra h 2 in peanut 




16.9   
(3.97-25.6) 
0.53++ 
ImmunoCAP rAra h 2 in peanut 
sensitised but tolerant patients 







ISAC nAra h 2 in allergic patients 







ISAC nAra h 2 in peanut sensitised 
but tolerant patients (median in 
ISAC units) 
0 (0-0.6) 0 (0-0) 0.15++ 
SPT size in peanut allergic  







SPT size in  peanut sensitised but 







Proportion of peanut allergic 







++    by Mann-Whitney test 
*     by chi-squared test  
$    statistically significant 
7.3.2. Risk factors for peanut allergy 
Age at the time of assessment:  
Peanut allergy was not significantly different in the younger age group (prevalence of peanut allergy 
20% in under 2 year olds, 28% in over 2 year olds, p=0.52).  The lower prevalence below the age of 2 
years is likely a reflection of late timing of first oral exposure to peanut, frequently after the age of 2 














Eczema severity:  
Of those patients in the moderate eczema severity category (SCORAD 15-40), 20% (10/49) had a 
peanut allergy; in those with more severe eczema SCORAD > 40, 28% (14/50) had a peanut allergy; 
this was not significantly different, p=0.48. 
Age of onset of eczema:  
Of those with early onset eczema (<6 months), 16/35 (46%) had peanut allergy; of those with 
intermediate onset eczema (6-12 months), 5/33 (15%) had peanut allergy and of those with later onset 
eczema (12 months and over), 3/31 (10%) had peanut allergy (p=0.001). The effect of age of onset of 
eczema on peanut allergy prevalence is depicted in figure 7.2. 
Figure 7.2 Effect of age of onset of eczema on peanut allergy prevalence  
 
 
7.3.3 Value of diagnostic tests in predicting peanut allergy in the study population overall (n=99) 
7.3.3.1 Value of history of past reaction to peanut allergy in the diagnosis of peanut allergy  
Overall, 23% (23) patients reported a reaction to peanut, of whom 16 were found to be allergic, 
therefore 70% (16/23) with a perceived peanut allergy had a true peanut allergy.   
8 patients subsequently found to be allergic had never eaten peanut before.  
By ethnicity, 19% (11/59) Xhosa patients reported a peanut allergy, of whom 64% (7/11) were found 
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(9/12) were found to be allergic. Difference between reported allergies and true allergies were not 
significantly different by ethnicity, as depicted in table 7.3. 
With the reported reactions, 88% (21/24) were immediate-type occurring within 2 hours of ingestion. 
The median age at first perceived reaction was 24 months (interquartile range 18-36 months). 
20 patients had positive history plus sensitisation to peanut, of whom 80% (16/20) were found to be 
allergic (77% of Xhosa and 81% mixed race); with no significant ethnic differences in these ratios. Table 
7.4 summarises the symptoms that patients described in reaction to peanut and their predictive value 
for allergy. 
Table 7.3 Value of history of peanut allergy in prediction of true peanut allergy 
 Overall (n=100) Xhosa (n=59) Mixed Race (n=41) Difference between 
ethnic groups (p-
value)* 
Positive history for any 
reactivity to peanut  
23% (23) 19% (11/59) 20% (12/41) 0.24 
% of those with positive 
history who were found to 
have  a true allergy 
70% (16/23) 64% (7/11) 75% (9/12)  0.57 
Positive history + 
sensitised to peanut  
20% (20) 15% (9/59) 27% (11/41) 0.14 
% of those with positive 
history + sensitisation who 
were found to have  a true 
allergy 
80% (16/20) 77% (7/9) 81% (9/11) 0.82 
*= by chi-squared test 
 
Table 7.4 Reported reactions to peanut and their predictive values  
Symptom % of Patients with history of 
reaction to peanut 
Proportion of Patients with this 
symptom who have been found to 
have peanut allergy 
Itchy rash  65%   (15/23) 67%  (10/15) 
Angioedema 39%   (9/23) 56%    (5/9) 
Exacerbation of eczema 39%   (9/23) 56%   (5/9) 
“Doesn’t like” the food 30%   (7/23) 71%   (5/7) 
Flushing  22%   (5/23) 80%    (4/5) 
Wheeze 22%   (5/23) 100%  (5/5) 
Vomiting 17%   (4/23) 75%    (3/4) 
Itchy mouth 13%   (3/23) 100%  (3/3) 
Tight throat 13%   (3/23) 100%  (3/3) 
Circulatory compromise (e.g. blue lips) 4%     (1/23) 100%  (1/1) 
















 7.3.3.2 Sensitivity, specificity and Receiver Operating Characteristic (ROC) Curves for SPTs and ISAC 
tests as screening tests for peanut allergy (n=99) 
All 100 patients underwent screening tests for peanut allergy by SPT to peanut and ISAC 103 test to 
components nAra h 1, nAra h 2, nAra h 3 and nAra h 8. The results of 99 patients who completed the 
study were utilised for analyses.   
Receiver Operating Characteristic (ROC) curves showed that the size of the SPT to peanut was superior 
in the prediction of peanut allergy (ROC area under curve (AUC) 0.98). This was followed by ISAC to 
nAra h 2 with ROC AUC 0.90, nAra h 1 with ROC AUC 0.72 and nAra h 3 with ROC AUC 0.67. ROC curves 
for SPT and nAra h 2 did not differ significantly between ethnic groups; however the ROC AUC for    
nAra h 1 was significantly lower in the Xhosa group (0.5 in Xhosas versus 0.8 in mixed race, p=0.02) as 
was that for nAra h 3 (0.48 in Xhosas versus 0.77 in mixed race group, p=0.003).  ROC curves for SPT 
and ISAC tests are depicted in table 7.5 and figures 7.3-7.6.  
 
Table 7.5 ROC AUC for SPT and ISAC tests as screening test for p anut allergy (n=99) 








0.98 (0.96-1) 0.97 (0.93-1) 1 (1-1) 0.9 



































Figure 7.3 ROC Curves for SPT and ISAC components overall, n=99 
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Figure 7.5 ROC Curves for SPT and ISAC components in mixed race patients 
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The SPT to peanut was the most sensitive screening test for peanut allergy (100% sensitive in both 
ethnic groups), but the PPV for peanut allergy was poor (53%). ISAC nAra h 2 had a reasonable 
sensitivity of 83% and PPV 80%, and a good specificity of 93%. Both ISAC nAra h 1 and 3 were specific 
(92% and 97% respectively) but not sensitive (50% and 38% respectively).  
The overall trend for all 4 screening tests was towards a lower specificity and PPV in Xhosa patients, 
therefore the Xhosa patients had significantly more false positive results for these screening tests. 
Sensitivity, specificity, PPV and negative predictive value (NPV) are described in table 7.6 below, with 
ethnic breakdown. 
Table 7.6. Sensitivities and specificities of screening tests for predicting peanut allergy 
 Overall (n=99) Xhosa (n=59) Mixed race (n=40) Difference between 
ethnic groups (p-
value)*  
SPT peanut positive 
(≥3mm) 
    
Sensitivity 100% 100% 100% 1.0 
Specificity 72% 70% 77% 0.44 
PPV 53% 38% 71% 0.001** 
NPV 100% 100% 100% 1.0 
     
ISAC nAra h 1≥0.3 ISU     
Sensitivity 50% 33% 60% 0.07 
Specificity 92% 90% 96% 0.27 
PPV 67% 38% 90% <0.001** 
NPV 85% 88% 81% 0.34 
     
 ISAC nAra h 2≥0.3 ISU     
Sensitivity 83% 78% 87% 0.26 
Specificity 93% 90% 100% 0.04** 
PPV 80% 58% 100% <0.001** 
NPV 95% 96% 93% 0.51 
     
ISAC nAra h 3≥0.3 ISU     
Sensitivity 38% 11% 53% <0.001** 
Specificity 97% 96% 100% 0.2 
PPV 82% 33% 100% <0.001** 
NPV 83% 86% 79% 0.36 
     
*By chi-squared test 
** statistically significant 
 
7.3.3.3 Sensitivity, specificity and Receiver Operating Characteristic (ROC) Curves for SPTs and ISAC 
tests in differentiating peanut allergy from tolerance in peanut-sensitised patients (n=44) 
Those patients who were found to be sensitised to peanut by the screening SPT/ISAC tests, underwent 














ROC in peanut-sensitised patients showed the highest AUC for SPT to peanut (0.94), followed by 
ImmunoCAP Ara h 2 and ISAC Ara h 2 (both 0.86), then ImmunoCAP to whole peanut (0.80). The ROC 
AUC was significantly lower for Ara h 1, both by ISAC (AUC 0.62) and ImmunoCAP (AUC 0.68); and for 
Ara h 3 for ISAC (AUC 0.62) and ImmunoCAP (AUC 0.64). The performance was poor for ImmunoCAP 
Ara h 8 (AUC 0.56) and Ara h 9 (AUC 0.51). Ethnic differences were seen only for ISAC Ara h 1 and 3, 
which had a significantly higher AUC in the mixed race group. The ROC AUC results and ethnic 
comparisons for peanut-sensitised patients are tabulated in table 7.7 and in figures 7.7-7.10. 
 
Table 7.7: ROC graphs for SPT, peanut ImmunoCAP and peanut components as predictors of peanut 
allergy in those who are peanut sensitised (n=44) 












Difference in AUC 
between ethnic 
groups   (p-value)* 
SPT Peanut 
 
0.94 (0.87-1) 0.91 (0.78-1) 1 (1-1) 0.15 
ImmunoCAP 
Peanut 
0.80 (0.66-0.94) 0.76  (0.55-0.96) 0.87 (0.69-1) 0.40 
ISAC nAra h 1 
 
0.62 (0.47-0.77) 0.50  (0.29-0.72) 0.8 (0.67-0.93) 0.02** 
ISAC nAra h 2 
 
0.86 (0.76-0.97) 0.79 (0.59-0.98) 0.93  (0.84-1) 0.18 
ISAC nAra h 3 
 
0.62 (0.49-0.75) 0.48 (0.34-0.62) 0.77  (0.64-0.89) 0.003** 
ImmunoCAP    
rAra h 1 
0.68 (0.48-0.89) 0.64  (0.37-0.91) 0.77  (0.55-0.99) 0.48 
ImmunoCAP   
rAra h 2 
0.86 (0.74-0.98) 0.85  (0.69-1) 0.91  (0.76-1) 0.60 
 
ImmunoCAP    
rAra h 3 
0.64 (0.44-0.84) 0.53  (0.27-0.8) 0.8  (0.49-1) 0.26 
ImmunoCAP   
rAra h 8 
0.56 (0.37-0.76) 0.43  (0.37-0.89) 0.63  (0.37-0.89) 0.31 
ImmunoCAP   
rAra h 9 
0.51 (0.31-0.71) 0.35  (0.08-0.61) 0.7  (0.19-1) 0.22 
*By chi-squared test 






















Figure 7.7 ROC Curves for ImmunoCAP tests and SPT in all peanut-sensitised patients (n=44) 
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Figure 7.9 ROC Curves for ImmunoCAP tests and SPT in peanut-sensitised mixed race patients (n=20) 
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In the 44 peanut-sensitised patients, who underwent further ImmunoCAP tests, the highest sensitivity 
for diagnosis of peanut allergy was achieved by both the SPT and ImmunoCAP test to whole peanut, 
at 100% in both ethnic groups.  However, the specificity of these tests and the PPV was poor: for SPT 
specificity 73% and PPV 55% and for ImmunoCAP peanut specificity 40% and PPV 67%. Component 
testing for Ara h 2 by both ISAC test and ImmunoCAP test produced lower sensitivities than the SPT 
but higher specificities and PPV: For ISAC Ara h 2 ≥ 0.3 ISU, sensitivity for peanut allergy diagnosis was 
83%, specificity 75% and PPV 80%, and for ImmunoCAP to Ara h 2 sensitivity was 92%, specificity 60% 
and PPV of 73%. Sensitivities, specificities and predictive values for peanut-sensitised patients are 
depicted in table 7.8. 
 The trend for all of the above screening tests was towards a lower specificity and PPV in the Xhosa 
patients, as depicted in table 7.8 below. For example, the PPV for an ImmunoCAP Ara h 2 ≥0.35 kU/L 
was 53% for Xhosa patients and 93% in mixed race patients.  
Table 7.8 Sensitivities and specificities of screening tests for predicting peanut allergy in peanut-sensitised 
patients 





SPT peanut positive 
(≥3mm) 
    
Sensitivity 100% 100% 100% 1.0 
Specificity 73% 70% 80% 0.45 
PPV 55% 38% 75% 0.01** 
NPV 100% 100% 100% 1.0 
     
ImmunoCAP Peanut 
≥0.35 kU/L 
    
Sensitivity 100% 100 % 100% 1.0 
Specificity 40% 33% 60 % 0.07 
PPV 67% 47% 88% 0.004** 
NPV 100% 100% 100% 1.0 
     
ISAC nAra h 2 ≥ 0.3 ISU     
Sensitivity 83% 78% 87% 0.44 
Specificity 75% 67% 100% 0.005** 
PPV 80% 58% 100% 0.001** 
NPV 79% 83% 71% 0.34 
     
ImmunoCAP Ara h 2 
≥0.35 kU/L 
    
Sensitivity 92 % 89% 93% 0.65 
Specificity 60% 53 % 80% 0.06 
PPV 73% 53 % 93% 0.004** 
NPV 86%  89 % 80% 0.41 
     














7.3.3.4 Baseline characteristics and median values of SPT, ISAC and ImmunoCAP tests in tolerant versus 
allergic patients who are peanut-sensitised  
There was no significant difference in age at the time of the study, age of onset of eczema, gender 
distribution, concomitant egg allergy, asthma, allergic rhinitis, or total IgE between peanut tolerant 
and peanut allergic patients in those who were peanut-sensitised (table 7.9). The mean SCORAD was 
higher in the allergic group (44.5 versus 36, p=0.06).  
The median value for SPT size, ImmunoCAP peanut, ImmunoCAP Ara h 2 and ISAC Ara h 2 were 
significantly higher (p<0.001) in the allergic group: for SPT, 13 mm in the allergic group versus 4.5 mm 
in the tolerant group; for ImmunoCAP peanut, 14.9 kU/L versus 4.5 kU/L; for ImmunoCAP Ara h 2, 
15.25 kU/L versus 0.21 kU/L, and for ISAC Ara h 2, 3.6 ISU versus 0 ISU. These values as well as the 
baseline characteristics are depicted in table 7.9 below. 
Table 7.9 Baseline characteristics and median values for screening tests in peanut allergic versus 
tolerant patients with peanut-sensitisation  
 Sensitised and allergic 




Difference   
(p-value) 
Age (median in 
months) 
43  30  P=0.32++  
Gender 
 
Male 55% Male 50% 0.74*  
SCORAD (median) 44.5 36 0.06++ 
 
Proportion with Egg 
allergy 
46% (11/24) 30% (6/20) 0.28* 
Proportion with 
Asthma 
46% (11/24) 50% (10/20) 0.78 * 
Proportion with 
Hayfever 
54% (13/24) 55% (11/20) 0.71*  
Total IgE (median in 
kU/L) 
1362  1222  0.7++ 
Age onset eczema 
(median in months) 
3 6 0.11++  
SPT peanut size 
(median in mm) 
13  4.5  P<0.001++$ 
Peanut specific IgE 
(median in kU/L) 
14.9 1.32 P<0.001++$ 
ImmunoCAP rAra h 2 
(median in kU/L) 
15.25 0.21 P<0.001++$ 
ISAC nAra h 2 
(median in ISU) 




++ by Mann-Whitney test 
*  by Chi-squared test 














7.3.4 Peanut component patterns 
7.3.4.1 Peanut component testing in in the overall study population (n=99) 
The most common peanut component in this population was ISAC nAra h 2 (25%), followed by ISAC 
nAra h 1 (18%) and ISAC nAra h 3 (11%). There were no cases of ISAC positivity for Ara h 8. When 
breaking down these components in the overall group by allergy versus tolerance to peanut, the 
proportion of patients was significantly higher for all three ISAC components in peanut allergic 
patients. For ISAC nAra h 2, 83 % of peanut allergic patients were positive, versus 7 % of peanut 
tolerant patients, p<0.001. For ISAC nAra h 1, 50 % of peanut allergic patients were positive, versus 
7%   of peanut tolerant patients, p<0.001.  For ISAC nAra h 3, 38 % of peanut allergic patients were 
positive, versus 3 % of peanut tolerant patients, p<0.001. These results for ISAC components in the 
overall study population are depicted in figure 7.11. 
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ISAC component positivity in peanut allergic 
versus tolerant patients in overall population, 
n=99 














7.3.4.2 Peanut component testing in peanut sensitised patients (n=44) 
In the 44 sensitised patients, the most common peanut components by ImmunoCAP were rAra h 2 
(69%), rAra h 1 (62%), rAra h 3 (58%), rAra h 9 (49%) and rAra h 8 (33%) as depicted in figure 7.12 
below.   
Figure 7.12  Distribution of peanut components by ImmunoCAP test in peanut-sensitised patients  
 
 
The proportion of patients with sensitisation to Ara h 2 and Ara h 3 by the ISAC test was significantly 
higher in allergic patients as depicted in table 7.10.  For ISAC Ara h 2, 83% of patients with peanut 
allergy were positive, versus 25% of patients without a peanut allergy despite sensitisation (P<0.001). 
Similarly, For ImmunoCAP Ara h 2, peanut-allergic patients were 92% positive, and peanut-tolerant 
patients were 40% positive, significantly higher in allergic patients with p<0.001. The components ISAC 
Ara h 1, ImmunoCAP Ara h 1, ImmunoCAP Ara h 3, ImmunCAP Ara h 8 and 9 were not significantly 
different between allergic and tolerant patients in this peanut-sensitised group. Peanut component 
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Table 7.10  Peanut component sensitisation in peanut-allergic versus tolerant patients in peanut-sensitised 
patients 
% Patients with Positive   
component test (≥0.3 ISU for ISAC 





% (n=20)  
 
Difference between 
allergic and tolerant 
patients (p-value)* 
ISAC nAra h 1  
 
50 %  25%  0.09 
ImmunoCAP rAra h 1  
 
71%  50%  0.16 
    
ISAC nAra h 2 
 
83% 25% <0.001** 
ImmunoCAP rAra h 2 
 
92% 40% <0.001** 
    
ISAC nAra h 3 
 
38% 10% 0.04** 
ImmunoCAP rAra h 3 
 
54% 60% 0.7 
    
ImmunoCAP rAra h 8 
 
29% 40% 0.45 
    
ImmunoCAP  rAra h 9 
 
38% 65% 0.07 
*By chi-squared test 
**Statistically significant 
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7.3. 4. 3 Peanut component patterns in peanut-sensitised patients (n=44) by ethnicity 
In both ethnic groups, the component rAra h 2 by ImmunoCAP test was significantly more frequently 
positive in allergic versus tolerant patients. In Xhosa patients, 89% of allergic vs 47% of tolerant 
patients were Ara h 2 positive (p=0.04), and in mixed race patients 93% of peanut allergic and 20% of 
tolerant patients were Ara h 2 positive (p= 0.001). The other components by ImmunoCAP (Ara1, 3, 8 
and 9) were not significantly higher in allergic versus tolerant patients (table 7.11). In all cases of 
peanut allergy with Ara h 1 and/or 3 positivity, Ara h 2 was also positive.  Ara h 8 and 9 were higher in 
tolerant than allergic patients in both ethnic groups, representing the broad cross reactivity of these 
components. In the Xhosa group, Ara h 9 was significantly more frequent in non-allergic patients 
(p=0.04). In all but one case of Ara h 8 positivity, Ara h 9 was also positive, hence in this population 
Ara h 9 seems to be the most useful test in assessing tolerance by cross-reactivity.   
ISAC patterns to Ara h 2 were similar to ImmunoCAP patterns with both ethnic groups having a 
significantly higher positive rate in allergic patients (ISAC Ara h 2 was positive in 78% of allergic 
patients versus 33% of tolerant patients in Xhosas, p=0.04; and ISAC Ara h 2 was positive in 87% of 
allergic versus 0% of tolerant patients in mixed race, p= < 0.001).  In mixed race patients only, ISAC 
Ara h 1 and Ara h 3 were also significantly more positive in allergic patients (table 7.12) 
Despite the overall superiority of Ara h 2 in differentiating allergy from tolerance in both ethnic groups, 
the Xhosa patients had a significantly higher false positive rate. The probability of being peanut allergic 
given a positive ImmunoCAP Ara h 2 was significantly lower in Xhosa patients (53%) than mixed race 
(93%), p= 0.01.   Similarly for a positive ISAC Ara h 2 test, the probability of peanut allergy was 58% for 
Xhosa patients, versus 100% for mixed race patients (p=0.009).  
Peanut component patterns in sensitised patients by ethnicity are depicted in tables 7.11 and 7.12, 










































































rAra h 1  
67%  (6) 47%  (7) 0.34 46% 73% (11)  60% (3) 0.57 79% 0.08 
ImmunoCAP 
rAra h 2 
89% (8) 47% (7) 0.04** 53% 93% (14) 20% (1) 0.001** 93% 0.01** 
ImmunoCAP 
rAra h 3 
33% (3) 53% (8) 0.34 27% 67% (10) 80% (4) 0.57 71% 0.03** 
ImmunoCAP 
rAra h 8 
22% (2) 33% (5) 0.56 29% 33% (5) 60% (3) 0.29 63% 0.19 
ImmunoCAP  
rAra h 9 
22% (2) 67% (10) 0.04** 17% 47% (7) 60% (3) 0.61 70% 0.01 (for 
tolerance) 
ImmunoCAP 
rAra h 1 and 2  
56%  (5) 27% (4) 0.16 56% 73% (11) 0% (0) 0.005** 100% < 0.001** 
 
Table 7.12  Frequency of Positive Components by ISAC in Peanut Allergic versus Tolerant Patients  
ISAC Component  
(Positive defined 














































ISAC nAra h 1  
 
33% (3) 33% (5) 1.0 38% 60% (9) 0%  (0) 0.02** 100% 0.005** 
ISAC nAra h 2 
 
78% (7) 33% (5) 0.04** 58% 87% (13) 0% (0) 0.00** 100% 0.009** 
ISAC nAra h 3 
 
11% (1) 13% (2) 0.87 33% 53% (8) 0% (0) 0.035** 100% 0.01** 
ISAC Ara h 8 
 
0%  (0) 0% (0) 1 N/A 0% (0) 0% (0) 1 N/A - 
ISAC nAra h 1 
and 2 positive 
22% (2) 13% (2) 0.56 50% 60% (9) 0% (0) 0.02** 100% 0.02** 
Bromelin (CCD) 
 
0% (0) 13% (2) 0.56 N/A 33% (5) 20% (1) 0.58 N/A - 
Glym5 22% (2) 13% (2) 0.55 N/A 40% (6) 0% (0) 0.09 N/A - 














Figure 7.14  Component patterns by ImmunoCAP test in peanut-sensitised Xhosa patients  
 
 
Figure 7.15 Component patterns by ImmunoCAP test in peanut-sensitised mixed race patients  
 
 
7.3.5 Cross Reactivity Patterns 
ImmunoCAP Ara h 8 was significantly more positive in Timothy grass sensitised patients:  Ara h 8 was 
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There was no significant difference in reactivity to bromelin (a marker of a cross-reactive carbohydrate 
determinant (CCD)) between peanut allergic and tolerant patients in both Xhosa and mixed race 
patients (table 7.12).  
7.3.6 Comparing ISAC versus ImmunoCAP tests for peanut allergy  
The ISAC test proved less sensitive but more specific for peanut allergy in comparison with the 
ImmunoCAP tests. In the peanut sensitised subgroup (n=44), in which both ISAC and ImmunoCAP test 
were performed, these 2 tests could be compared. For peanut allergic patients, 88% tested positive 
to at least one ISAC components, and 83 % for ISAC Ara h 2; whilst 96% tested positive to any 
ImmunoCAP component, and  92 % to ImmunoCAP Ara h 2 (p=0.35). For peanut tolerant patients, 40% 
tested positive to at least one ISAC component and  25%  to ISAC nAra h 2, whilst 84% tested positive 
to any ImmunoCAP component and 40 % to ImmunoCAP Ara h 2 (p=0.31). With comparison of 
proportions positive by ISAC versus ImmunoCAP, the only statistically significant result was attained 
for Ara h 3, for which tolerant patients were positive in 10% of cases for ISAC Ara h 3, and in 60% of 
cases for ImmunoCAP Ara h 3, p<0.001.  Testing by ISAC components alone would have missed 3 cases 
(12.5%) of peanut allergy.  
Median values for ImmunoCAP component levels were significantly higher than ISAC values for both 
allergic and tolerant patients for both Ara h 2 and Ara h 3; for Ara h 1 the difference was only significant 
in tolerant patients (table 7.13). The median value for Ara h 2 by ImmunoCAP in peanut allergic 
patients was 15.25 kU/L, versus 3.6 ISU by the ISAC test (p<0.001). In tolerant patients, the median 
value for Ara h 2 by immunoCAP patients was 0.21 kU/L, versus 0 ISU by the ISAC test (p<0.001). 
 In our study, the ISAC and ImmunoCAP tests are therefore not directly comparable. 
 
Table 7.13 Median values of RAST versus ISAC values in peanut-sensitised patients 
 Immuno-CAP        
rAra h 1: 
median value 
in kU/L (IQR) 
ISAC      









CAP         
rAra h 2: 
median in 
kU/L (IQR) 
ISAC       






CAP        
rAra h 3: 
median in 
kU/L (IQR) 
ISAC       



































 IQR: Interquartile Range 














7.3.7 Epitope diversity and peanut allergy 
Diversity of IgE binding to peanut allergens has been proposed as being more predictive of peanut 
allergy and severe peanut allergy.30  In our study, the combination of Ara h 1 and 2 positivity gave the 
best overall predictive value for peanut allergy at 80% (56% for Xhosas and 100% in mixed race 
patients). If Ara h 1 and 2 were positive, and Ara h 9 was negative, the predictive value became 100% 
for peanut allergy in both ethnic groups (table 7.14)  
Table 7.14 Combination of components giving best predictive values  
 Overall: % (n) Xhosa: % (n) Mixed Race: % (n) 
















Ara h 1 and 2 positive, 8 
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7.3.8 Severe peanut allergy 
5 patients (4 of mixed race, 1 Xhosa) had symptoms of severe peanut allergy. All 5 were ImmunoCAP 
Ara h 2 and ISAC Ara h 2 positive, as well as ISAC Ara h 1 positive; 80% (4/5) were, in addition, 
ImmunoCAP Ara h 1 positive and ImmunoCAP Ara h 3 positive, and 80% (4/5) were ISAC Ara h 3 
positive. Only 40% (2/5) were Ara h 8 and/or 9 pos. The presence of ISAC Ara h 1 and ISAC Ara h 3 in 
addition to a positive ISAC Ara h 2 significantly increased the likelihood of the allergy being severe, as 
depicted in table 7.15.   
The median value for ImmunoCAP to whole peanut was significantly higher in those with a severe 
peanut allergy in comparison to those with an allergy but no anaphylactic symptoms (88 kU/L versus 
12.1 kU/L, p=0.04). Similarly, the median value for ImmunoCAP Ara h 2 was significantly higher (64.5 
kU/L versus 8.98 kU/L, p=0.01) and the median ISAC to Ara h 2 was significantly higher (11.0 ISU versus 














Table 7.15 Component patterns and median values in patients with severe peanut allergy 
 Severe peanut allergy  Peanut allergy,                   
no severe reaction 
Difference (p- value)  
 











































































Median ImmunoCAP to 
peanut (kU/L) 



















Median SPT size (mm) 
 
12 mm 13 mm 0.45++ 
*   by chi-squared test                                                                 
++ by Mann Whitney test 















7.3.9 Value of internationally derived 95% positive predictive values in each ethnic group 
The sensitivities, specificities and positive predictive values in diagnosing peanut allergy were analysed 
by ethnicity at the levels of internationally derived SPT and specific IgE widely used as 95% predictive 
for peanut allergy: these levels were 8mm for SPT to peanut extract, 27 14kU/L for ImmunoCAP to 
Peanut,28 and 0.35 kU/L for ImmunoCap rAra h 215  (table 7.16).  Overall, these cut-off values proved 
useful in the mixed race population (PPV 88%, 93% and 100% respectively for SPT 8mm, ImmunoCAP 
peanut 14 kU/L and Ara h 2 0.35 kU/L) but of significantly less predictive value in the Xhosa population 
(80%, 57% and 53% respectively).  
For the skin prick test to whole peanut extract, the cut-off point producing the highest combination 
of sensitivity and specificity, and thus the highest rate of correct classification into allergic versus 
tolerant, was 9mm for patients of mixed race (100% sensitivity and specificity), and 11 mm for Xhosa 
patients (at which level sensitivity was 78%, specificity was 98%, and 95% of patients were correctly 
classified). In analysing the cut-off points producing the highest PPV for allergies, at a SPT of 9mm, the 
PPV was 100% for mixed race patients and 80% for Xhosas; at a SPT of 11mm the PPV in Xhosas was 
88% and at 15 mm, it was 100%.  
For peanut specific IgE, best performance overall for Xhosa patients was at 6.66 kU/L (sensitivity 78%, 
specificity 73%, correctly classifying 75% of patients) and for mixed race patients at 1.68kU/L 
(sensitivity 100%, specificity 60%, correctly classifying 90%). Looking at PPVs, in mixed race patients 
the PPV was 90% at a level of 14 kU/L and 100% at 15 kU/L (versus 57% in Xhosas for both levels). For 
Xhosas, the maximum PPV of 66% was attained at a level of 65 kU/L. 
For ImmunoCAP rAra h 2, in Xhosas the optimal cut-off point was 6.43 kU/L, which had sensitivity of 
67%, specificity of 87% and correctly classified 79% of patients. For mixed race patients, the optimal 
cut-off came at 0.38 kU/L, which had sensitivity 93%, specificity 80%, and correctly classified 90%.  At 
a level of 0.38 kU/L, in the mixed race population this produced a 93% PPV, versus 53% in Xhosas; for 
the Xhosa population the maximum PPV of 80% was attained at a level of 8 kU/L.  
For ISAC Ara h 2, in Xhosas the optimal level was 2.2 ISAC units/L (sensitivity 56%, specificity 98%, 
correctly classifying 92%) and for mixed race patients 0.8 ISAC units/L (sensitivity 87%, specificity 
100%, correctly classifying 95%). Taking a cut-off level of 0.3 ISAC units/L, the PPV value in the mixed 
race population was 100% versus 58% in Xhosas. For the Xhosa population, a maximum PPV of 83% 
















      Table 7.16: Comparison of use of widely used 95% PPVs in Xhosa versus mixed race patients 
 Sensitivity Specificity Positive Predictive 
Value for Allergy 
Skin Prick Test to 
Peanut ≥8mm 
 
   
Xhosa 89%    96%  80% 
Mixed Race 100%  92%   88%   




   
Xhosa 44%  80%  57%  
Mixed Race 60%  80%   90%  
Difference (p-value)* 0.29 1.0 0.02** 
ImmunoCAP     rAra h 2 
≥0.35 kU/L 
   
Xhosa 89%  53%  53%  
Mixed race 93%  80%  93%  
Difference (p-value)* 0.65 0.06 0.004** 
ISAC nAra h 2 ≥0.3 ISAC 
U/L 
   
Xhosa 78 % 90 % 58%  
Mixed Race 87%  100 % 100%  
Difference (p-value)* 0.44 0.04** 0.001** 
*by chi-squared test 
** statistically significant 
 
7.4 Discussion 
This is the first study in South Africa to explore challenge-proven peanut allergy, as well as component 
patterns. The study was performed in children with moderate to severe atopic dermatitis, a 
population at higher risk of peanut allergy than the general population. Overall, sensitisation and 
allergy rates in both ethnic groups were higher than previously shown in this setting, being equivalent 
to or higher than those in studies of peanut allergy in patients with moderate to severe eczema from 
developed countries.31-33   Early onset eczema was a risk factors for peanut allergy. The 5 patients with 
severe peanut allergy tended to be sensitised to multiple storage proteins (Ara h 1, 2 or 3) and had 















Allergy rates were significantly higher in mixed race patients (38%) as compared with Xhosa patients 
(15%), despite similar sensitisation rates.  
The reasons for the lower peanut allergy rates despite similar sensitisation rates in Xhosa patients are 
unclear.  Previous population studies have postulated cross reactivity to Timothy grass34 as a cause of 
falsely raised peanut specific IgEs. In our population of peanut sensitised patients, timothy grass 
sensitisation was actually higher in the mixed race group (55%) versus Xhosas (33%), so this does not 
provide a plausible explanation for ethnic differences. Moreover, our results do not concur with a 
recently published study in Ghanaian school children in which IgE against peanut was strongly 
correlated with IgE against CCD, concluding that parasite- induced IgE against CCD may account for 
high levels of asymptomatic peanut sensitisation in this population.35  Conversely, in our study there 
were no significant ethnic differences in reactivity to CCD  amongst peanut sensitised patients, and 
indeed no difference in CCD levels between sensitised but tolerant versus peanut allergic patients.  
Total IgE levels, and timing of peanut introduction and peanut consumption patterns, did not differ 
significantly between ethnic groups.  
Thus the reasons for the relative “protection” of Xhosa patients against expression of allergy are not 
known, but the concern is that the protective factors may be waning.  The rapid increase in peanut 
allergy prevalence over one generation in Asian children in the HealthNuts study is a concerning 
demonstration of the potential to epigenetic changes which may be secondary to modifiable lifestyle 
factors. African populations are at risk of epigenetic influences as they take on a westernised diet and 
lifestyle.  
Components measured in this study included Ara h 1,2,3,8 and 9. Ara h 1-3 are peanut storage 
proteins, shown in previous studies to be the major allergens among allergic patients.36 Ara h 8 is a 
Betv1 homologous PR 10 protein, the major allergen in concurrent peanut and birch allergies or grass 
sensitisation (Cynd1, Phlp1 and Phlp12.) 34   Ara h 9 is a lipid transfer protein which is a pan-allergen.  
In this study, the patterns of component reactivity between the 2 ethnic groups were similar, with  
Ara h 2 being the superior component in both ethnic groups for differentiating true allergy from 
tolerance. Our study concurs with previous studies that Ara h 2 seems to be the most important 
peanut allergen.14-20,36  Ara h 2 by ImmunoCAP as well as ISAC test differed significantly between 
asymptomatic and symptomatically sensitised patients in both ethnic groups with respect to 
frequency of positivity and level.  The proportion of patients who were ImmunoCAP Ara h 2 positive 














China37 which showed 87% positivity and Japan19 which showed 88% positivity to Ara h 2. However, 
the component reactivity amongst asymptomatically sensitised patients was significantly higher in the 
Xhosa population than the mixed race patients. Therefore in Xhosa patient sensitised to Ara h 2, the 
probability of having a peanut allergy was significantly lower (53% if Ara h 2 positive by ImmunoCAP 
and 58% if Ara h 2 positive by ISAC) compared with the mixed race group (93% by ImmunoCAP and 
100% by ISAC). Food challenges may therefore be of particular importance in Xhosa patients with 
sensitisation to peanut.  
Little additional benefit was shown from ImmunoCAP Ara h 1, and Ara h 3, which were not significantly 
higher in allergic patients than tolerant patients in either ethnic group.  ISAC Ara h 1 and Ara h 3 were 
significantly higher in allergic patients in the mixed race group only.  However, if Ara h 1 and Ara h 2 
were both positive, the risk of true peanut allergy versus asymptomatic sensitisation was higher. 
ImmunoCAP Ara h 8 or 9 reactivity in the absence of Ara h 2 reactivity was highly suggestive of 
tolerance despite positive skin prick test or ImmunoCAP to peanut.   
Ninety-five percent positive predictive values (95% PPV) have been developed as a surrogate to oral 
food challenges to avoid laborious and sometimes potentially dangerous food challenges; also to 
minimise the over- diagnosis of food allergy based on laboratory results alone.38 Although there is 
some variation in the international literature of PPVs for peanut allergy, a specific IgE level of ≥14 kU/L 
is commonly used, 28 as is a SPT value of over 8 mm.27  In a recent British study, an excellent 
performance of rAra h 2 ImmunoCAP was attained with 97.5% of the 80 included peanut allergic 
patients correctly classified as peanut allergic versus tolerant at a cut off of 0.35kU/L. 14,15 
However, 95% PPVs may be age- and population-specific. 12,13   The HealthNuts study, performed in 
infants in Australia, recently showed that a SPT of 8 mm had a PPV of 95% in this population, similar 
to previous studies, however the serum IgE with a 95% PPV for peanut allergy was higher than 
previously quoted, at 34 kUa/L. 13 
Our study shows that 95% PPV for peanut may differ significantly between ethnic groups in the same 
geographical area. Cut off levels for SPT of 8mm, ImmunoCAP Peanut of 14 kU/L and ImmunoCAP      
Ara h 2 of 0.35 kU/L produced good PPVs in the mixed race group:  88%, 93% and 100% respectively. 
However, at the same levels, PPV in the Xhosa group were far lower at 80%, 57% and 53% respectively.  
These findings suggest that 95% PPVs may have to be tailored to the ethnicity of the patient, and 
larger studies in unselected population may be needed to determine 95% PPVs amongst different 














The use of ISAC technology offers a wider sensitisation profile for each patient, and may have 
significant impact on patient management in terms of risk assessment and diagnosis of cross-
reactivity.  However, our study shows that the ISAC technology may be less sensitive than ImmunCAPs 
in peanut allergy although these two technologies have in the past shown high concordance in the 
measurement of IgE to peanut allergens.29    Our results show that the ISAC ImmunoCAP test has lower 
sensitivity (87.5% vs 100%), higher specificity (60% v 40%) and generally lower values than the 
ImmunoCAP test, and missed 12.5% cases of peanut allergy. We therefore advocate that ISAC and 
ImmunoCAP tests are not equivalent or interchangeable.   
 
7.5 Conclusion 
Peanut allergy may be increasing in South African children, including Xhosa patients, in whom peanut 
allergy was previously thought to be rare. However, despite equivalent sensitisation rates, peanut 
allergy rates are still lower in Xhosa than in mixed race patients, for reasons which are incompletely 
understood. In Xhosa patients, sensitisation to peanut (including Ara h 2) is significantly less likely to 
equate to true allergy than in mixed race patients. Internationally derived 95% PPVs for peanut allergy 
perform sub-optimally in Xhosa patients. The component Ara h 2 is the most valuable for 
differentiating sensitisation from allergy in both ethnic groups; little added benefit is derived from 
measuring Ara h 1 and 3; and Ara h 8 and 9 are associated with tolerance.  
Further exploration of ethnic differences in peanut allergy rates and possible factors influencing 
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CHAPTER 8:  
Egg Sensitisation, Allergy and Component patterns in South African 
Children with Atopic Dermatitis 
 
ABBREVIATIONS 
AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SCORAD: Scoring Atopic Dermatitis Score 
SPT:          Skin Prick Test 
ISAC:        Immuno Solid Phase Allergen Chip 
PPV:         Positive Predictive Value 
NPV:         Negative Predictive Value 
 
8.1 Introduction 
Egg allergy is one of the most common allergies in infants and young children. The estimated 
prevalence of egg allergy is 0.5-5% in early childhood. 1-6 Owing to the high degree of natural 
acquisition of tolerance to egg over time, the prevalence of egg allergy is lower in older children and 
adults at less than 0.5%.1,4,7 
Atopic dermatitis (AD) is a major risk factor for egg allergy, and in a previous series of food challenges 
in children with AD, egg allergy was the most common associated allergy, with 2/3 of positive food 
challenges being to egg. 8 
Previous studies in Europe and the United States have shown the prevalence of egg sensitisation in 
patients with AD to be 35-73%, and egg allergy 16-22%. 9-12 
Egg allergy and sensitisation have in past studies been shown to be risk factors for aeroallergen 
sensitisation, especially indoor perennial allergens such as house dust mite, as well as asthma. 13-15  
Therefore egg allergy may be an important association with the propagation of the atopic march.  
The major allergenic proteins in hen’s (Gallus domesticus) egg have been designated Gal d 1-Gal d 5 
















- Ovomucoid (Gal d 1): makes up 11% of the proteins in egg white 
- Ovalbumin (Gal d 2):  makes up 54% of the proteins in egg white 
- Ovotransferrin (Gal d 3): makes up 12% of the proteins in egg white 
- Lysozyme (Gal d 4): makes up 3.4% of the proteins in egg white 
 
Gal d 5 is the major allergen in egg yolk.  
Measurement of specific IgE antibodies to individual egg white components has been shown to predict 
different clinical patterns of egg allergy.18   Ovomucoid (Gal d 1) is a heat and protease-stable antigen 
and is the dominant allergen in egg allergy.19,20  High IgE levels to ovomucoid are associated with 
persistence of egg allergy.21 Ovalbumin (Gal d 2) is heat labile, and children who are mainly sensitised 
to ovalbumin tend to tolerate the “baked” (heat denatured) form of egg. 22,23   Sensitisation to a high 
diversity of egg allergen components has also been found to be correlated with an increased chance 
of egg allergy.24 
Quantitative measurements of specific IgE to egg white, either by ImmunoCAP test or by skin prick 
test (SPT), have been used to create 95% positive decision points for egg allergy. Internationally 
derived and widely used decision points were described by Sampson (for specific IgE by ImmunoCAP 
test) 25 and Sporik (for SPT).26 However, such decision points may be age-dependent and may not be 
applicable to all populations.27  Table 8.1 shows a summary of previous studies showing positive 
predictive values (PPVs) for various levels of SPT, and Table 8.2 shows a summary of previous studies 
of PPVs for specific IgE (by ImmunoCAP test) to egg white. 
 
Table 8.1: Diagnostic decision points for SPT diameter (egg white) in predicting egg allergy 
Study SPT (mm) Positive predictive value 
Sampson et al  28 
 
≥ 3mm 85% 
Sporik et al 26 ≥ 7 mm (over 2 year olds) 
≥ 5 mm (under 2 years) 
100% 
Boyano Martinez et al 29 
 
≥ 3 mm (< 2 years) 93% 
Hill et al 30 ≥ 7 mm (over 2 year olds) 
≥ 5 mm (under 2 years) 
100% 
Verstege  et al 31 ≥ 13 mm (overall) 
≥ 13.3mm (≥ 1 year) 
≥ 11.2mm ≤1 year) 
95% 
Peters et al 32 
 
















Table 8.2: Diagnostic decision points for ImmunoCAP to egg white in predicting egg allergy 
Study ImmunoCAP egg white (kiU/L) Positive predictive value 
Sampson et al 28  ≥ 6.0 kU/L 95% 
Sampson et al 25 ≥ 2.0 kU/L 
≥ 7.0 kU/L 
95% 
Boyana-Martinez et al 29 ≥ 0.35 kU/L (< 2 years) 94% 
Roehr  et al 33 ≥ 17.5 kU/L 100% 
Osterballe et al 34 ≥ 1.5 kU/L 95% 
Celik-Bilgilli et al 35 ≥ 12.6 kU/L 95% 
Komato  et al 36 ≥ 25.5 kU/L 95% 
Benhamou et al 37 ≥ 7 kU/L 100% 
Ando et al  38 ≥ 7.4 kU/L 95% 
Peters et al 32 ≥ 1.7 kU/L 95% 
 
The prevalence of egg allergy in South African children with atopic dermatitis is unknown. The EPAAC™ 
study (Early Prevention of Allergy and Asthma in Children), which looked at sensitisation patterns in 
children with AD, showed that of 117 South African children participating, 49% were egg-sensitised. 12 
This study did not, however, explore challenge-proven egg allergy. Moreover, the egg component 
patterns in South African children have not been explored previously, and the value of commonly used 
PPV have not been explored.  
The aims of this part of the study were to determine: 
- egg sensitisation and allergy patterns 
- component patterns in egg allergic and tolerant patients  
- the value of positive predictive values (PPVs) for SPT and specific IgE in egg allergy  diagnosis 
- ethnic difference in egg allergy and sensitisation patterns  
- ethnic differences in performance characteristics of tests of food allergy 
 
8.2  Methodology 
This was part of the wider study investigating food sensitisation and allergy patterns in South African 
children with atopic dermatitis, including 59 children of Xhosa origin, and 41 of mixed race origin.  
Screening tests for egg allergy were performed in all 100 patients by taking a thorough history of 














(raw) egg white, and an Immuno Solid Phase Allergen Chip (ISAC 103®, Phadia) test, which included 
components Gal d 1, 2, 3 and 5. Please see chapter 5 for full study methodology. 
In those children who were sensitised to egg by the screening tests (n=54), bloods were sent for 
ImmunoCAP (Phadia) egg white and ovomucoid (Gal d 1). In all patients in whom there was uncertainty 
regarding egg allergy, an incremental open food challenge was performed as a day case at the Red 
Cross Children’s Hospital. The challenge food was given in the form of scrambled egg, starting with  a 
lip challenge, then incremental increasesevery 15-20 minutes from 0.5g to 30g scrambled egg over 2 
hours.  
8.2.1 Study definitions 
IgE-mediated egg sensitisation was defined as a positive skin prick test to egg white extract or fresh 
egg white (3 mm or more above the negative control) and/ or positive egg specific IgE by ISAC (≥ 0.3 
ISAC units) 
 IgE-mediated egg allergy was defined as either: 
 Positive food challenge 
 A convincing clinical history of significant type I allergic reactions after isolated ingestion of egg-
containing food in the preceding 6 months, with significantly positive SPT/sIgE above the 
internationally derived 95% positive predictive value for egg of 7mm for SPT26 and 7 kU/L for 
Immuncap.25   
8.3 Results 
All of the patients completed the screening tests and food challenges where indicated, hence 
screening data for SPT and ISAC components from all 100 participants was utilised. Of the 54 patients 
who were egg-sensitised, blood from one patient was insufficient, thus ImmunoCAP results to egg and 
ovomucoid were obtainable from 53 patients.  
8.3.1 Egg Sensitisation and Allergy Patterns 
Overall, 54 (54%) patients were sensitised to egg, 35/59 (59%) Xhosas and 19/41 (46%) mixed race 
children, p=0.2. Of the 54 sensitised patients, 48 were sensitised by SPT to fresh egg white, 40 by SPT 
to egg white extract and 32 to any ISAC component for egg.  
Overall, 25 patients (25%) were found to be allergic to egg:  14/59 (24%) Xhosas and 11/41 (27%) 
mixed race patients (p=0.7). All 25 cases of egg allergy had a positive SPT to fresh egg white. Twenty 
out of twenty-five (80%) of patients with egg allergy had a positive SPT to egg white extract, hence 














were positive to any one or more ISAC components to egg, hence ISAC missed 16% of egg allergy 
cases.  
Thirty-one patients underwent an egg challenge, of whom 14 were positive and 17 negative. Eleven 
patients diagnosed with egg allergy did not have a challenge but had a significant recent history of a 
reaction and a SPT or specific IgE above the frequently used 95% PPV of 7mm for SPT and 7 kU/L for 
ImmunoCAP (please refer to table6.4 in chapter 6 for a description of results and reactions of patients 
who did not undergo an egg challenge). 
The median age of patients with an egg allergy was 18 months (interquartile range 15-37 months). 
8.3.2 Proportion of egg-sensitised patients who were found to be allergic 
Overall, 46% of egg-sensitised patients were found to be allergic. This proportion was 58% in mixed 
race and 40% in Xhosas, a difference which was considerable but did not reach statistical significance 
(p=0.08).  
Table 8.3 and figure 8.1 depict egg sensitisation and allergy patterns. 
Table 8.3: Egg sensitisation and allergy patterns by ethnicity 
 Sensitised to egg Allergic to egg  Ratio of allergic: 
sensitised 
Overall (n=100) 54% 25% 46% 
Xhosa (n=59) 59% 24% 40% 
Mixed race (n=41) 46% 27% 58% 
Difference between 
ethnic groups (p-value)* 
0.2 0.7 0.08 
*by chi-squared test 
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8.3.3 Risk factors for egg allergy 
8.3.3.1 Age at the time of assessment:  
Egg allergy was significantly higher in the younger age groups (50% in under 2 year olds, 13% in over 
2 year olds, p< 0.001).  This is likely a reflection of the natural acquisition of tolerance to egg over time. 
8.3.3.2 Eczema severity:  
Of those patients in the moderate eczema severity category (SCORAD 15-40), 6/50 (12%) had an egg 
allergy; in those with more severe eczema SCORAD > 40, 19/50 (38%) had an egg allergy (p=0.003) 
8.3.3.3 Age of onset of eczema:  
Of those with early onset eczema (<6 months), 16/36 (44%) had egg allergy; of those with intermediate 
onset eczema (6-12 months), 6/33 (18%) had egg allergy and of those with later onset eczema (12 
months and over), 3/31 (10%) had egg allergy (p=0.001). The effect of age of onset of eczema on egg 
allergy prevalence is depicted in figure 8.2. 
Figure 8.2: Effect of age of onset of eczema on egg allergy prevalence 
 
 
8.3.4 Value of diagnostic tests in predicting egg allergy in the population overall (n=100) 
8.3.4.1 Value of history of past reaction to egg in diagnosis of egg allergy 
Forty-three patients (43%) reported one or more symptoms of a reaction to egg (25/59 Xhosas (42%) 
and 18/41 mixed race (44%), p=0.88). Of these, 24/43 (56%) were found to be allergic, hence in those 
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truly allergic: history positive was 56% for both ethnic groups (14/25 Xhosa and 10/18 mixed race).  
Five patients (5% overall) reported a severe reaction to egg, of whom 2 were subsequently found to 
have outgrown their egg allergy. Out of 21 patients who reported “not liking” egg, 12 were found to 
be allergic (57%). 
The vast majority of perceived reactions (39/43: 91%) were immediate or had an immediate 
component followed by late eczema. The median age at reaction was 12 months (interquartile range 
8-18 months).  
The most commonly reported symptoms of a reaction to egg, as well as their association with true egg 
allergy, are described in table 8.4. Itchy mouth, wheeze and tight throat, though uncommon 
symptoms, were most closely associated with true egg allergy.    
Table 8.4: Most Commonly Reported Reactions to Egg  
Symptom % with this symptom amongst 
those patients with a history of 
reaction to egg (n=43) 
Proportion of patients with this 
symptom with true egg allergy 
Itchy rash  53%      
(23/43) 
65%       
(15/23)    
“Doesn’t like” the food 49%      
(21/43) 
57%       
(12/21) 
Exacerbation of eczema 33%     
 (14/43) 
57%       
(8/14) 
Flushing  23%       
(10/43) 
60%       
(6/10) 
Angioedema 19%       
(8/43) 
62.5%    
(5/8) 
Vomiting 16%       
(7/43) 
71%       
(5/7) 
Itchy mouth 14%       
(6/43) 
83%       
(5/6)         
Wheeze 9%         
(4/43) 
75%       
(3/4)     
Tight throat 2%         
(1/43) 
75%      
(3/4)        







8.3.4.2 Value of history together with positive sensitisation in prediction of egg allergy 
36 patients (36%) had an egg-positive history as well as positive sensitisation to egg white, of whom 
24 (67%) were found to be allergic; this ratio was 14/22 (64%) in Xhosas and 10/14 (71%) in mixed 
race patients, p=0.66. Therefore, in the population overall, if one had a positive history of a reaction 














Table 8.5 shows the value of history, as well as history together with sensitisation to egg, in the 
diagnosis of egg allergy.  
Table 8.5 Value of history of reaction to egg, coupled with sensitisation, in prediction of true egg allergy 
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8.3.4.3 Sensitivity, specificity and Receiver Operating Characteristic (ROC) Curves for SPTs and ISAC 
tests as screening tests for egg allergy (n=100) 
All 100 patients participating in the study underwent screening tests to egg allergy by SPT to egg 
extract and fresh egg white, as well as ISAC 103 test to egg components Gal d 1,2,3 and 5.  
Receiver Operating Curves (ROC curves) showed that the size of the SPT to fresh egg white was 
superior in the prediction of egg allergy (ROC area under the curve (AUC) 0.92).This was followed by 
ISAC to Gal d 1 (ROC AUC 0.84) and SPT to egg white extract (ROC AUC 0.79), with poor performance 
of components Gal d 2, 3 and 5 (ROC AUC 0.69, 0.67 and 0.66 respectively). The difference in ROC AUC 
between fresh egg white and egg white extract SPT was significant (p=0.005).  There was no significant 
ethnic difference in the pattern of the ROC prediction curves.  
ROC curves for various screening tests in the overall study population are depicted in table 8.6 and 



















Table 8.6:  ROC area under curves for SPT and ISAC components in predicting egg allergy in all patients 
(n=100) 
 Overall (n=100) Xhosa (n=59) Mixed Race (n=41) Difference 
between ethnic 
groups (p-value) 
SPT fresh raw egg 
white 
0.92 0.90 0.94 0.36 
SPT egg white 
extract 
0.79 0.76 0.83 0.47 
ISAC nGal d 1 
 
0.84 0.80 0.90 0.26 
ISAC nGal d 2 
 
0.69 0.71 0.67 0.7 
ISAC nGal d 3 
 
0.67 0.60 0.76 0.15 
ISAC nGal d 5 
 
0.66 0.61 0.71 0.35 
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               Figure 8.4: ROC curves for SPT and ISAC components for Xhosa patients (n=59) 
 
 
              Figure 8.5: ROC curves for SPT and ISAC components for mixed race patients (n=41) 
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The SPT to fresh egg white was the most sensitive screening test for egg allergy (100% sensitive in 
both ethnic groups), but positive predictive value (PPV) for egg allergy was poor (PPV 52 % overall).  
SPT to egg white extract performed sub-optimally in both sensitivity (80%) and specificity, with PPV 
for egg allergy 50%. ISAC to Gal d 1 had poor sensitivity (72%) but good specificity (93%), and the best 
PPV of all the screening tests (78% overall, 69% in Xhosas and 90% in mixed race patients). 
The overall trend for all 3 screening tests was towards a lower specificity and PPV in Xhosa patients, 
thus Xhosa patients had more false positive results. Sensitivity, specificity as well as PPV and negative 
predictive values (NPV) for SPTs and ISAC Gal d 1 are summarised in table 8.7. 
Table 8.7: Overall sensitivities and specificities in predicting egg allergy 
 Overall (n=100) Xhosa (n=59) Mixed race (n=41) Difference (p-
value)* 
SPT egg white 
extract positive 
(≥3mm) 
    
Sensitivity 80% 86% 73% 0.11 
Specificity 73% 67% 83% 0.08 
PPV 50% 44% 62% 0.08 
NPV 92% 94% 89% 0.37 
     
SPT fresh egg 
white positive 
(≥3mm) 
    
Sensitivity 100% 100% 100% 1.0 
Specificity 69% 67% 73% 0.52 
PPV 52% 48% 58% 0.34 
NPV 100% 100% 100% 1.0 
     
ISAC Gal d 1 
positive ( ≥    0.3 
ISAC U/L) 
    
Sensitivity 72% 64% 82% 0.052 
Specificity 93% 91% 97% 0.24 
PPV 78% 69% 90% 0.01** 
NPV 91% 89% 94% 0.39 
     
*By chi-squared test 



















8.3.4.4 Sensitivity, specificity and Receiver Operating Curves (ROC) for SPTs and ISAC tests in predicting 
egg allergy in egg-sensitised patients (n=54) 
Those patients who who found to be egg-sensitised by screening SPT/ISAC tests underwent 
ImmunoCAP screening to Egg White and Ovomucoid (Gal d 1). Of the 54 egg-sensitised patients, 53 
completed these additional tests and will be included in the analyses of egg-sensitised patients.  
Receiver Operating Curves (ROC curves) in egg-sensitised patients (n=53) showed that the size of the 
ImmunoCAP test to Gal d 1 was superior in the prediction of egg allergy (ROC area under the curve 
0.83). This was followed closely by ISAC to Gal d 1 (ROC area under curve 0.81), SPT to raw egg white 
(0.78), and ImmunoCAP to egg white (0.77). The difference in ROC AUCs for ImmunoCAP Gal d 1, ISAC 
Gal d 1, SPT raw egg and ImmunoCAP egg white was not significant at p=0.81, hence these tests had 
comparable value in differentiating egg allergy from tolerance in sensitised patients. SPT to egg white 
extract performed poorly (AUC 0.60), statistically significantly lower than the other parameters 
(p=0.005). There were no significant ethnic difference in the pattern of the ROC prediction curves.  
ROC curves for various tests in predicting egg allergy in the egg-sensitised population are depicted in 
table 8.8 and figure 8.6.   
 
Table 8.8  ROC area under curves for SPT, ImmunoCAP and ISAC components size in predicting egg allergy in 
egg-sensitised patients (n=53) 
 Overall (n=100) Xhosa (n=59) Mixed Race (n=41) Difference 
between ethnic 
groups (p-value) 
SPT fresh egg 
white 
0.78 0.75 0.80 0.66 
SPT egg white 
extract 
0.6 0.55 0.68 0.41 
ISAC nGal d 1 
 
0.81 0.77 0.89 0.24 
ImmunoCAP      
Gal d 1 
0.83 0.85 0.83 0.96 
ImmunoCAP Egg 
White 




















Figure 8.6: ROC curves for SPT and ISAC components in egg-sensitised patients 
 
 
In the 53 egg-sensitised patients who underwent further ImmunoCAP tests, the SPT to fresh egg 
showed the highest sensitivity in diagnosing egg allergy (100% in both ethnic groups) but poor 
specificity, and a PPV of 54%. A positive ImmunoCAP to egg white also showed high sensitivity of 96% 
(100% in Xhosas and 91% in mixed race) but poor specificity in both ethnic groups. ISAC test to              
Gal d 1 showed poor sensitivity (72%) but the highest specificity (82%) and PPV (78%).   
Again, the overall trend for all 3 screening tests was towards a lower specificity and PPV in Xhosa 
patients. Table 8.9 shows sensitivities and specificities of various SPT, ISAC and ImmunoCAP tests in 
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Table 8.9: Sensitivities and specificities of tests in predicting egg allergy in patients who are egg-sensitised (n=53) 
 Overall (n=53) Xhosa (n=34) Mixed race(n=19) Difference (p-
value)* 
SPT egg white 
extract ≥3mm 
    
Sensitivity 80% 86% 73% 0.24 
Specificity 39% 32% 56% 0.09 
PPV 54% 48% 67% 0.18 
NPV 69% 75% 63% 0.36 
     
SPT fresh egg 
white ≥3mm 
    
Sensitivity 100% 100% 100% 1.0 
Specificity 25% 21% 33% 0.34 
PPV 54% 48% 65% 0.23 
NPV 100% 100% 100% 1.0 
     
ImmunoCAP egg 
white≥0.35 kU/L   
    
Sensitivity 96% 100% 91% 0.08 
Specificity 18% 16% 22% 0.59 
PPV 51% 47% 59% 0.4 
NPV 83% 100% 67% <0.001** 
     
ImmunoCAP      
Gal d 1 ≥0.35 kU/L 
    
Sensitivity 88% 93% 82% 0.22 
Specificity 50% 42% 67% 0.08 
PPV 61% 54% 75% 0.13 
NPV 82% 89% 75% 0.18 
     
ISAC Gal d 1 > 0.3 
ISAC Units/L 
    
Sensitivity 72% 64% 82% 0.17 
Specificity 82% 79% 89% 0.36 
PPV 78% 69% 90% 0.08 
NPV 77% 75% 80% 0.68 
 
8.3.4.5 Median values of SPT, ISAC and ImmunoCAP tests in tolerant versus allergic patients who are 
egg -sensitised 
The median values in allergic versus tolerant egg-sensitised patients were significantly higher for all 
tests except SPT egg white extract (Table 8.10).  For SPT fresh egg white, the overall median value in 
allergic patients was 13mm, in comparison to that of 8mm in tolerant patients (p<0.001). For ISAC       
Gal d 1, median values in allergic and tolerant patients were 0.9 and 0.0 ISAC units respectively 
(p<0.001); for ImmunoCAP Gal d 1 median values were 8 kU/L and 0.32 kU/L respectively (p<0.001), 
and for ImmunoCAP to egg white median values were 14.6kU/L and 1.54 kU/L respectively (p= 0.003). 
These trends were similar between ethnic groups with no statistically significant differences. In both 
ethnic groups, the SPT to egg white extract was not significantly different between allergic and 














The median SPT to fresh egg was significantly higher than the median SPT value to egg white extract 
(p<0.001 by Wilcoxon sign-rank test). Moreover, when comparing ImmunoCAP and ISAC median 
values, the median ImmunoCAP Gal d 1 was found to be significantly higher than the median ISAC 
levels ( p<0.001 by Wilcoxon sign rank test) in both tolerant and allergic patients.  These results suggest 
that ISAC and ImmunoCAP to egg are not directly comparable. 
Table 8.10:  Median values of SPT, ISAC and ImmunoCAP tests in allergic versus tolerant patients who are egg-sensitised  












SPT egg white  in 
egg-allergic patients 
6 mm  
(4-7mm) 
5 mm  
(4-7mm) 
6 mm  
(1-9mm) 
0.68 
SPT egg white in egg-
tolerant patients 








allergic and tolerant 
patients (p-value) 
0.21 0.61 0.15  
SPT fresh egg white  




12 mm  
(10-15mm) 
15 mm  
(10-20mm) 
0.14 
SPT fresh egg white 
in egg-tolerant 
patients 
8 mm  
(2.5-12mm) 
8 mm  
(5-12mm) 




allergic and tolerant 
patients (p-value) 
P<0.001** 0.01** 0.02**  
ImmunoCAP egg 
white  in egg- allergic 
patients 
14.6 kU/L  
(5.15-53.6 kU/L) 
14.34 kU/L  
(5.15-100 kU/L) 




white in egg-tolerant 
patients 
1.54 kU/L  
(0.68-3.72 kU/L) 
1.51 kU/L  
(0.65-3.57 kU/L) 




allergic and tolerant 
patients (p-value) 
0.003** 0.001** 0.06  
ImmunoCAP Gal d 1 
in egg- allergic 
patients 
8 kU/L  
(1.33-52.6 kU/L) 





ImmunoCAP Gal d 1 
in egg- tolerant 
patients 
0.32 kU/L (0.01-2.06 
kU/L) 
0.53 kU/L (0.01-3.48 
kU/L) 




allergic and tolerant 
patients (p-value) 
P<0.001** P<0.001** 0.001**  
ISAC nGal d 1 in egg-
allergic patients 
 
0.9 ISU/L  
(0-2.5 ISU/L) 
1.3 ISU/L  
(0-7.7 ISU/L) 
0.7 ISU/L  
(0.4-2.2 ISU/L) 
0.76 
ISAC nGal d 1 egg-
tolerant patients  
 
0 ISU/L (0-0) 0 ISU/L (0-0) 0 ISU/L (0-0) 0.44 
Difference between 
allergic and tolerant 
patients (p-value) 
 
P<0.001** 0.004** 0.002**  















8.4 Egg component patterns  
8.4.1 Egg component patterns in overall study population (n=100) 
In the population overall (n=100), the most common egg component detected by ISAC (103) analysis 
was Gal d 1 (23%), followed by Gal d 3 (16%), Gal d 5 (13%) and Gal d 2 (12%). This pattern was similar 
between both ethnic groups (table 8.11). 
In the overall population, the proportion of patients with positive reactivity to the component Gal d 1 
was significantly higher in egg allergic (72%) versus egg tolerant patients (7%), p<0.001.  Significant 
differences between allergic and tolerant patients (p<0.001) were also found for all of the other egg 
components: for Gal d 2 40% versus 3%; for Gal d 3 40% versus 8%; for Gal d 5 36% versus 5%. (table 
8.12) 
Table 8.11:  Egg component patterns by ISAC test in the population overall (n=100) 
 Overall (n=100) 
% positive (n) 
Xhosa (n=59) 
% positive (n) 
Mixed (n=41) 
% positive (n) 
Difference 
between ethnic 
groups (p-value by 
chi2 test) 
ISAC nGal d 1  
 
23%   
(23/100) 
22%   
(13/59) 
24%   
(10/41) 
0.78 
ISAC nGal d 2 
 
12%   
(12/100) 
12%   
(7/59) 
12%   
(5/41) 
0.96 
ISAC nGal d 3 
 
16%   
(16/100) 





ISAC nGal d 5 
 
13%   
(13/100) 
12%   
(7/59) 































Table 8.12: Egg component patterns amongst egg allergic versus tolerant patients in the population overall 
(n=100) 
 Overall (n=100) 
% positive (n) 
Xhosa (n=59)  
% positive (n) 
Mixed race (n=41)               

























allergic and tolerant 
patients (p-value) 
 
P<0.001** P<0.001** P<0.001**  





















allergic and tolerant 
patients (p-value) 
 
P<0.001** P<0.001** 0.004**  





















allergic and tolerant 
patients (p-value) 
 
P<0.001** 0.06 0.001**  





















allergic and tolerant 
patients (p-value) 
 
P<0.001** 0.03** 0.009**  
*by chi-squared test 
** statistically significant 
 
 
8.4.2 Egg component patterns in egg sensitised patients (n=54) 
The pattern of component sensitivity were similar in egg sensitised patients (n=54) to that in the 
population overall, as described in section 8.4.1 above. In egg sensitised patients, the most common 
positive component was Gal d 1 (43%), followed by Gal d 3 (28%), Gal d 5 (25%) and Gal d 2 (23%) 














Figure 8.7:  Egg component patterns in egg-sensitised patients (n=54) 
 
 
Table 8.13:  Egg component patterns in egg-sensitised patients (n=54) by ethnicity 
 Overall (n=54) 
% positive (n) 
Xhosa (n=34) % 
positive (n) 






ISAC nGal d 1  
 
43%    
(23/53) 
38%   
(13/34) 
53%    
(10/19) 
0.31 
ISAC nGal d 2 
 
23%    
(12/53) 
21%    
(7/34) 
26%   
(5/19) 
0.63 
ISAC nGal d 3 
 
28%    
(15/53) 
21%    
(7/34) 
42%    
(8/19) 
0.10 
ISAC nGal d 5 
 
25%    
(13/53) 
21%    
(7/34) 




In the egg-sensitised population, the proportion of patients with positive reactivity to the component 
Gal d 1 was significantly higher in egg allergic (72%) versus egg tolerant patients   (18%), p<0.001.  This 
difference in proportion with Gal d 1 positivity was mirrored by ImmunoCAP Gal d 1, which was 
positive in 88% of those with egg allergy, and 50% of those with tolerance (p=0.03). Gal d 2 positivity 
was also significantly higher in egg allergic patients 40% versus 7%. (p=0.004). Gal d 3 and Gal d 5 were 
higher amongst allergic patients, but the difference did not reach statistical significance (40% versus 
18% for Gal d 3, and 36% versus 14% for Gal d 5, p=0.07 in both cases). 
There were no significant ethnic differences in component reactivity in egg allergic versus tolerant 
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Table 8.14: Egg component patterns amongst egg allergic versus tolerant patients who are egg sensitised 
(n=54) 
 Overall (n=53) 
% positive (n) 
Xhosa (n=34) 
% positive (n) 
Mixed (n=19) 

























allergic and tolerant 
patients (p-value) 
 
P<0.001** 0.009** 0.003**  










ISAC nGal d 2 in egg-
tolerant patients 
 








allergic and tolerant 
patients (p-value) 
 
0.004** 0.007** 0.25  
ISAC nGal d 3 in egg-
allergic patients 
 







ISAC nGal d 3 in egg-
tolerant patients 
 








allergic and tolerant 
patients (p-value) 
 
0.07 0.32 0.19  
ISAC nGal d 5 in egg-
allergic patients 
 







ISAC nGal d 5 in egg-
tolerant patients 
 
14%    
(4/28) 






allergic and tolerant 
patients (p-value) 
 
0.07 0.32 0.13  










ImmunoCAP Gal d 1 
in egg-tolerant 
patients 








allergic and tolerant 
patients (p-value) 
 
0.03** 0.02** 0.047**  
















Figure 8.8: Egg component patterns amongst egg allergic versus tolerant patients who are egg 
sensitised (n=54) 
 
  *Denotes statistically significant difference (Chi2 test) 
 
8.5 Epitope diversity and egg allergy 
Our study demonstrates that a greater number of positive ISAC components increases the probability 
of egg allergy:  if any one component was positive, the probability of an egg allergy was 73%;  if two 
or more components were positive, the probability of egg allergy was 85%. If three or more 
components were positive, there was a 92% probability of egg allergy, and if all 4 ISAC components 
were positive, there was a 100% probability of egg allergy (figure 8.9). These results are detailed in 
table 8.15. 
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Egg components in allergic vs tolerant patients 
who are egg-sensitised (n=54)
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Table 8.15:  Role of egg-component diversity in predicting egg allergy  
 Proportion of patients with egg 
allergy if component positive % 
(n) 
 
ISAC nGal d 1 positive 
 
78%   
(18/23)  
 
ISAC nGal d 2 positive 
 
83%   
(10/12) 
 
ISAC nGal d 3 positive  
 
63%  
(10/16)   
 
ISAC nGal d 5 positive  69%  
(9/13) 
Likelihood of egg allergy if one or 
more components positive:  73% 
(47/64)  
   

























Gal d 3 and 5 positive  73%  
(8/11) 
Likelihood of egg allergy if 2 or 
more components positive:  85% 
(44/52)  
   















Gald 2,3 and 5 positive 83%  
(5/6) 
Likelihood of egg allergy if 3 or 
more components positive:  92% 
(23/25) 
   
Gald 1,2,3 and 5 positive 100%  
(4/4) 
Likelihood of egg allergy if all 4 
components positive:  100% 
 (4/4) 
 
8.6 Value of 95% Positive Predictive Values (PPVs) 
Internationally derived 95% PPVs for a positive food challenge to egg were described by Sporik for 
SPT26 and Sampson for specific IgE.25 Both differentiate between younger children under the age of 2 
years (SPT≥ 5mm or specific IgE to egg ≥ 2 kU/L) and older children over 2 years (SPT≥7mm or specific 
IgE to egg ≥7 kU/L). These values are used widely in South African clinics as guidelines for egg allergy 














7 kU/L for specific IgE to egg white, to assess their value in egg allergy prediction in our study 
population.   
For the population overall, a SPT egg white extract of ≥7 mm had a positive predictive value of 53% 
(46% in Xhosas and 75% in mixed race patients); a SPT to fresh raw egg white of ≥7mm had a PPV of 
57% (52% in Xhosas and 65% in mixed race); and an ImmunoCAP of ≥7 mm had a PPV of 74 % (75% in 
Xhosas and 73% in mixed race) (table 8.16).    
Further analysis looking into optimal values for this population to establish local 95%+ PPV showed 
for SPT, an optimal PPV of 100% was reached at 12 mm for egg white extract. Overall, for SPT fresh 
raw egg, the value of 17 mm achieved the highest positive predictive value for the overall study 
population of 87.5% (at this level PPV was 67% in Xhosas and 100% in mixed race). By ethnic group, 
maximal PPVs were achieved at values of 21 mm in Xhosas (100%) and 16 mm in mixed race group 
(100%). 
For ImmunoCAP to egg, a value of 13 kU/L obtained a PPV of 93% overall (PPV 88% for Xhosas and 
100% for mixed race at this level).  
 
Table 8.16: Sensitivities, specificities and Positive Predictive Values of tests in predicting egg allergy in egg-
sensitised patients (n=53) 
 Overall Xhosa Mixed race Difference (p-
value)* 
     
SPT egg white 
extract ≥7mm 
    
Sensitivity 32% 36% 27% 0.5 
Specificity 75% 68% 89% 0.09 
PPV 53% 46% 75% 0.04** 
NPV 55% 59% 50% 0.53 
     
SPT fresh egg 
white ≥7mm 
    
Sensitivity 96% 93% 100% 0.24 
Specificity 36% 37% 33% 0.77 
PPV 57% 52% 65% 0.34 
NPV 91% 88% 100% 0.12 
     
RAST egg white≥ 7 
kU/L   
    
Sensitivity 68% 64% 73% 0.50 
Specificity 79% 84% 67% 0.15 
PPV 74% 75% 73% 0.87 
NPV 73% 76% 67% 0.88 















In this study of food allergy in children with atopic dermatitis, hen’s egg was the most common 
allergen overall causing sensitisation (54% overall) and allergy (25%), comparable with previous results 
from westernised countries. 2-9  Similar to previous studies,8 egg allergy was seen in approximately 2/3 
of children with moderate to severe AD with a food allergy (25/40, 63%). Analysis by ethnic group 
showed that sensitisation rates did not differ significantly between Xhosa and mixed race patients 
(59% and 46% respectively), neither did allergy rates (24% in Xhosa and 27% in mixed race).  
Prevalence of egg allergy, specifically in Xhosa patients, was unexpectedly high. 
Of all the food allergens tested, egg was the most common cause of sensitisation as well as allergy in 
Xhosa patients. In mixed race patients, egg was the second most common cause of sensitisation and 
allergy, with peanut the most common (see chapter 6). 
Young age at the time of assessment (< 2 years), age of onset of eczema below 6 months and severe 
eczema were significant risk factors for egg allergy.   
Overall, egg sensitisation by SPT or ISAC test significantly overestimated true egg allergy, with 46% of 
patients who are sensitised to egg actually having a clinically significant IgE mediated food allergy. This 
proportion was even lower in Xhosa patients (40% versus 58% in mixed race patients) but the ethnic 
difference did not reach statistical significance (p=0.08).   A patient-reported history of symptoms of 
egg allergy also significantly overestimated egg allergy. Of the 43% of patients who reported 
symptoms of an egg allergy, 56% were found to be allergic.  Thirty-one patients with egg sensitisation 
required an egg challenge for clarification of their allergy status (57%). These figures emphasise the 
risk of over-diagnosing egg allergy significantly by relying on screening allergy tests or patient history 
alone. Over half of sensitised cases may require a food challenge for confirmation. 
As a screening test for egg allergy, a skin prick test to fresh raw egg white was significantly more 
sensitive than a skin prick test to commercial egg white extract (100% versus 80% respectively).  This 
is in agreement with previously published findings that fresh foods may be more effective for 
detecting sensitivity to food allergens.39   A positive ISAC to the egg component Gal d 1 was specific 
for egg allergy (specificity 93%) but not adequately sensitive as a screening test (sensitivity 72%). In 
prediction of egg allergy in the population overall, SPT to fresh raw egg white had the highest receiver 
operating curve (ROC) area under the curve in both ethnic groups.  
In patients who were sensitised to egg (54 of the 100 participants), SPT to raw egg as well as 
ImmunoCAP to egg white showed the highest sensitivity (100% and 96% respectively), but low 














ImmunoCAP egg white respectively). Similar to the analysis in the whole study population, ISAC to Gal 
d 1 was specific (82%) but not sensitive (sensitivity 72%) for egg allergy.  
In prediction of egg allergy in the egg-sensitised population, ImmunoCAP to Gal d 1 showed the 
greatest area under the ROC curve (0.83), followed closely by ISAC Gal d 1 (0.81), SPT raw egg (0.79) 
and ImmunoCAP egg white (0.78), with an insignificant difference between these parameters. SPT egg 
extract performed sub-optimally with a significantly lower predictive value by ROC curve. 
Median values for SPT raw egg, ISAC egg Gal d 1, ImmunoCAP Gal d 1 and ImmunoCAP egg white were 
significantly higher in allergic versus tolerant egg-sensitised patients, for both ethnic groups. In both 
ethnic groups, SPT egg extract was not significantly different between allergic and tolerant patients. 
Egg component pattern analysis was similar between ethnic groups, and found that egg-sensitised 
patients, Gal d 1 was the most common component, followed by Gal d 3, Gal d 5 and Gal d 2. Even 
though Gal d 2 is the most abundant protein in egg white, it is one of the least allergenic in this 
population. Ovomucoid (Gal d 1) is a heat and protease-stable antigen and is the dominant allergen in 
egg allergy.19,20   The proportion of positive components in allergic versus tolerant patients was higher 
for all of the tested components, significantly so for Gal d 1 and Gal d 2.   
In this study, the greater the number of positive egg components in a patient, the greater was the 
probability of egg allergy. This is in keeping with previous studies of component reactivity which have 
shown that increased component diversity (i.e. larger number of components bound) is a risk factor 
for egg allergy. 24   
The commonly used PPV of ≥7mm in SPT to egg white produced poor results overall for both egg white 
extract (53%) and fresh raw egg white (57%). These PPVs were even poorer for Xhosa patients (for egg 
white extract SPT≥7mm, PPV was 46% for Xhosas and 75% for mixed race patients; for fresh raw egg 
white SPT≥7mm, PPV was 52% for Xhosas and 65% for mixed race patients). For ImmunoCAP egg white 
≥7 kiU/L, the PPV did not vary significantly by ethnicity, but were still suboptimal at 75% for Xhosa and 
73% for mixed race patients. 
These findings suggest that PPVs may be population specific and even race specific and may require 
further exploration in the local context to ascertain optimal local 95% PPVs. Furthermore, the vast 
difference in values producing “optimal PPVs” between skin prick to commercial egg extract and fresh 
egg white suggest that studies to determine population-specific 95% PPVs must take into account 
















In this population of South African children with moderate to severe AD, the prevalence of egg allergy 
is high in both Xhosa and mixed race patients, and equivalent to those in westernised countries. 9-12   
Egg allergy is significant in South African children, including Xhosa patients, in whom food allergy was 
previously thought to be rare. SPT to fresh raw egg white is significantly more sensitive than SPT to 
commercial egg white extract in the diagnosis of egg allergy, thus addition of fresh raw egg white is 
recommendable in a screening SPT panel for food allergy.  
The component Gal d 1 (ovomucoid) is the superior component in differentiating asymptomatic 
sensitisation from egg allergy. Internationally derived widely used 95% PPVs for egg allergy perform 
sub-optimally in both Xhosa and mixed race patients and may need to be revised for our population.  
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 Sensitisation and Allergy Patterns to Cow’s Milk, Soya, Wheat, Fish 
and Tree Nut in South African Children with Atopic Dermatitis 
ABBREVIATIONS 
AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SCORAD: Scoring Atopic Dermatitis Score 
SPT:          Skin Prick Test 
ISAC:        Immuno Solid Phase Allergen Chip 
PPV:         Positive Predictive Value 
NPV:         Negative Predictive Value 
 
9.1 Introduction 
In this study, hen’s egg and peanut were by far the most common sources of sensitisation and proven 
food allergy, as described in chapters 7 and 8.  This chapter serves to explore the sensitisation and 
allergy patterns of the other foods tested in this study of 100 children of South African origin with 
atopic dermatitis (AD), namely cow’s milk, soya, wheat (flour), fish (cod)  and tree nut (cashew). The 
chapter also describes the characteristics and value of perceived reactions to these foods, and the role 
of diagnostic tests and component patterns. 
Cow’s milk allergy is one of the most common allergies in early childhood. The tendency to natural 
acquisition of tolerance to cow’s milk over time accounts for a far lower prevalence of cow’s milk 
allergy in older children and adolescents.1 The documented prevalence of cow’s milk allergy is 
between 0.3% and 3.5% of young children (under the age of 5),2-7 less than 1% in older children, and 
less than 0.5% in adults. 3,8   Cow’s milk allergy, along with egg and peanut allergy, is one of the most 
common allergies in children with AD. Rates of cow’s milk sensitisation (19-27%) and allergy (11-15%) 
were found to be significantly above that of the general population in previous studies of children with 
AD from Europe and the USA. 9-11 
Cow’s (Bos Domesticus) milk consists of casein and whey proteins.12,13  Casein (Bosd8) makes up 
approximately 80% of the total protein in cow’s milk and is relatively heat stable. The whey proteins 
are α-lactalbumin (Bos d 4), β-lactoglobulin (Bos d 5), bovine serum albumin (Bos d 6) and bovine 














sensitive. Milk-allergic children are often sensitised to several cow’s milk proteins. Casein and beta-
lactoglobulin specific IgE antibodies are associated with persistent allergy to milk, including heated 
milk, in milk allergic patients; while undetectable levels indicate tolerance to baked milk products.14 
Studies have shown that in children over the age of 2 years, a SPT wheal of ≥8mm15 or milk specific 
IgE by ImmunoCAP test ≥15ku/L16 convey a 100% and 95% likelihood respectively that the child will 
have a positive milk challenge. In children 2 years and younger the corresponding values are an SPT ≥ 
6mm and IgE ≥5kU/L. However, these values may vary depending on age, concomitant disease and 
geographical differences, and have not yet been evaluated in South Africa. 15,17,18  Skin prick tests are 
excellent at ruling out the diagnosis with a negative skin test having a negative predictive value of 
≥95%.19 
Soya allergy: The prevalence of allergy to the soybean is lower than that to cow’s milk, and estimated 
in the region of 0.4-1.2% of children. 20-21   In children with AD, previous studies in the USA and Europe 
have found a sensitisation rate to soya of around 5% and allergy rate 0-1%, 9,10,11 similar to studies in 
unselected populations.21  
Tolerance acquisition to soya is common in late childhood. Soya (Glycine Max) consists of 3 main 
components, Gly m 4, Gly m 5 and Gly m 6.  Gly m 5 (β-conglycinin) and Gly m 6 (glycinin) are the most 
important markers of soya allergy. 22 Gly m 4 is a Bet v 1 (birch) homologue and is associated with 
cross-reactivity. Previous studies have shown that, in patients who have antibodies to the peanut 
allergen Ara h 2, up to 60% have IgE antibodies to soya as a cross-reactive phenomenon, and most of 
these patients are soya tolerant. 23,24 
Wheat Allergy: Wheat allergy is confirmed in less than 1% of the general population, 6-8,25 however, 
symptoms to wheat allergy are self-reported in about 4.5% of the population.26, 27 In studies of children 
with AD, the prevalence of wheat sensitisation was in the region of 5-10% and the prevalence of wheat 
allergy around 5%. 9-11 
Wheat (Triticum Aestivum) consists of several components, of which Tri a 19 (omega-5-gliadin) is the 
most sensitive indication of genuine wheat allergy. 14,28   Other components are Tri a 18 (Agglutinin), 
Tri a gliadin (crude gliadin), and Tri a aA (alpha amylase). There is significant cross-reactivity between 
wheat and grass pollen, which may lead to over-diagnosis of wheat allergy based on sensitisation 
alone.29  
Fish allergy: The prevalence of fish allergy in children is ≤ 0.2% in unselected populations, and in the 
majority of cases the fish allergy is persistent.30,31  Fish allergy is one of the few allergies that can 














be around 5% and fish allergy to range from 0-9%,9-10 so fish allergy generally seems significantly less 
common than allergies to egg, peanut and cow’s milk in AD patients. 
The prevalence of fish allergy is grossly overestimated based on history of reactions alone:  a South 
African study showed that only 15-21% of those patients with a perceived fish allergy had proof of 
allergy by sensitisation or food challenge.32,33 
The major allergen in cod (Gadus Callarias) is the parvalbumin Gad c 1. Parvalbumins are typically 
stable to heat and digestive enzymes, and show a high degree of cross reactivity between fish 
species.14   In our study, the screening SPT and ISAC test (Gad c 1) tested for cod, which cross reacts 
frequently with carpfish, salmon, herring, pollack and hake. Hake is one of the most common species 
associated with fish allergy in South Africa.32 Hake and cod are closely related as members of the 
Gadiformes group.34 
Treenut allergy: The prevalence of tree nut allergy varies from 0.2% to 1.4% depending on 
geographical area.35,36  Cashew nut is one of the most allergenic tree nuts, and was thus chosen for 
analysis in this study. Most cases of tree nut allergy are persistent, with only 10-20% outgrowing the 
allergy. 37   The main allergens in cashew nut (Anacardium occidentale) are the Ana o 1 allergen of the 
2S albumin family and the Ana o 2 legumin-like protein. 
9.2  Methodology 
This was part of the wider study investigating food sensitisation and allergy patterns in South African 
children with atopic dermatitis, including 59 children of Xhosa origin, and 41 of mixed race origin.  
Screening tests for cow’s milk, soya, wheat, fish and cashew nut allergy were performed in all 100 
patients. This included taking a  thorough history of previous reactions, performing skin prick tests to 
commercial extract (ALK) to cow’s milk, soya and cod fish, a modified SPT to fresh cow’s milk, and an 
Immuno Solid Phase Allergen Chip (ISAC 103®, Phadia) test. The ISAC test included components Bos d 
4, Bos d 5, Bos d 6 and Bos d 8 for cow’s milk; Glym  4, 5 and 6 for soya; Tri a gliadin, Tri a 18, Tri a 19 
and Tri a aA for wheat, Gad c 1 for cod and Ana o 2 for cashew nut. Please see chapter 5 for full study 
methodology. 
In selected patients further blood was sent for ImmunoCAP tests for specific IgE: 15 to whole cow’s 
milk, 10 to casein (Bos d 8), 10 to soya, 1 to wheat, 12 to cod and 3 to cashew nut.  
In all patients in whom there was uncertainty regarding food allergy, an incremental open food 
challenge was performed as a day case at the Red Cross Children’s Hospital. The challenge food was 














roasted cashew nuts. Food challenges started with  a lip challenge, then moved through gradual dose 
increments every 15-20 minutes to a final dose of 100 mL (cow’s milk or soya), 20 g wheat cereal,  40g 
hake or 15g cashew nut.  
9.2.1 Study definitions 
IgE-mediated food sensitisation was defined as a positive skin prick test to the food in question (3 mm 
or more above the negative control) and/ or positive food-specific IgE by ISAC (≥ 0.3 ISAC units) 
 
 IgE-mediated food allergy was defined as either: 
 Positive food challenge 
 A convincing clinical history of significant type I allergic reactions after isolated ingestion of the 
food in the preceding 6 months, with significantly positive SPT/sIgE; in the case of cow’s milk above 
the internationally derived 95% positive predictive value for cow’s milk of 8mm for SPT15 and 15 
kU/L for Immuncap.16 
 
9.3 Results 
All of the patients completed the screening tests and food challenges where indicated, hence 
screening data for SPT and ISAC components from all 100 participants was utilised. Sensitisation and 
allergy patterns, with ethnic breakdown, are depicted in Table 9.1 as well as in figure 9.1.  
 
Table 9.1: Sensitisation and Allergy Patterns for cow’s milk, soya, wheat, fish and cashew nut 
   Cow’s Milk Soya Wheat Fish Cashew Nut 
 Sens Allergy Sens Allergy Sens Allergy Sens Allergy Sens+ Allergy 
Overall (n=100) 27% 2% 16% 0% 8% 0% 13% 1% 0 3% 
Xhosa  (n=59) 
 
22% 0% 12% 0% 8% 0% 7% 1.6% 0 0% 
Mixed race 
(n=41) 




0.2 0.1 0.18 1 0.8 1 0.03** 0.7 1 0.04** 
  
* By chi-squared test                                                     ** statistically significant  















Figure 9.1: Sensitisation and allergy patterns for cow’s milk, soya, wheat, fish and cashew nut 
 
 
9.3.1 Cow’s Milk 
9.3.1.1 Sensitisation and Allergy Patterns 
Twenty-seven patients were sensitised to cow’s milk. Of these, all 27 had a positive SPT to fresh cow’s 
milk, and only 2 to cow’s milk extract (both of whom were also fresh cow’s milk positive). Overall 5 
patients showed sensitisation to cow’s milk by ISAC component tests, all of whom were SPT positive 
to fresh cow’s milk.  Of the 5 patients who were ISAC positive, 1 was positive to Bos d 4 (4% of all cow’s 
milk-sensitised patients), 2 were positive to Bos d 5 (7% of all cow’s milk-sensitised patients), and 5 
were positive to Bos d 8 (19% of all cow’s milk-sensitised patients)–as depicted in figure 9.2.  
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Two patients were found to be allergic to cow’s milk at the time of the study. Both patients were SPT 
positive to fresh milk but negative to cow’s milk extract. One was diagnosed by a positive challenge, 
one had a highly suggestive history of a reaction, sensitisation above the 95% PPV for SPT and 
ImmunoCAP to cow’s milk, and a reaction whilst awaiting milk challenge.  
A further 8 patients were assessed as likely to have outgrown a previously described IgE-mediated 
cow’s milk allergy; of these, 5 were SPT negative and were consuming cow’s milk regularly, 1 was SPT 
(fresh milk) and ImmunoCAP positive and was challenged (negative), and 2 were still SPT positive (to 
fresh milk) but ImmunoCAP negative, and were consuming cow’s milk products regularly without 
immediate reactions.   
Fifteen of the 27 patients with sensitisation to cow’s milk underwent an ImmunoCAP test to whole 
cow’s milk, of who 13 were positive (≥0.35 kU/L) and 2 were found to be allergic. Ten of the 27 patients 
with cow’s milk sensitisation underwent an ImmunoCAP test to casein, of who 6 were positive (≥0.35 
kU/L) and 2 were found to be allergic. Therefore, both children diagn sed with milk allergy were 
ImmunoCAP whole cow’s milk, ImmunoCAP Bos d 8 (casein), ISAC Bos d 8 and SPT fresh milk positive, 
but both were negative to SPT cow’s milk extract. The number of allergic children was too low (n=2) 
to allow for meaningful ROC curve analysis. Moreover, the low number of cow’s milk allergic children 
meant that the value of traditionally used PPVs was not possible to analyse for most parameters 
except SPT to fresh cow’s milk.  Using SPT to fresh milk ≥8mm as a cut off, the overall PPV of this SPT 
size in determining cow’s milk allergy was only 17% in this population.  
The sensitivities and specificities of the various tests to diagnose cow’s milk allergy are summarised in 
table 9.2. 
Table 9.2: Value of SPT milk extract, SPT fresh milk, ISAC Bos d  8 and ImmunoCAP tests in predicting cow’s 
milk allergy 
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Sensitivity 0% 100% 100% 100% 100% 50% 100% 
Specificity 96.9% 75% 96% 50% 13% 95% 85% 
PPV 0% 7.4% 33% 33% 13% 17% 50% 
















9.3.1.2 Reported reactions to cow’s milk or dairy 
Fourteen patients (14%) reported a reaction to cow’s milk, 6/59 Xhosas (10%) and 8/41 mixed race 
(20%). Overall, of the 14 patients with reported cow’s milk symptoms, only 2 were found to have an 
ongoing IgE-mediated allergy (14%).This ratio was 0/6 (0%) in Xhosas and 2/8 (25%) in mixed race 
patients.  There were no significant inter-ethnic differences in these ratios (table 9.3).  
Of the 14 patients who reported a reaction to cow’s milk, 5 (36%) reported an immediate reaction 
(within 2 hours of ingestion), and 9 (64%) reported a delayed reaction, more than 2 hours post 
ingestion. Of the 14 patients with reported reaction to cow’s milk, 85% reported a worsening of 
eczema, 50% reported an itchy macular rash, 29% reported flushing, 14% reported angioedema and 
7% reported each of diarrhoea, vomiting and itchy throat.  
Of the 14 patients with reported cow’s milk allergy symptoms, only 6 were sensitised to cow’s milk; 
and of those 6 with symptoms and sensitisation, 2 were found to be allergic (33%). 
The prevalence and value of reported reactions to milk are summarised in table 9.3, and the value of 
individual symptoms in table 9.4. 
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Table 9.4: Most Commonly Reported Reactions to Cow’s Milk   
Symptom % with this symptom amongst 
those patients reporting a 
reaction to milk (n=14) 
Proportion of patients with this 
symptom with true cow’s milk 
allergy 
Exacerbation of eczema 86%      (12/14) 8 %    (1/12) 
Itchy rash  50%      (7/14) 29%   ( 2/7)    
Flushing  29%      (4/14) 15%   (1/4) 
Angioedema 14%      (2/14) 50%   (1/2) 
Diarrhoea 14%      (2/14) 0%     (0/2) 
Vomiting 7%        (1/14) 100% (1/1) 
Itchy mouth 7%        (1/14) 0%      (0/2)         
Wheeze 0%         - 
Tight throat 0%         - 
Circulatory compromise (blue 
lips, shock) 
0% - 
“Doesn’t like” cow’s milk 0% - 
 
9.3.2 Soya 
Overall, 16 patients were found to be sensitised to soya, 9 by SPT to soya extract, 11 by ISAC test (4 to 
both SPT and ISAC). Of those 11 with a positive result on the ISAC test, 9 were positive to the 
component Gly m 5, 8 to Gly m 6 and none to Gly m 4. By ethnicity, 12% (7/59) Xhosas and 22% (9/41) 
mixed race patients were sensitised to soya, p= 0.18. There were no cases of soya allergy, despite a 
high median result of 25.6kU/L (interquartile range 12.2-29.7) in the 10 patients who underwent soya 
ImmunoCAP testing.  
2 patients reported reactivity to soya, both had a soya challenge and were found to be soya tolerant.   
9.3.3 Wheat 
Overall, 8 patients were sensitised to wheat, 5 by SPT to wheat extract, and 3 by ISAC test (2 to               
Tri a aA and 1 to Tri a gliadin, none to Tri a 19).  Sensitisation rates by ethnicity were 8% (5/59) in 
Xhosa patients and 7% (3/41) in mixed race patients, p=0.83. 

















Overall, 13% (13) patients were sensitised to white fish (cod): 7% in Xhosas (4/59) and 22% of mixed 
race children (9/41), with a significantly higher sensitisation rate in the mixed race group (p=0.03).  Of 
the 13 sensitised patients, 11 were positive by SPT to fish extract, and 6 by ISAC (4 were both ISAC and 
SPT positive). Only one patient was found to be fish allergic.  
Although cod was the fish tested for, there is a high degree of cross reactivity between fish species, 
hence in the questionnaire reactions were asked for “to any fish species.” 21 (21%) patients reported 
a reaction to any fish species, 15 Xhosas (25% of Xhosas) and 6 of mixed race (14%).  The median age 
at first reported reaction was 24 months. The most common complaints were itchy rash (in 71% of 
those who reported a reaction), facial flushing (in 33% of those who reported a reaction) and eczema 
flare (29% of those who reported a reaction). Only 2 patients with perceived food allergy were SPT 
positive, of whom 1 was found to be allergic. Therefore, overall only 5% (1/21) of those with a 
perceived reaction to fish were found to have an IgE-mediated reaction t  white fish.  
9.3.5 Cashew Nut 
Three patients reported allergic symptoms in response to cashew nut (all mixed race), all immediate 
reactions. All 3 were found to be allergic. The median age at the time of the first reported reaction 
was 42 months. None of those found to be allergic were ISAC positive (to the cashew nut component 
Ana o 2), but all were positive to the ImmunoCAP to cashew nut, which was performed in those with 
a reported allergy.  
9.3.6  Overall summary of reported reactions to foods 
Table 9.5 summarises the percentage of patients reporting a reaction to each food tested; the 
percentage of those patients found to be truly allergic, the percentage of those reported reactions 
classified as immediate reactions, and the median age at the time of the first reaction. Overall, 42% of 




















Table 9.5: Perceived Reactions to the Foods Studied 
Food % of all patients 
with a perceived 
allergy (n=100) 
Age at time of first 
reaction (median 
and IQ Range, in 
months) 




% of those with a 
perceived allergy 
who were found to 
be truly allergic   
Any Food 109 cases   42% (46 cases) 
Peanut 23% 24 (18-36) 88% (21/24) 70% 
Hen’s Egg 43% 12 (8-18) 91% (39/43) 56% 
Cow’s Milk 14% 12 (9-24) 36% (5/14) 14% 
Soya 2% 2.5 (1-4) 100% (2/2) 0% 
Wheat 2% 7.5 (6-9) 100% (2/2) 0% 
Fish 21% 24 (12-36) 68% (13/19) 5% 
Tree Nut 3% 42 (26-60) 100% (3/3) 100% 
 
9.4 Discussion 
Egg and peanut allergy were by far the most prevalent allergies in this cohort of South African children 
with atopic dermatitis. Smaller numbers of children were, at the time of the study, allergic to cow’s 
milk, fish and tree nut, and none were found to be allergic to wheat and soya. Moreover, there were 
no reported cases of sesame allergy and no sensitisation to sesame by ISAC test. This is unlike in 
countries where the consumption of sesame is high and the prevalence of sesame allergy relatively 
high, such as in Israel. 38 
 
The prevalence of patient-reported reaction to foods far exceeded the true prevalence of food allergy, 
hence patient history on its own is a poor predictor of food allergy. Overall, of 109 reported cases of 
allergic reactions to the 7 foods studied, 46 (42%) were found to be truly allergic.   
 
The prevalence of sensitisation to cow’s milk (CM) in our study (27%) was similar to that in studies of 
children with moderate to severe AD from Europe and the USA (19-27%).9-11 The EPAAC study, which 
studied the prevalence of food sensitisation in children with AD, analysed data from 2154 patients and 
found the prevalence of sensitisation to cow’s milk to be 27%, equivalent to that in our study. 
However, cow’s milk allergy in our study was low (2%) in comparison to other studies of food allergy 
in AD, which showed prevalence of 11-15%.9-11 There were no significant ethnic differences between 
sensitisation and allergy rates for cow’s milk.  Possible reasons for the lower than expected prevalence 
of allergy to cow’s milk include the relatively high median age of the study population (42 months), by 














fairly convincing history of a past reaction to cow’s milk which had been outgrown, but this past history 
of cow’s milk allergy could not be confirmed retrospectively. Moreover, many symptoms of cow’s milk 
allergy such as worsening of eczema, reflux or severe colic represent non-IgE mediated cow’s milk 
allergy, which was not explored in this study. The possible large contribution of non-IgE mediated 
mechanisms of cow’s milk allergy was evidenced by the finding that 64% (9/14) of the reported 
reactions to cow’s milk were not within 2 hours of ingestion.  
 
The rate of asymptomatic sensitisation to cow’s milk was high in this study, in both ethnic groups, with 
a high fall off between sensitisation (27%) and IgE-mediated allergy to cow’s milk protein (2%).  SPT to 
fresh milk had a greater sensitivity ( 100% sensitive) in diagnosing cow’s milk allergy in comparison to 
SPT to cow’s milk extract (which was not positive in either of the 2 allergic children); therefore a SPT 
to fresh milk should be recommended as part of a SPT panel to assess cow’s milk allergy.39   Widely 
used positive predictive values (PPVs) for cow’s milk allergy, derived from other studies in high socio-
economic settings, may not be applicable to this population: a SPT to fresh milk ≥  8mm gave a PPV of 
17%  and an ImmunoCAP to cow’s milk of  ≥ 15 kU/L gave a PPV of 50%. Larger studies are needed to 
establish more appropriate PPVs for our population.  
 
There were 3 cases of tree nut allergy in this study, all of whom also had a peanut allergy, and all of 
whom described symptoms of cashew allergy. The ISAC performed poorly as a screening test for 
cashew nut allergy and was negative in all 3 cashew-allergic patients. All 3 patients with cashew allergy 
had a positive ImmunoCAP to cashew nut.  
 
Sensitisation to cod fish was high in this study (13%) and significantly higher in mixed race patients, 
but allergy rates were low (1%), which mirrors the fish allergy prevalence in the general population 
rather than in a high-risk population. This was despite a high reported rate of reactions to fish. 
 
The reason for the low allergy rate may be explained partly by the fact that only codfish was used as 
a screening test for fish, whereas the consumption of many other fish species (eg the “snoek” fish, 
similar to Jack Mackerel) are common in the Western Cape and may have a different allergy pattern. 
Moreover, several patients (32% of those reporting a reaction to fish) described a delayed (≥ 2 hours 
post consumption) rash to fish with no immediate component, mostly in response to tinned pilchards. 
This may represent a reaction to the spices or preservatives in the tinned pilchards rather than a 
reaction to the fish itself. Other mechanisms of reaction to fish could include scromboid reactions and 














There was a high rate of sensitisation to soya (16% overall) but no cases of proven soya allergy, similar 
to other studies of food allergy in patients with AD. Moreover, there were no cases of wheat allergy 
in our study, despite a significant sensitisation of 8%, whereas studies in the UK and USA show around 
5% prevalence of wheat allergy in children with AD. 9-11  However, of the 8 patients sensitised to wheat, 
5 (63%) were also sensitised to Timothy grass, which cross-reacts with wheat, and could account for 




Sensitisation rates to cow’s milk, cod fish, soya and wheat were significantly higher than the general 
population and equivalent to those from studies of children with AD in Europe and the USA. Allergy 
rates were higher than the general population for cashew nut (3%), but lower than expected to cow’s 
milk (2%), and were low for cod fish (1%), wheat and soya (0%). However, several patients may have 
already outgrown their cow’s milk allergies at the time of study entry due to the natural history of 
tolerance acquisition in a significant proportion of patients with cow’s milk allergy by the age of 3-4 
years, which was the median age of the study population.  The ISAC test fared well as a screening test 
for allergies to cow’s milk and fish, but poorly for cashew nut. SPT to fresh cow’s milk was superior to 
cow’s milk extract in the diagnosis of cow’s milk allergy. Widely used internationally derived 95% PPV 
for SPT and ImmunoCAP cow’s milk fared poorly in this population and may need to be investigated 
in large population studies in infants and young children. Patient history of a reaction to any food 
significantly overestimates true food allergy rates.  
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Chapter 10:  




AD :          Atopic Dermatitis 
IgE :          Immunoglobulin E 
SCORAD: Scoring Atopic Dermatitis Score 
SPT:          Skin Prick Test 
ISAC:         Immuno Solid Phase Allergen Chip 
PPV:         Positive Predictive Value 
NPV:         Negative Predictive Value 
DerP:        Dermatophagoides Pteronyssinus  
DerF:        Dermatophagoides Farinae 
ISAAC:      International Study on Asthma and Allergies in Children 
TSLP:         Thymic stromal lymphopoietin 
 
10.1 Introduction 
Food allergy is associated with several co-morbid conditions, which can increase morbidity and 
influence risk for severity of reactions. Atopic dermatitis (AD) in children has also been related to 
multiple co-morbid conditions and increased healthcare utilisation. 1  
Eczema and food allergy 
The complex and multi-directional association between food allergy and AD is described in chapter 5. 
Food allergies can exacerbate eczema in a proportion of patients, most often together with typical 
IgE-mediated reactions.  On the other hand, eczema is a major risk factor for food allergies. 
Epicutaneous sensitisation on a disrupted skin barrier has been recognised as a potential factor 
increasing the development and persistence of food allergy.2  Filaggrin loss of function mutations are 
associated with atopic dermatitis, but also with food allergy in childhood and adolescence.2 Atopic 
dermatitis is the main risk factor for food sensitisation in exclusively breastfed infants, and the risk 
increases as disease severity increases.3  The mechanism for epicutaneous sensitisation on a disrupted 














of TSLP-elicited basophils in the skin promote antigen specific Th2 cytokine response, antigen-specific 
serum IgE levels and accumulation of mast cells in the intestine, promoting the development of 
intestinal food allergy. 4 
Early onset eczema under 12 months of age, severe eczema and younger age at the time of assessment 
have been identified as significant risk factors for food allergy in eczema. 5 
Atopic dermatitis and aerollergen-related disorders 
AD is considered to be one of the first manifestations in the atopic march. On the basis of longitudinal 
studies, approximately a third to half of AD patients will develop asthma, and two thirds or more will 
develop allergic rhinitis.6-11 Epicutaneous sensitisation to aeroallergens has been thought to be 
responsible, with subsequent migration of sensitised T cells into the nose and airways, causing upper 
and lower airway disease.12-13  Aeroallergen sensitisation is common in AD patie ts, and in the EPAAC 
(Early Prevention of Asthma and Allergies in Children) study, 20-40% of AD patients were sensitised to 
house dust mite.14   The presence of allergic sensitisation to aeroallergens in AD at one year was 
positively related to the occurrence of asthma. In contrast to food allergy sensitisation, aeroallergen 
sensitisation continued well beyond the first year of life in the EPAAC cohort.14 
However, the classical sequence of atopic dermatitis followed by aeroallergen sensitisation then 
asthma is not always followed:  in the Multicenter Allergy Study, a German birth cohort study following 
1314 children from birth to age 7 years, in many of the asthmatic children, wheezing manifested 
before or with the onset of AD. Children with AD and wheeze may have a marked loss in lung function, 
suggesting that they may have a distinct phenotype rather than a progressive development from AD 
to asthma.15 
Studies have shown that the severity of AD, as well as co-morbidity of AD and food allergy, are 
particular risk factors for asthma and allergic rhinitis.16 In a study looking at the natural history of 
children with both AD and food allergy attending a tertiary allergy clinic, 75% of children had another 
atopic condition as follows: 16  
•44% had allergic rhinitis and asthma 
 
•27% had allergic rhinitis 
 
•4% had asthma, without another atopic condition    
 
Early responses to egg represent an important infantile marker for atopy. In children with AD and egg 














In a 7 year follow-up study of children with AD, 80% of the children became sensitised to airborne 
allergens and 75% of them noticed symptoms when exposed. Family history of atopy and eczema, 
sensitisation to hen's egg, and early onset of eczema imparted an increased risk of becoming 
sensitised.18 Another prospective study on eczema and co-morbid conditions showed that egg 
sensitisation and severity of AD were positively related to the occurrence of asthma.19 
 AD is a major risk factor for propagation of the allergic march, which is the typical sequence of IgE 
responses and clinical symptoms which appear in atopic people. Studies have suggested that early 
intervention in AD may reduce further manifestations of the allergic march.20    
Food allergy and asthma 
Food allergy, has been found to be an independent risk factor for asthma and allergic rhinitis.  Early 
sensitisation to food allergens, especially hen's egg, has been shown to be a valuable predictor of 
subsequent sensitisation to inhalant allergens.6   Co-existence of food allergy with asthma may be a 
risk factor for hospitalisation for severe asthma exacerbations.21 
Asthma, on the other hand, is a risk factor for severe reactions to foods, and a high prevalence of 
asthma is reported amongst patients with life-threatening or fatal allergic food-allergy reactions.22 
Respiratory symptoms as part of a food-allergic reaction are a risk factor for persistence of food 
allergy: patients with both skin and respiratory tract symptoms on exposure to a food are less likely 
to have their food allergy resolve than patients with only skin or gut symptoms.16 
 
This chapter explores the co-morbidity between AD, food allergy, aeroallergen sensitisation, asthma 
and allergic rhinitis. Age-dependent patterns of aeroallergen sensitisation are explored, and indoor 
versus outdoor aeroallergens are differentiated with respect to risk profiles for co-morbid conditions.  
10.2 Methodology 
This was part of the wider study investigating food sensitisation and allergy patterns in South African 
children with atopic dermatitis, including 59 children of Xhosa origin, and 41 of mixed race origin.  
Only children with atopic dermatitis were included in this study, and the severity of the atopic 
dermatitis was assessed using the SCORAD index as described in chapter 5. Patients were assessed for 
food allergy by questionnaire, skin prick tests, ISAC 103 test and controlled open oral food challenge 
where indicated.  
Aeroallergen sensitisation was tested using the ImmunoCAP ISAC (103) test. Patients were assessed 














House dust mite Dermatophagoides pteronyssimus (DerP): components nDer p 1 and nDer p 2 
House dust mite Dermatophagoides Farinae (DerF): nDer f 1 and rDer f 2 
Storage Mite: rEur m 2 
Bermuda Grass: nCyn d 1 
Timothy Grass: r Phl p 1,2,4,5 6, 7, 11, 12 
Tree Pollen: Olive tree nOle e 1, nOle e 2 
                      Plane tree rPla a1, rPla a2 
                      Cypress nCup a 1 
                      Japanese Cedar nCry j 1 
                      Birch rBet v1,2 and 4 
                      Alder rAln g 1 
 Alernaria Mould: rAlt a 1, rAlt a 6 
Dog:  rCan f 1 and 2 
Cat: rFel d 1 and 4 
Symptoms of asthma and allergic rhinitis were elicited using a questionnaire modified from the ISAAC 
study questions: 23 
1. For asthma: Has your child ever had symptoms of asthma (such as wheeze, persistent cough at 
night or when exercising, shortness of breath)?   If yes, was the asthma diagnosed by a doctor, 
nurse or self-diagnosed? 
2. For allergic rhinitis: Has your child ever had symptoms of hayfever (such as itchy runny eyes, itchy 
runny nose, blocked nose, frequent sneezing)?  If yes, was the hayfever diagnosed by a doctor, 
nurse or self-diagnosed? 
 
Furthermore, all patients were examined for signs of asthma and allergic rhinitis, and a list of all their 
preventer and reliever medications for asthma and allergic rhinitis was recorded.  
10.2.1 Statistical analysis 
The prevalence of asthma and allergic rhinitis symptoms was determined, and differences between 
those with or without food allergy were analysed by the chi squared test. Aeroallergen sensitisation 
patterns were described and analysed for their association with asthma, allergic rhinitis and food 
allergy. 
As egg allergy has been deemed a major risk factor for respiratory allergies, a separate analysis was 














between peanut allergy and egg was also explored in view of the substantial co-sensitisation between 
egg and peanut. 
10.3 Results 
10.3.1 Asthma 
10.3.1.1 Prevalence of asthma in this study cohort of patients with AD 
Overall, 39% of patients described symptoms of asthma; 36% (21/59) in the Xhosa group and 44% 
(18/41) in the mixed race group. The interethnic difference in symptoms of asthma was not significant, 
p=0.4.  Overall, 29% of patients had doctor-diagnosed asthma, 25% (15/59) of Xhosas and 34% (14/41) 
of mixed race patients, p=0.34. Of those with doctor-diagnosed asthma, 48% (14/29) were on a regular 
preventer and 86% (25/29) were on a regular reliever. By ethnicity, 27% (4/15) Xhosas with doctor-
diagnosed asthma were taking a regular preventer and 71% (10/14) of mixed race patients; controller 
medication use was significantly lower in the Xhosa patients p=0.02.  However, the difference in 
reliever medication use was insignificant between ethnic groups, with 80% Xhosas (10/14) and 93% 
(13/14) of mixed race patients having a reliever medication, p=0.3.  
Asthma prevalence increased with age: 22% (7/32) children under the age of 2 years had asthma 
symptoms, 43% (12/28) children between 2-4 years and 50% (20/40) of children above the age of 4 
years had asthma symptoms.  
10.3.1.2 Food allergy and asthma 
Of the 40 patients with food allergy, 18 had symptoms of concurrent asthma (45%), and of the 60 
without food allergy 21 had asthma symptoms (35%), p= 0.31.  
For doctor-diagnosed asthma, 35% (14/40) with food allergy had doctor-diagnosed asthma versus 25% 
(15/60) without food allergy, p=0.28.  By ethnicity, in Xhosa patients 35% (7/20) with food allergy had 
doctor-diagnosed asthma versus 21% (8/39) without asthma (p=0.23), and in mixed race patients, 35% 
(7/20) with food allergy had doctor-diagnosed asthma versus 33% (7/21) without food allergy, p=0.9. 
The most common food allergens associated with asthma were egg and peanut. In those patients with 
doctor diagnosed asthma, 38% (11/29) had egg allergy and 38% (11/29) had peanut allergy.  There 
was no significant relevant relationship between multiple food allergies and asthma.  
Therefore, in this cohort of children with moderate to severe atopic dermatitis, the co-existence of 
food allergy was not associated with a higher prevalence of asthma. Moreover, increasing eczema 
severity was not associated with higher asthma rates: 46% (23/50) with moderate eczema had 














and 28% (14/50) for doctor-diagnosed asthma, p=0.8. Age of onset of eczema similarly did not 
influence asthma prevalence:  28% (10/36) with early onset eczema under the age of 6 months had 
asthma symptoms versus 45% (29/64) with later onset eczema (p=0.08); for doctor diagnosed asthma, 
paradoxically early onset eczema had a lower incidence of doctor-diagnosed asthma then later onset 
eczema: 14% (5/36) with early onset eczema had doctor-diagnosed asthma, versus  38% (24/64) with 
later onset eczema (p=0.01).  However, the median age of patients with early onset eczema at the 
time of study participation was 28.5 months, versus 52.5 months in those patients with later onset 
eczema, hence this may bias asthma prevalence, which tends to increase with age.  
However, age at study entry had a significant influence on asthma prevalence: in those under the age 
of 42 months at study entry (n=49), 24% (12/49) had symptoms of asthma, versus 53% (27/51) in those 
who entered the study at or above 42 months (p=0.004).  This reflects the finding that asthma 
prevalence increases with age in this high-risk population, with the median age at study entry of those 
with asthma symptoms being 51 months.  
10.3.2 Allergic Rhinitis 
10.3.2.1 Prevalence of allergic rhinitis in this study cohort of patients with AD 
53% of patients described symptoms of allergic rhinitis, 53% in Xhosas (31/59) and 54% (22/41) in 
mixed race patients, p=0.9. Overall, 28% of patients had doctor-diagnosed allergic rhinitis, 25% (15/59) 
Xhosa patients and 32% (13/41) mixed race patients, p=0.41.    
Age at study entry had a significant influence on allergic rhinitis prevalence: in those under the age of 
42 months at study entry (n=49), 37% (18/49) had symptoms of allergic rhinitis, versus 69% (35/51) in 
those who entered the study at or above 42 months (p=0.001).  This reflects the finding that allergic 
rhinitis prevalence increases with age in this high-risk population:  31% (10/32) children under the age 
of 2 years had allergic rhinitis symptoms, 53% (15/28) children between 2-4 years and 70% (28/40) of 
children above the age of 4 years. 
 
10.2.2.2. Food allergy and allergic rhinitis 
Overall, 48% (19/40) of patients with food allergy had symptoms of allergic rhinitis (9 cases egg, 13 
cases peanut), and 57% (34/60) of those without food allergy had symptoms of allergic rhinitis 
(p=0.37).  By doctor-diagnosed allergic rhinitis, 28% (11/40) with food allergy had allergic rhinitis and 
28% (17/60) without food allergy had allergic rhinitis. (p=0.93).  Therefore, the presence of food allergy 















Of the 28 cases of doctor-diagnosed allergic rhinitis (who therefore had access to treatment), 64% 
(18/28) were on an intranasal corticosteroid; by ethnic breakdown 53% (8/15) in Xhosas and 77% 
(10/13) in mixed race patients, p=0.19.  Overall, 86% (24/28) of patients with doctor-diagnosed allergic 
rhinitis were on antihistamines; 80% (12/15) in Xhosas and 92% (12/13) in mixed race patients, p=0.37. 
Patterns of asthma and allergic rhinitis in the cohort of 100 patients with AD are summarised in table  
10.1. Age-related changes in food allergy, asthma and allergic rhinitis prevalence are shown in figure 
10.1. 
 
Table 10.1: Prevalence patterns of asthma and allergic rhinitis 
 % Patients 
overall 
% of Xhosa 
patients 






























53% 53% 54% 0.9 48% 57% 0.37 
*Chi-squared test 
 











Food allergy Asthma Allergic Rhinitis
Food allergy, asthma and allergic rhinitis 
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 10.3.3 Sensitisation Pattern to Aeroallergens 
Overall, 89% of patients tested positive to at least one aeroallergen on the ISAC test. The median 
number of positive aeroallergen tests was 3.5. Aeroallergen sensitisation was most common to 
Dermatophagoides Pteronyssinus (Der P) at  81%, followed by Dermatophagoides Farinae (Der F) at 
78%, storage mite at 51%, Timothy Grass at 36%, cat at 35%, Bermuda Grass  at 30%, dog at 18%, tree 
pollen at 17% and alternaria mould at 16%. Aeroallergen sensitisation patterns are depicted in table 
10.2 and figures 10.2 and 10.3.  Sensitisation to tree pollen, cat dander, Bermuda grass and dog dander 
was significantly more common in the mixed race group in comparison to the Xhosa group.  
  
Table 10.2 Aeroallergen sensitisation patterns 
 % sensitised 
overall 
% of Xhosas 
sensitised 








89% 86% 93% 0.33 
DerP 
 
81% 80% 83% 0.68 
DerF 
 
78% 78% 78% 0.99 
Storage Mite 
 
51% 54% 46% 0.51 
Timothy Grass 
 
36% 29% 46% 0.08 
Cat 
 
35% 27% 46% 0.05** 
Bermuda Grass 
 
30% 20% 44% 0.011** 
Dog 
 
18% 10% 29% 0.014** 
Tree pollen 
 
17% 10% 27% 0.03** 
Alternaria 
 
16% 14% 20% 0.42 
*by chi-squared test 























Figure 10.2 Overall prevalence of aeroallergen sensitisation  
 
 
Figure 10.3: Prevalence of aeroallergen sensitisation by ethnic group 
 
*Statistically significant difference by Chi-squared test 
Der P= Dermatophagoides Pteronnysinus      Der F=Dermatophagoides Farinae      S/mite=storage mite 
 
 
10.3.3.1 House dust mite sensitisation: 
Dermatophagoides Pteronyssinus (DerP) 
Overall, 81% of patients were sensitised to DerP, 80% (47/59) in Xhosa patients and 83% (34/41) in 
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the component Der p 1 and 65 (80%) to Der p 2.  In those patients sensitised to DerP, The median 
value for Der p 1 was 10 ISU, and for Der p 2 5.8 ISU.  
 
There was no significant increase in asthma or allergic rhinitis symptoms in those patients with DerP 
sensitisation: 87% (34/39) of patients with asthma symptoms were DerP sensitised, compared with 
77% (47/61) of non-asthmatics (p=0.21). 83% (44/53) of patients with symptoms of allergic rhinitis 
were DerP sensitised versus 79% (37/47) without allergic rhinitis symptoms (p=0.59). There was, 
however, a significant association between DerP sensitisation and food allergy: 93% (37/40) with food 
allergy were DerP sensitised versus 73% (44/60) without food allergy, p=0.02. 
 
Dermatophagoides Farinae (DerF) 
Overall, 78% of patients were sensitised to DerF, 78% (46/59) in Xhosa patients and 78% (32/41) in 
mixed race patients, p=0.99. Of these 78 patients with DerF sensitisation, 71 (91%) were sensitised to 
the component Der f 1 and 62 (79%) to Der f 2.  The median value for Der f 1 was 7.15 ISU, and for  
Der f 2  7.5 ISU.  
There was no significant increase in asthma or allergic rhinitis symptoms in those patients with DerF 
sensitisation: 82% (32/39) of patients with asthma symptoms were DerF sensitised, compared with 
75% (46/61) non-asthmatics (p=0.43).  Eighty-three percent (44/53) of patients with symptoms of 
allergic rhinitis were DerF sensitised versus 72% (34/47) without allergic rhinitis symptoms (p=0.2). 
There was, however, a significant association between DerF sensitisation and food allergy: 90% 
(36/40) of children with food allergy were DerF sensitised versus 70% (42/60) without food allergy, 
p=0.02. 
 
77/78 (99%) patients with sensitisation to DerF were also DerP sensitised, and 77/81 (95%) of patients 
with sensitisation to DerP were also DerF sensitised; hence there was a near complete overlap 
between house dust mite species.  
 
10.3.3.2 Storage Mite Sensitisation 
Overall 51% of patients were sensitised to storage mite, 54% (32/59) Xhosas and 46% (19/41) in mixed 
race patients (p=0.51). The median level in the positive group was 3.8 ISU. Fifty of the 51 patients with 
storage mite sensitisation (98 %) were co-sensitised with DerP.  
 
There was a significant increase in asthma symptoms in those patients with storage mite sensitisation: 














(25/61) of non-asthmatics (p=0.015). There was a trend towards higher storage mite sensitisation in 
those patients with allergic rhinitis symptoms, but it did not reach statistical significance: 60% (32/53) 
of patients with symptoms of allergic rhinitis were storage mite sensitised versus 40% (19/47) without 
allergic rhinitis symptoms (p=0.06). There was no significant association between storage mite 
sensitisation and food allergy: 60% (24/40) with food allergy were storage mite sensitised versus 45% 
(27/60) without food allergy (p=0.16). 
 
10.3.3.3 Timothy Grass Sensitisation 
Overall, 36% of patients were sensitised to at least one of the Timothy Grass antigens, 29% (17/59) 
Xhosas versus 46% (19/41) in mixed race patients, p=0.08. In those who were Timothy grass sensitised, 
the median level was 12 ISAC units.  83% (30/36) patients with Timothy grass sensitisation were also 
Bermuda grass sensitised.  
 
There was a significant increase in asthma symptoms in those patients with Timothy grass 
sensitisation: 51% (20/39) of patients with asthma symptoms were Timothy grass sensitised, 
compared with 26% (16/61) non-asthmatics (p=0.008). Timothy grass sensitisation was also 
significantly associated with allergic rhinitis symptoms: 51% (27/53) of patients with symptoms of 
allergic rhinitis were Timothy grass sensitised versus 19% (9/47) without allergic rhinitis symptoms 
(p=0.001). There was no significant association between Timothy grass sensitisation and food allergy: 
38% (15/40) with food allergy were Timothy grass sensitised versus 35% (21/60) without food allergy, 
p=0.73. 
 
10.3.3.4 Cat sensitisation 
Overall, 35% of patients were sensitised to at least one of the cat allergens tested, significantly higher 
in mixed race patients at 46% (19/41) versus Xhosa patients at 27% (16/59), p=0.047.  Forty percent  
(14/35) of patients with cat sensitisation were also dog-sensitised. Of those who were sensitised to 
cat, the median level was 3.6 ISU. 
 
There was no significant increase in asthma or allergic rhinitis symptoms in those patients with cat 
sensitisation: 41% (16/39) of patients with asthma symptoms were cat sensitised, compared with 31% 
(19/61) non-asthmatics (p=0.31). Thirty-six percent (19/53) of patients with symptoms of allergic 
rhinitis were cat sensitised versus 34% (16/47) without allergic rhinitis symptoms (p=0.85). There was, 
however, a significant association between cat sensitisation and food allergy: 58% (23/40) of patients 














10.3.3.5 Bermuda grass sensitisation  
Overall, 30% of patients were Bermuda grass sensitised. Bermuda grass sensitisation was significantly 
higher in the mixed race group 44% (18/41) versus Xhosas 20% (12/59), p=0.011. In those who were 
Bermuda grass sensitised, the median ISAC value was 10.3 ISU. All patients with Bermuda grass 
sensitisation were also Timothy grass sensitised, hence there was significant co-sensitisation with the 
grasses.  
 
There was a significant increase in asthma symptoms in those patients with Bermuda grass 
sensitisation: 46% (18/39) of patients with asthma symptoms were Bermuda grass sensitised, 
compared with 20% (12/61) non-asthmatics (p=0.005). Bermuda grass sensitisation was also 
significantly associated with allergic rhinitis symptoms: 43% (23/53) of patients with symptoms of 
allergic rhinitis were Bermuda grass sensitised versus 15% (7/47) without allergic rhinitis symptoms 
(p=0.002). There was no significant association between Bermuda grass sensitisation and food allergy: 
(33% (13/40) with food allergy were Bermuda grass sensitised versus 28% (17/60) without food 
allergy, p=0.66). 
 
10.3.3.6 Dog sensitisation 
Overall, 18% of patients were dog sensitised; significantly higher in mixed race patients at 29% (12/41) 
versus Xhosa patients at 10% (6/59), p=0.014. Of those who were positive to dog, the median value 
was 7.3 ISU.  Seventy-eight percent (14/18) of patients with dog sensitisation were also cat sensitised. 
 
Dog sensitisation was not significantly associated with asthma or allergic rhinitis symptoms. Overall, 
23% (9/39) of patients with asthma were dog sensitised, compared with 15% (9/61) in non-asthmatics 
(p=0.3). 19% (10/53) of patients with symptoms of allergic rhinitis were dog sensitised versus 17% 
(8/47) without allergic rhinitis symptoms (p=0.81). There was a significant association between dog 
sensitisation and food allergy: 38% (15/40) of those with food allergy were dog sensitised versus 5% 
(3/60) of those without food allergy, p< 0.001.  
 
10.3.3.7 Tree Pollen Sensitisation 
17% of patients were sensitised to any of the tree pollens tested, the percentage being significantly 
higher in mixed race patients: 10% (6/59) in Xhosas and 27% (11/41) in mixed race, p=0.03.   
 
There was a trend towards an increase in asthma symptoms in those patients with tree pollen 
sensitisation, but it did not reach statistical significance: 26% (10/39) of patients with asthma 














pollen sensitisation was not significantly associated with allergic rhinitis symptoms:  23% (12/53) of 
patients with symptoms of allergic rhinitis were tree pollen sensitised versus 11% (5/47) without 
allergic rhinitis symptoms (p=0.111). There was no significant association between tree pollen 
sensitisation and food allergy: 25% (10/40) with food allergy were tree pollen sensitised versus 12% 
(7/60) without food allergy, p=0.08. 
 
10.3.3.8 Alternaria mould sensitisation 
Overall, 16% of patients were Alternaria mould sensitised, 14% (8/59) in Xhosas versus 20% (8/41) in 
the mixed race group, p=0.42.  The median level of Alternaria in those who were sensitised was 4.75 
ISU. 
 
Alternaria sensitisation was not significantly associated with asthma or allergic rhinitis symptoms.  
Twenty-three percent (9/39) of patients with asthma were Alternaria sensitised, compared with 11% 
(7/61) of non-asthmatics (p=0.12).    Thirteen percent (7/53) of patients with symptoms of allergic 
rhinitis were Alternaria sensitised versus 19% (9/47) without allergic rhinitis symptoms (p=0.42). There 
was no significant association between Alternaria sensitisation and food allergy: 15% (6/40) of those 
with food allergy were Alternaria sensitised versus 17% (10/60) without food allergy, p=0.82.  
 
Aeroallergen sensitisation pattern in patients with asthma, allergic rhinitis and food allergy in this 





























Table 10.3: Aeroallergen sensitisation patterns in concomitant asthma, allergic rhinitis and food allergy 







































































23% 11% 0.12 13% 19% 0.42 15% 17% 0.82 
*by chi-squared test                                




























Figure 10.4 Pattern of aeroallergen sensitisation in patients with asthma 
 
Figure 10.5 Pattern of aeroallergen sensitisation in patients with allergic rhinitis 
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Prevalence of Aeroallergen Sensitisation in Children with 
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10.3.4 Age and aeroallergen sensitisation patterns 
The sensitisation pattern to aeroallergens by age is depicted in table 10.4 and figure 10.7. For the 
indoor allergens, including house dust mite, cat and dog, the sensitisation rates were similar in the 
younger children (even at one year of age) compared to the older children, suggesting that this 
sensitisation occurs early on in life to these allergens. Timothy grass, Bermuda grass, storage mite and 
tree pollen sensitisation increased with age, suggesting an ongoing sensitisation process far beyond 
the first year of life to certain aeroallergens. The mean number of aeroallergens the patient is 
sensitised to was 2.25 in children under the age of 2 years; 2.8 at or below 4 years and 3.63 at or below 
10 years. This suggests that aeroallergen sensitisation may continue beyond 4 years of age.  
 
Table 10.4  Aeroallergen sensitisation by age 
                                                                                Age in Years 
 
 1 year 
 
2 years 4 years 10 years 
Any aeroallergen 88% 
 
78% 85% 89% 
DerP 
 
88% 72% 77% 81% 
DerF 
 
75% 72% 75% 78% 
Storage Mite 
 
13% 22% 37% 51% 
Timothy Grass 
 
0% 3% 18% 36% 
Cat 
 
38% 31% 32% 35% 
Bermuda Grass 
 
0% 3% 12% 30% 
Dog 
 
25% 19% 15% 18% 
Tree pollen 
 
0% 0% 5% 17% 
Alternaria 
 





























Figure 10.7 Aeroallergen sensitisation by age 
 
 
10.3.5 Egg Allergy and Co-Morbidity 
10.3.5.1 Egg allergy and asthma 
Forty-four percent (11/25) of children with egg allergy had symptoms of asthma, compared with 37% 
(28/75) without egg allergy (p=0.55). This finding was similar between ethnic groups: 50% (7/14) of 
Xhosa patients with egg allergy had asthma, and 36% (4/11) of mixed race patients with egg allergy 
had asthma symptoms, p=0.49.  There was a tendency for the older children (over 24 months) with 
egg allergy to have more asthma than the younger children with egg allergy, but this did not reach 
statistical significance: 31% (5/16) under 24 month’s age with egg allergy had asthma symptoms; and 
67% (6/9) of children over 24 month’s age with egg allergy had asthma, p=0.08. 
 
10.3.5.2 Egg allergy and allergic rhinitis 
Thirty-six percent (9/25) of children with egg allergy had symptoms of asthma, compared with 59% 
(44/75) without egg allergy; paradoxically this resulted in egg allergic children having a lower risk of 
allergic rhinitis, p=0.049. This finding was similar between ethnic groups: 36% (5/14) Xhosa patients 
with egg allergy had allergic rhinitis, and 36% (4/11) of mixed race with egg allergy had allergic 
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10.3.5.3 Egg sensitisation/allergy and aeroallergen sensitisation 
Overall, there was a high rate of aeroallergen sensitisation which was not statistically different in those 
with or without egg sensitisation or allergy. Eighty-one percent (44/54) of patients with egg 
sensitisation were sensitised to at least one aeroallergen, and 96% (45/47) of those without egg 
sensitisation had aeroallergen sensitisation (p=0.41).   Ninety-two percent (23/25) of patients with egg 
allergy were sensitised to at least one aeroallergen, compared with 88% (66/75) without egg allergy 
(p=0.58). 
Moreover, in the population overall, there was not a significant difference in house dust mite 
sensitisation rates between egg sensitised patients and those not sensitised to egg. Seventy-eight 
percent (42/54) of patients with egg sensitisation were sensitive to DerP, and 85% (39/46) of those 
without egg sensitisation were sensitised to DerP (p=0.11).  Ninety-two percent (23/25) of patients 
with egg allergy were sensitised to DerP, compared with 77% (58/75) of those without egg allergy 
(p=0.11).  
However, there was an interethnic difference in the association between house dust mite and egg 
sensitisation, with a stronger association in the mixed race group. In the Xhosa group, 79% (23/29) 
with egg sensitisation were also sensitised to DerP, compared with 80% (24/30) without egg 
sensitisation (p=0.95). In the mixed race group, 100% (19/19) of egg sensitised patients were also DerP 
sensitised, compared with 68% (15/22) who were not egg-sensitised, p=0.007.  The interethnic 
difference in proportion of egg sensitised patients who were are also DerP sensitised was significant 
at 0.034.  
10.3.5.3 Egg Allergy and Peanut allergy 
In this study, 44% (11/25) of children with egg allergy had a peanut allergy, versus 17% (13/75) without 
egg allergy (p=0.005). By ethnic breakdown, this relationship between egg allergy and peanut allergy 
was significantly stronger in the mixed race group, in whom 64% (7/11) with egg allergy had peanut 
allergy versus 27% (8/30) without egg allergy (p=0.014). In the Xhosa group with egg allergy, 29% 
(4/14) had peanut allergy; compared with 11% (5/45) of those without egg allergy (p=0.113).  
 
10.4 Discussion 
The significant comorbidity between atopic dermatitis, food allergy, asthma and allergic rhinitis 
reflects the process of the allergic march, with epicutaneous sensitisation to allergens via a broken 














Allergic co-morbidity was significant in our cohort of children with moderate to severe atopic 
dermatitis. The prevalence of asthma symptoms, at 39%, is significantly higher than in the general 
population, estimated at 14% in South Africa adolescents based on data from the ISAAC study.23 
Although the ISAAC study was based on adolescents, it is the only data for respiratory allergies that 
we have from a large unselected population in South Africa. The prevalence of reported allergic rhinitis 
symptoms of 53% is higher than the figure of 39% in South African adolescents in the ISAAC study. 
There were no significant ethnic differences in asthma and allergic rhinitis prevalence, and no 
significant difference between food allergic and food tolerant children in terms of asthma and allergic 
rhinitis prevalence. Although egg sensitisation was significantly associated with house dust mite 
sensitisation in mixed race children, egg sensitisation and allergy rates were not overall associated 
with an increase in asthma or AR symptoms.  AD per se rather than food allergy therefore seems to 
be the more important risk factor for progression to respiratory diseases in this cohort.  
The prevalence of both asthma and allergic rhinitis increased with age, in contrast to the prevalence 
of food allergy, which fell with age. This reflects the progression of the allergic march, with eczema 
and food allergy peaking earlier than asthma and allergic rhinitis. 
Aeroallergen sensitisation was extremely common in this population, and the pattern was age-
dependent. 81% of patients were sensitised to house dust mite DerP. Sensitisation to indoor allergens 
such as house dust mite, cat and dog dander peaked already by the age of 2 years, whereas 
sensitisation to grass pollen, tree pollen, Alternaria mould and storage mite increased with age.  Unlike 
food allergy sensitisation, which peaked by 2 years and then declined steadily, aeroallergen 
sensitisation occurred well after 2 years, hence a negative aeroallergen test at a young age should be 
repeated at an older age in high risk patients. Also, the aeroallergen pattern evolves over time with 
the seasonal allergens becoming more important in the older children.  
Sensitisation to Timothy grass, Bermuda grass and storage mite was significantly higher in asthmatic 
than non-asthmatic patients, and sensitisation to Timothy and Bermuda grass was significantly higher 
in patients with allergic rhinits symptoms. The indoor allergens DerP, DerF, cat and dog were not 
significantly higher in asthma or AR. It may be that the induction of specific IgE responses to certain 
aeroallergens and the development of childhood asthma are, at least partly, determined by 
independent factors.24 
The indoor allergens DerP, DerF, cat and dog were, however, significantly higher in children with food 
allergy.  As these are the allergens which peak in sensitisation at a young age, this may reflect early-
onset epicutaneous sensitisation to a number of food and aeroallergens with which the young child is 














Food allergies can also co-exist in patterns, and co-sensitisation with egg and peanut allergy was 
common in this population, especially in those of mixed race. Overall, 44% of patients with egg allergy 
also had a peanut allergy, and 64% in the mixed race subgroup. 
Poor control of one atopic condition can lead to increased morbidity as result of another atopic 
condition, e.g. poor asthma control is a significant risk factor for a more severe food-allergic 
reactions.22 This particularly concerning in light of the low rates of controller medication use reported 
by asthmatic patients in this cohort: only 27% of Xhosa patients with doctor- diagnosed asthma took 
a regular controller.  
On the other hand, improved control of atopic conditions may reduce the progression to or severity 
of associated atopic conditions, e.g. better control of atopic dermatitis may reduce the risk of food 
allergy or asthma. An Italian study following up 176 children with AD suggested that early diagnosis 
and improved management of AD may lead to a reduction in percentage of children evolving towards 
asthma from 29% to 15%.25 Integrated management of the allergic patient is therefore essential, 
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Patterns of Introduction of Complementary Feeding and Solids 
 
11.1 Introduction 
The optimal timing of the introduction of solids to minimise the risk of food allergies is currently under 
study. Some immunological and epidemiological evidence has suggested that early exposure of the 
immune system to allergens, especially via the enteral route, may enhance immunological tolerance.1 
Delaying the introduction of solids beyond 6 months has not been shown to have any significant effect 
on reduction in allergies; indeed, recent studies for wheat, egg, cow’s milk and fish allergy have shown 
that delayed introduction may lead to a higher incidence in allergies.2-5  
Several large prospective studies are currently underway to investigate whether early or late exposure 
to highly allergenic foods such as peanut and egg results in a lower rate of allergies to those foods. 6-8 
This chapter explores the timing of introduction of solids and peanut dietary intake patterns of 
children with atopic dermatitis and their potential influence on allergy rates.  
 
11.2 Methodology 
 As part of the study investigating food allergy prevalence in 100 children with atopic dermatitis, 
parents were asked about dietary int oduction patterns by questionnaire.  They were asked about the 
timing of the first introduction of peanut, egg, cow’s milk or dairy, soya, wheat, fish, tree nuts and 
sesame seed. For peanut, there was an additional questionnaire to ascertain the average weekly 
consumption of peanut and peanut-containing foods.  
11.3 Results 
11.3.1 Peanut introduction and consumption patterns  
Overall, 81 (81%) of patients in the study had consumed peanut:  78% (46/59) of Xhosa children and 
85% (35/41) of mixed race children (p=0.4).  Overall, 62% of patients were still eating peanut on a 
regular basis, this was equal in both ethnic groups at 62% each. Despite a difference in monthly 
household income (median R2000 in Xhosa patients and R3500 in mixed race patients, p=0.01 by 
Mann-Whiney test), there were no significant differences in peanut consumption patterns between 
Xhosa and mixed race groups. In those who had introduced peanut into their diets, the median age of 














group (p=0.08). The median number of peanut servings per week in those consuming peanut was 3 
for both ethnic groups.  
Only 7 of the Xhosa patients (12%) had introduced peanut before 12 months of age, and 8 of the mixed 
race patients (20%), p=0.28.  
Of the 13 Xhosa patients who had never consumed peanut before, 2 were found to be allergic on 
challenge (15%), and of the 6 mixed race patients who had never consumed peanut, 4 were 
subsequently found to be allergic on challenge (67%).  The median age at the time of the first reaction 
to peanut was 24 months.  
11.3.1.1 Age of Peanut Introduction and Allergy Risk 
In those patients who had introduced peanut before the age of one year (n=15), 5 were found to have 
a peanut allergy (33%), compared to those who introduced peanut butter after a year (n=84), in whom 
21 were found to be allergic (25%), p=0.51. Therefore, in this cohort there was not an obvious 
protective effect of peanut introduction before a year of age in comparison to after a year of age. 
However, with age of introduction of peanut below 8 months, the trend was towards a lower 
prevalence of peanut allergy: in those who introduced peanut below 8 months (n=8), only 1 had an 
peanut allergy (12.5%), compared to those introducing peanut at or after 8 months (n=92) in whom 
23 were allergic (25%); however, this did not reach statistical significance (p=0.42). 
11.3.2  Hen’s egg introduction patterns 
Overall, 96 (96%) of patients had eaten egg before, this was 98% in Xhosa patients (58/59) and 93% 
(38/41) in mixed race patients, p=0.21. The median age of egg introduction was 12 months in both 
ethnic groups. Of those who had never eaten egg before, 2 were sensitised to egg and were 
challenged, of whom one was positive. Of all the patients with an egg allergy, the median age of the 
first allergic reaction was 12 months. 
Overall, 36 (36%) of patients introduced egg before a year of age: 34% (20/59) of Xhosas and 39% 
(16/41) of mixed race origin introduced egg before a year of age, p=0.6.  
In those patients who introduced egg before a year of age (n=36), 11 were found to have an egg allergy 
(31%), compared to those who introduced egg after a year (n=64), in whom 14 were fund to be allergic 
(22%), p=0.32. Therefore, in this cohort there was not an obvious protective effect of egg introduction 
before a year of age in comparison to after a year. However, with introduction of egg below the age 
of 8 months, the trend was towards lower prevalence of egg allergy: in those who introduced egg 














8 months (n=88) in whom 24 were allergic (27%). However, this did not reach statistical significance 
(p=0.15).  
11.3.3   Cow’s milk and dairy products introduction  
Overall, 89 (89%) of patients had consumed a cow’s milk based formula:  92% (54/59) of Xhosas and 
85% (35/41) of mixed race patients, p= 0.27. The median age of introduction of cow’s milk formula 
was 3 months in both ethnic groups. 
Whole cow’s milk had been introduced in 86 (86%) cases: in 89% (50/56) of Xhosas and 88% (36/41) 
of mixed race patients, p=0.9. The median age of introduction of whole cow’s milk was 18 months 
overall: 13.5 months in Xhosa patients and 18 months in mixed race patients.     
Overall, 96 (96%) patients had consumed dairy products:  95% (56/59) of Xhosas and 98% (40/41) of 
mixed race patients, p=0.44.  These were introduced at a median age of 8 months overall, 8 months 
in Xhosa patients and 12 months in mixed race patients. 
The median age at first reported reaction to cow’s milk was 12 months, and to dairy products 18 
months. 
11.3.4  Soya Introduction 
Overall, 26 patients (26%) had consumed a soya formula, 27% (16/59) in Xhosa patients and 24% 
(10/41) in mixed race patients, p=0.77. The median age of soya introduction was 6 months overall: 6.5 
months in Xhosa patients and 3 months in mixed race patients.  The median age at the time of 
perceived soya allergy was 2.5 months, but none of the patients with perceived reactions were 
subsequently found to have an IgE-mediated allergy to soya at the time of the study.  
11.3.5 Wheat introduction  
All 100 patients in this cohort had consumed wheat. The median age of wheat introduction was 6 
months overall, 7 months in Xhosa patients and 6 months in mixed race patients.  The median age at 
first perceived reaction to wheat was 7.5 months, but at the time of study no patients were found to 
have IgE-mediated wheat allergy.  
11.3.6  Fish introduction  
Overall, 87 (87%) of patients had consumed fish at the time of the study: 83% (49/59) Xhosa patients 
and 93% (38/41) mixed race patients, p=0.14.  The median age at fish consumption was 24 months 
overall: 24 months in Xhosa patients and 15 months in mixed race patients. The median age at first 














11.3.7   Tree Nut introduction 
Only 30 patients (30%) had knowingly consumed tree nuts. Tree nut consumption was significantly 
more common in the mixed race patients: 22% (13/59) of Xhosas and 41% (17/41) of mixed race 
patients had introduced tree nut into their diet, p=0.04.  Of those who consumed tree nuts the average 
age of introduction was 24 months in both ethnic groups. The average age at the time of first reaction 
to tree nuts was 42 months.  
11.3.8  Sesame introduction 
 Overall, 16 (16%) of patients had knowingly consumed sesame. Sesame consumption was significantly 
higher in mixed race patients: 8% (5/59) of Xhosas had consumed sesame and 27% (11/41) of mixed 
race patients had consumed sesame, p=0.01. The median age at introduction of sesame was 24 
months in both ethnic groups.  
Complementary food introduction patterns are summarised in table 11.1 
Table 11.1: Table showing age of introduction of complementary feeds 
 % of patients who had 
introduced the food into 
their diet 








Cow’s Milk-based formula 
 
89% 3 























In this cohort of patients with atopic dermatitis, consumption patterns of complementary feeding did 
not differ significantly between ethnic groups. The tendency was towards relatively late introduction 














These foods are known to be allergenic; and atopic dermatitis patients may well deliberately delay the 
introduction of such solids to try and minimise allergic reactions. This is despite the increasing 
evidence that a delay in introduction of allergenic foods does not reduce allergy risk. Despite the 
delayed introduction of these solids, the prevalence of egg and peanut allergy in this cohort was 
particularly high.  Recall bias could have influenced the reported age of solids introduction in the older 
children, reporting introduction either earlier or later than occurred in true life. Those children who 
had not yet introduced a certain feed were omitted from the analysis of that particular food.   
Of particular interest is a possible shift in peanut consumption patterns amongst the Xhosa group.  
In a dietetic study in 2006, mothers (n = 198) of Black infants aged 4 – 36 months in Cape Town were 
interviewed about their infants’ peanut intake using a peanut consumption questionnaire.9 In that 
study, the mean age of introduction of peanuts and peanut products was found to be 10 months, and 
64% of subjects started eating peanuts before one year of age.  The median total peanut intake was 
12 g/day (1-2 portions per day).  In comparison, in the 59 Xhosa patients from our study cohort, the 
median age of introduction of peanut was 24 months, and only 12% of children had consumed peanut 
before the age of one.  Of those consuming peanut, the average consumption was 3 portions per 
week.   
Caregivers of patients with eczema may deliberately delay the introduction of peanuts to the child’s 
diet because of a growing public knowledge about peanut allergy or because of the advice of a 
healthcare practitioner. This may lead to reverse causation, with the eczema actually leading to later 
introduction of peanut. However, the cautious introduction of allergenic solids is a potential concern 
with mounting evidence that delaying the introduction of allergenic solids is not beneficial in allergy 
prevention. 1-5 
In our study, there was a trend towards lower allergy rates in those who had introduced egg and 
peanut earlier (younger than 8 months), however, this did not reach statistical significant and requires 
larger studies for accurate results.  
Wheat products were consumed in all children at the time of study and were introduced relatively 
early at a median age of 6 months. There was no IgE-mediated wheat allergy in this cohort of children.  
Cow’s milk formula had been consumed in a majority of the population (89%) at a median age of 3 
months, once again relatively early. The prevalence of cow’s milk allergy in this population was lower 














cow’s milk was ingested at a reasonably late age, 18 months, suggesting prolonged formula or 
breastfeeding well past a year of age before switching to fresh whole cow’s milk.  
The consumption of tree nuts (30%) and sesame (16%) was low, especially in Xhosa patients.  
Overall, this study suggests the trend towards late introduction of certain allergenic foods, particularly 
peanut. The outcome of studies investigating the ideal time of enteral introduction of allergenic foods 
such as peanut and egg is awaited,6-8 and will help guide our patients as to the best strategy to try and 
minimise allergies. This is particularly important in children at high risk of food allergies, such as those 
with atopic dermatitis. The trend towards later introduction of solids does not seem to benefit allergy 
reduction.   
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Chapter 12  
Conclusion: Clinical Application of Study Findings and the Increasing 
Burden of Food Allergy in South Africa 
 
12.1 Summary and Clinical Application of Study Findings 
 
This was the first study in South Africa designed to investigate the prevalence of IgE-mediated food 
allergy in a defined population, and to include the use of controlled food challenges. Several modalities 
of screening for food allergy were performed and could be compared: patient history, skin prick test 
(SPT) results, specific IgE components by the ISAC (Immuno Solid Phase Allergen Chip) 103 test, 
ImmunoCAP tests to whole foods as well as components, as well as results from controlled 
incremental food challenges. Patient history alone significantly overestimated true allergy prevalence, 
and of those cases of reported allergies, only 42% were found to be truly allergic.  
The prevalence of sensitisation (66%) as well as confirmed food allergy (40%) in our cohort of South 
African children with atopic dermatitis was unexpectedly high, in both Xhosa children as well as those 
of mixed race.  It mirrored that of previous studies in high socio-economic areas, mainly Europe and 
the USA.1-3 Egg (25%) and peanut (24%) allergies were by far the most common. However, although 
sensitisation rates were comparable between the 2 ethnic groups, allergy rates were generally higher 
in the mixed race group than in Xhosa patients, significantly so for peanut (38% versus 15%, p=0.01) 
and cashew nut (7% versus 0%, p=0.04).  Therefore, although food allergy prevalence is high in this 
selected population, the Xhosa patients may still have a relative protection from manifesting as 
allergic when they are sensitised.  
Overall, 60% of sensitised patients had a true allergy, this ratio was significantly lower in the Xhosa 
group: 49% versus 80% in mixed race patients (p=0.002). This means that less than half of Xhosa 
patients who are sensitised to one or more food are actually truly allergic, indicating a high rate of 
false positives. Once again, this was especially evident for peanut allergy, in which 75% of peanut-
sensitised mixed race patients but only 39% of peanut-sensitised Xhosa patients were found to be 
allergic (p<0.001). This emphasises the need for further confirmatory tests in the form of the 
controlled food challenges, especially so in the Xhosa population.  
Risk factors for food allergy included early age of onset of eczema (< 6 months), young age at the time 














any of these risk factors together with moderate to severe eczema, especially if inadequately 
controlled by topical skin care, should thus be screened for food allergy.  
In the diagnosis of peanut allergy, out of all the tests performed (SPT, ISAC components, ImmunoCAP 
peanut and ImmunoCAP peanut components) the diameter of the SPT was the superior test in 
differentiating allergy from tolerance to peanut. Although the widely used positive predictive value 
(PPV) of 8 mm4 for the peanut SPT is applicable to the mixed race group (88% PPV at SPT diameter ≥8 
mm), it performed slightly less well in the Xhosa population (80% PPV at SPT diameter ≥8 mm), who 
fared better at a higher SPT diameter (88% PPV at SPT diameter of 11 mm). Thus, although the SPT to 
peanut remains a sensitive test for peanut allergy, its specificity may be increased by revising the 95% 
PPV levels for the prediction of peanut allergy in our local population, especially in the Xhosa 
subgroup. 
Peanut components measured in this study included Ara h 1, 2, 3, 8 and 9. Component patterns were 
similar amongst ethnic groups.   Ara h 2 was the superior component in both ethnic groups for 
differentiating true allergy from tolerance. However, the component reactivity amongst 
asymptomatically sensitised patients was significantly higher in the Xhosa population than the mixed 
race patients, leading to higher false positives in the Xhosa group. For a positive ImmunoCAP to              
Ara h 2 (≥0.35 kU/L), the chances of a peanut allergy were high (93%) for mixed race patients but 
significantly lower (53%) in Xhosa patients.  Once again, the role of food challenges is crucial to 
differentiate tolerance from allergy in sensitised patients.  In this study, the component Ara h 9 (a lipid 
transfer protein, which is a significant allergen in Mediterranean countries5) was associated with 
tolerance, representing a cross-reactive component. The greater the number of peanut storage 
proteins (Ara h 1, 2 and 3) positive, the greater was the chance of peanut allergy and also more severe 
peanut allergy. Positivity to Ara h 8 and 9 actually reduced the chances of a true allergy.  
Importantly, in our study there was no evidence of parasitaemia or reactivity with cross-reactive 
carbohydrate determinants causing false positive sensitisation in the Xhosa group in comparison to 
the mixed race group.6 Moreover, SPT reactivity and peanut component reactivity were high amongst 
our Black participants, unlike findings from other regions which suggest low SPT positivity but high 
specific IgE reactivity to whole peanut amongst the Black population.7 
Egg allergy was the most common allergy overall (25%) and peaked in the younger age group under 
the age of 2 years. As a screening test for egg allergy, the SPT to raw egg white was 100% sensitive, in 
comparison to the SPT to egg extract which was 80% sensitive and thus missed 20% of cases of egg 
allergy. Moreover, In prediction of egg allergy in the population overall, SPT to fresh raw egg white 














Egg component pattern analysis was similar between ethnic groups, and found that egg-sensitised 
patients, Gal d 1 (ovomucoid) was the most common component, followed by Gal d 3, Gal d 5 and     
Gal d 2. In differentiating egg allergy from tolerance in egg-sensitised patients, the component Gal d 
1 gave best results with the highest ROC area under the curve. The higher the number of egg 
components positive, i.e. the greater the epitope diversity, the greater was the chance of egg allergy. 
Widely used 95% PPV cut-offs for SPT to egg as well as ImmunoCAP4,8 to egg white performed sub-
optimally in this population, more so in the Xhosas, and may need to be revised. 
The prevalence of cow’s milk allergy was surprisingly low (2%) in comparison to cohorts from 
westernised countries. This may reflect the higher median age of our study population (42 months, by 
which time many children have outgrown their cow’s milk allergy) or it may truly indicate that IgE-
mediated cow’s milk allergy is less common in the South African population, and deserves further 
investigation. SPT to fresh cow’s milk was superior to cow’s milk extract in the diagnosis of cow’s milk 
allergy, and was 100% sensitive for cow’s milk allergy, whilst SPT to cow’s milk extract was negative in 
both cases of cow’s milk allergy. Therefore, in the case of both egg and cow’s allergy screening, SPT to 
fresh raw egg white and fresh milk should be included in the screening panel of SPTs. Widely used 95% 
PPV for SPT and ImmunoCAP cow’s milk4,8  fared poorly in this population and may need to be 
investigated in large population studies in infants and young children.  
Allergic co-morbidity was significant, with 39% of children reporting symptoms of asthma, and 53% of 
children reporting symptoms of allergic rhinitis. 89% of participating patients were sensitised to at 
least one aeroallergen, and over 80% to a house dust mite species. Sensitisation to house dust mite, 
cat and dog allergens already peaked by 2 years of age. Sensitisation to grass and tree pollen increased 
with age and was associated with an increased risk of asthma and allergic rhinitis. Asthma controller 
medications and intranasal corticosteroids for allergic rhinitis were underused, which is concerning in 
view of the fact that poor asthma control can increase the risk of severe food allergy reactions. 
Epicutaneous sensitisation to food as well as aeroallergens is a result of the defective skin barrier in 
eczema, which should be addressed at an early stage in order to try and dampen the progression of 
the allergic march.  
In this cohort of patients with atopic dermatitis, consumption patterns of complementary feeding did 
not differ significantly between ethnic groups. However, there was a trend towards late introduction 
of certain allergenic foods, especially peanut, which was introduced at a median age of 18 months (24 
months in Xhosa, 12 months in mixed race group). This introduction of peanut is more conservative 
than in a previous study amongst Xhosa patients,9  in whom peanut has traditionally been a commonly 














an increase in allergy rates have led to several studies which are currently investigating the ideal time 
of solids introduction, including amongst high-risk patients with eczema.7  Results of these studies are 
awaited, and will allow us to advise our patients more appropriately on the optimal time of solids 
introduction.  
The ImmunoCAP ISAC test has many advantages in terms of small volume of blood required, multiple 
food and aeroallergen components tested simultaneously and identification of co- and cross reactivity 
patterns.10 However, we found it to be less sensitive in the diagnosis of food allergy than skin prick 
tests and traditional ImmunoCAP tests, and it missed 15% of cases of food allergy. Thus, the skin prick 
test has proven to be an excellent screening test for food allergy, and more complex and costly tests 
such as the ISAC test should be reserved for those with complex or multiple allergies.  
Co-existing food allergies in children with moderate to severe AD are currently being underdiagnosed 
in South African children, and co-ordinated interaction between dermatology and allergy clinics is 
needed. In this study, 47% of patients required at least one food challenge to correctly identify their 
allergies, therefore, a full allergy service offering food challenges is needed as part of a 
multidisciplinary team offering comprehensive care for atopic children.  
The unexpectedly high prevalence of food allergy in this cohort of South African children has led to 
the concern that food allergy may be on the increase in South Africa, amongst all ethnic groups, and 
that the local buden of food allergy may be significant. Although this cannot be extrapolated to an 
unselected population, the general trend amongst allergy clinics in South Africa, including Red Cross 
Hospital, has been an increase in case load of food allergy patients over the past 5-10 years.11 In 
addition, previously rare food allergy manifestations such as eosinophilic oesophagitis have been 
increasingly identified in South Africa in the past few years.12 
Indeed food allergies may also be on the increase in other African countries.  In a recent study in 
Ghanaian school children, 11% of 1407 children reported adverse reactions to foods, and 5% of 1431 
children showed positive SPT reactivity.13   Food challenges were not performed as part of this study. 
Protective and aggravating factors which affect allergy expression, possibly by epigenetic mechanisms, 


















12.2   What Factors Could be Driving an Increase in Food Allergy in South Africa?  
Food allergy is usually associated with other atopic disorders and hence likely shares many common 
risk factors. However, unique food allergy considerations such as the delay between the “respiratory 
allergy” epidemic and the “food allergy epidemic”, the potential life-threatening nature of food allergy 
and related public health measures make the identification of specific risk factors a priority. Two 
factors which deserve further mention in allergy causation are early life influences, and migration of 
populations. 
12.2.1  Early life influences 
The distinct sequence of the allergic march suggests that certain individuals are prone to manifesting 
their atopic conditions under the influence of environmental factors within a particular timeframe. 14   
Expression of food allergy in very early infancy dictates that early post-natal events and likely antenatal 
events play a critical role in abrogating the normal default response of tolerance to food allergens. 15 
Factors which could play a role in the expression of food allergy include:14,16,17 
1. Allergen exposure 
2. Gut microflora 
3. Gastric acid 
4. Changes in diet 
5. Infections 
6. Eczema and other atopic conditions 
7. Genetic and epigenetic factors 
12.2.2   Migrant Populations 
The rapid urbanisation, adoption of a westernised lifestyle and diet in South Africa simulate the 
characteristics of a large “migrant” population. In migrant populations, the change in environment 
and lifestyle may affect genotype expression, thus leading to the manifestation of an allergy. Three 
factors are important in migrant populations: 18   
1. The population must have an innate genetic predisposition to development of allergies 
2. Environment or lifestyle factors in their place of birth actively prevented/ suppressed  the 
expression of allergy 
3. Exacerbating factors in an altered environment actively allow the genetic potential for allergy 














The following section discusses some of the factors influencing the expression of allergy and their 
change in South Africa over the last decade or two. 
12.2.3 Factors influencing the expression of allergy 
12.2.3.1 Allergen Exposure 
Whether a person becomes sensitised or tolerant to an allergen depends on multiple factors such as 
the timing, dose, route of exposure and possibly the nature of the allergen.19   Allergen exposure via 
the inhaled or cutaneous route may abrogate the tolerance normally afforded via gut exposure.  
There seems to be a window of opportunity for optimal allergenic solid food introduction between      
4-6 months of age. Delayed introduction of allergenic foods such as wheat, egg and cow’s milk has 
been associated with higher risk of food allergy in some studies.20,21   
In South Africa, patterns of utilisation, consumption and exposure of foods need to be explored in 
depth as urbanisation occurs. Consumption patterns, for example with peanut, may be changing.  
Furthermore, the presence of potentially allergenic food components in non-food items, such as 
peanut oil in emollients, need further clarification. 
12.2.3.2  Gut Microflora 
There is a delicate balance between bacteria and the immune system. Early colonisation of the 
intestinal tract by appropriate microbiota is important for healthy maturation of the immune system, 
especially appropriate programming of oral tolerance to dietary antigens.22,23   Differences in certain 
bacterial populations between allergic and non-allergic infants have been noted.24   
In South Africa, an increase in the rate of caesarian sections, changing diet in childhood, more frequent 
use of antibiotics and a changing maternal intestinal microbial milieu could all impact on a child’s 
microflora. Much of the microbiome may be shaped by early exposures to environmental soil/dust by 
hand to mouth transmission (personal communication Christine Cole, Detroit USA).  As the 
environmental dust and maternal microflora change in a migrant population, so too does the 
microbiome of children, which may affect immune responses to allergens.  
12.2.3.3  Gastric Acid 
Most food allergens are susceptible to acid digestion in the stomach. This has raised the concern that 














Indeed, the increasing use of anti-acids in young babies with presumed gastro-oesophageal reflux 
disease has paralleled the rise in food allergies.25   
12.2.3.4 Changes in Diet 
In African countries, considerable changes in diet have occurred. Notably, the intake of plant foods 
has diminished, with increasing ingestion of animal products, and a decrease in fibre intake.26 Anti-
inflammatory immunomodulating factors in the diet such as prebiotics, fat soluble vitamins and 
polyunsaturated fatty acids may be reduced in westernised diets, making them more 
“inflammatory”.27   An increase in “fast food” consumption is a concern: the ISAAC study (International 
Study on Asthma and Allergy in Children) showed that consuming 3 or more portions of fast food per 
week increased the risk of asthma significantly, whilst fruit consumption more than 3 times a week 
was protective.28 
Large urban-rural differences in diet do not only affect allergen exposure to food allergens, but have 
been found to affect skin sensitivity to common aeroallergens; in other words they can shift the entire 
allergic “make up.”29 
The influence of maternal diet during pregnancy and lactation on allergy expression in the infant 
remains controversial and under study. 
12.2.3.5   Burden of Infection 
Developing countries including South Africa are frequently plagued by poor sanitation and housing, 
overcrowding and lack of access to clean water.  It seems that early exposure to such environments 
with high microbial and endotoxin levels, can be protective against allergic conditions (the hygiene 
hypothesis).30 However, the degree of protection depends on the intensity and timing of the 
infections. 
Certain helminthic infestations may protect an individual from allergic predisposition by mechanisms 
that are incompletely understood. These may include IL-10 related suppression of the allergic 
response.31    
In South Africa, the intensity of infection exposure may be lessening with urbanisation, more ready 
access to medical treatment and smaller family size. In addition, helminthic infections are treated 














An interesting theory is that the increase in allergic burden in Black Africans may be even more 
dramatic as parasitic infections could have primed the immune system for IgE responses.30,32 
12.2.3.6   Genetic Factors 
A family history of atopy is a strong risk factor for developing atopic diseases later in childhood. Rising 
rates of maternal allergy, which is a strong direct determinant of allergic risk, may have implications 
for allergic burden in generations ahead. 15  
The rapidity of the increase in food allergies worldwide suggests that epigenetic changes modify 
disease expression under the influence of environmental changes.  Epigenetic changes may be 
heritable, and even amplified across generations.  It has been suggested that the new generation of 
food allergy patients is more likely to have a more severe or persistent clinical course. 15 
Moreover, evidence suggests that development of allergy in non-White populations is heightened in 
a westernised environment, over and above that of the local western population.32,33  This suggests a 
strong genetic propensity that is amplified in a western environment. This is of particular concern in 
the Black South African population as urbanisation and movement away from traditional lifestyles 
occur.  
12.3 Future Directions 
The results of this study suggest a significant burden of food allergy in South Africa. As opposed to 
other allergic conditions, when considering food allergies, a critical time and dose of the food, in 
conjunction with the delicate balance between exacerbating and protecting factors are vitally 
important.  The question remains as to whether there are as yet unidentified factors influencing the 
food allergy epidemic, or whether it is simply an amplification of allergic manifestations from one 
generation to the next. 
Following the surprising burden of food allergy revealed by this study, we have now embarked on a 
large food allergy prevalence study in an unselected population of 1-3 year olds in South Africa.34 The 
aim is to examine rural-urban differences and ethnic patterns in food allergy prevalence. The results 
of this forthcoming study will provide important data on the possible food allergy epidemic in South 
Africa, allowing more targeted and informed planning of healthcare services. Moreover, by exploring 
factors which may influence the current food allergy epidemic, we hope to identify early determinants 
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